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Abstract 
 
 
 
Conjugates of phenols with biological thiols have recently received increasing interest 
because of their peculiar properties in most cases enhanced or significantly modified 
with respect to the parent phenols. 
Main focus of the research activity developed in this PhD work was the 
chemistry of thioalkyl conjugates of catechols, among these cysteinyldopas, mainly the 
5S and 2S isomers, that are produced by epidermal melanocytes of man and other 
mammals and are involved in the biosynthesis of pheomelanins, the characteristic 
pigments of red hair, commonly implicated in the abnormal susceptibility of red haired 
fair complexioned individuals to sunburn and skin cancer. Overall the results of this 
work have greatly contributed to the definition of the structure, biosynthesis and 
functional significance of pheomelanins.  
Traditionally pheomelanins have been regarded to arise primarily via the 
oxidative polymerization of 5-S-cysteinyldopa (5SCD). Yet, it was observed that, in 
addition to 5SCD, 2-S-cysteinyldopa (2SCD) is an important building block of red 
human hair pigments. By an improved analytical procedure, allowing simultaneous 
determination of benzothiazole markers, BTCA and 2-BTCA, originating from 
oxidative degradation of 5SCD- and 2SCD-derived units respectively, evidence was 
obtained that the pigment suffers extensive degradation during hair growth affecting 
mainly the 5SCD-derived components, whereas the 2SCD-derived units remain largely 
unaffected. Model studies suggested that structural degradation occurs during hair 
growth probably as a result of oxidative processes related in part to sun exposure.  
Detailed studies on the properties of synthetic pheomelanin from 5SCD showed 
that the pigment is an efficient redox cycler, promoting oxygen-dependent 
polycatechol(amine) formation and deposition of eumelanin-like antioxidant coatings. 
Scanning electron microscopy coupled with chemical analysis of the material revealed a 
eumelanin-like coating completely masking the pheomelanin component. The system 
provides a new explanation to the origin of the casing architecture of human melanin. 
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The benzothiazoles BTCA and 2-BTCA turned out to be important and selective 
markers for pheomelanin quantitation in tissues and identification of red-haired 
individuals
 
at high risk for skin cancer. A straightforward synthetic procedure for large 
scale preparation of these compounds was developed which might allow their use for 
routine population screenings, and for genetic and epidemiologic correlations studies.  
The presence of benzothiazole compounds was also investigated in the urine of 
patients with melanoma with or without diffuse melanosis, a rare condition which may 
occur in metastasizing melanoma and is associated with a very poor prognosis. The 
urinary BTCAs were found to be highly associated with melanosis. Moreover, analysis 
of the pigmented fraction of urine after oxidative degradation provided evidence for the 
presence of pheomelanins at high levels in patients with melanosis. This finding 
provided for the first time a direct evidence that benzothiazoles are pheomelanin 
metabolites, whose formation is associated with advanced stages of melanoma.  
Due to the unfavourable chemical and physical properties of pheomelanins, their 
structure is still mainly unknown. Biomimetic oxidation of the pheomelanin precursor 
5SCD led to the isolation of two unprecedented 
benzothiazolylthiazinodihydroisoquinoline dimers. Although the existence of 
isoquiniline-containing structural motifs in pheomelanins has long been postulated, this 
study was the first to demonstrate their presence in red hair and to uncover possible 
precursor compounds and formation mechanism. 
As part of studies on thiol-quinone coupling as a viable biomimetic access to 
novel bioactive compounds for practical applications, the reaction of dihydrolipoic acid 
(DHLA), a strong endogenous antioxidant, with p-naphtoquinones was examined, 
leading to the identification of novel dithiepines arising from ring expansion of an 
unstable spirocyclic dithiane. In addition new conjugates of DHLA with naturally 
occurring polyphenols, such as hydroxytyrosol, caffeic acid and piceatannol, were 
prepared, which showed higher antioxidant power than the parent catechol, as 
evidenced by the higher H-donating ability and the tendency to oxidation at 
physiological pHs. 
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1. Introduction 
 
 
 
1.1 . Thioconjugated polyphenol metabolites: cysteinyldopas and 
pheomelanin pigments  
 
 
1.1.1. Melanin pigments: classification and origin  
 
The pigments responsible for the carroty to fire-red hues of hair, which are commonly 
found in Celtic populations, have ever stimulated the curiosity of investigators as 
representative members of the very limited group of animal pigments. In recent years, 
interest in these pigments has been renewed by epidemiological and clinical data 
pointing to the association of a fair complexion and red hair in Caucasians with an 
abnormal susceptibility to actinic damage and skin cancer.
1,2
 The biogenetic relationship 
with the other more widely diffused group of epidermal melanin pigments, determining 
black pigmentation was first recognized in the 1960s by Prota and Nicolaus
3
 who 
proposed that red hair pigments might be formed in vivo by some deviation of the 
normal course of melanogenesis involving cysteine, which would have explained the 
common origin of dark and red melanins in melanocytes. Once the biogenesis was 
definitely assessed, the red hair pigments were named pheomelanins, to indicate that 
they represented a lighter variant (ς: dusky) of the dark melanin pigments, 
thereafter termed eumelanins (: good; ς, black).4 
Spurred in part by the observation that these two types of melanin react differently – 
eumelanin acts as a photoprotective anti-oxidant while pheomelanin exhibits phototoxic 
pro-oxidant behavior – there is an increasing research effort to understand the molecular 
structure of melanins, their organization within intact melanosomes, and how these 
structures perform biological function(s).
5
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1.1.2. Melanocytes, melanosomes and melanin 
 
Melanin biosynthesis is a complex pathway that appears in highly specialized cells, 
called melanocytes, responsible of the production of melanosomes, highly organized 
elliptic membrane-bound organelles in which melanin synthesis takes place.
6
 
Melanosomes are transferred via dendrites to surrounding keratinocytes, where they 
play a critical role in photoprotection. The anatomical relationship between 
keratinocytes and melanocytes is known as “the epidermal melanin unit” and it has been 
estimated that each melanocyte is in contact with 40 keratinocytes in the basal and 
suprabasal layers.
7
  
Melanosomes are typically divided into four maturation stages (I–IV) determined by 
their structure and the quantity, quality, and arrangement of the melanin produced (Fig. 
1).
8,9
 Nascent melanosomes are assembled in the perinuclear region near the Golgi 
stacks, receiving all enzymatic and structural proteins required for melanogenesis. Stage 
I melanosomes are spherical vacuoles lacking tyrosinase activity (the main enzyme 
involved in melanogenesis) and have no internal structural components. At this point, 
the presence and correct processing of Pmel17, an important melanosomal structural 
protein, determines the transformation of stage I melanosomes to elongated, fibrillar 
organelles known as stage II melanosomes;
9,10
 they contain tyrosinase and exhibit 
minimal deposition of melanin. At this stage melanin synthesis starts and the pigment is 
uniformly deposited on the internal fibrils, leading to stage III melanosomes. The last 
developmental stage (IV) is detected in highly pigmented melanocytes; these 
melanosomes are either elliptical or ellipsoidal. The developmental stages detailed 
above refer mainly to eu-melanosomes (containing black-brown pigments); however, 
they are quite in the case of pheo-melanosomes (containing yellow-reddish melanin), 
the only difference being that the latter remain round and are not fibrillar during 
maturation.  
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Figure 1. Schematic illustration of a melanocyte with melanosomes at the four 
developmental stages, moving toward the periphery of the cell within the dendrites. 
 
In general, highly pigmented skin contains numerous single large melanosomal particles 
(0.5–0.8 mm in diameter), which are ellipsoidal and intensely melanotic (stage IV). 
Lighter pigmentation is associated with smaller (0.3–0.5 mm in diameter) and less 
dense melanosomes (stages II and III), which are clustered in membrane-bound 
groups.
11
 These distinct patterns of melanosome type and distribution are present at 
birth and are not determined by external factors (such as sun exposure). They are 
responsible for the wide variety of skin complexions. 
The variation in skin color among various races is determined mainly by the number, 
melanin content, and distribution of melanosomes produced and transferred by each 
melanocyte to a cluster of keratinocytes surrounding it.
12
 Once in keratinocytes, the 
melanin granules accumulate above the nuclei and absorb harmful UV-R before it can 
reach the nucleus and damage the DNA. When melanin is produced and distributed 
properly in the skin, dividing cells are protected at least in part from mutations that 
might otherwise be caused by harmful UV.
13
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1.1.3. Pheomelanins as result of MC1R mutation 
 
The melanin content of human melanocytes varies not only among different skin types 
but also among different sites of the skin for the same individual. This heterogeneity is 
highly regulated by gene expression, which controls the overall activity and expression 
of melanosomal proteins within melanocytes.
14
 
The melanocortin 1 receptor (MC1R) is a 317 amino acid transmembrane G-protein 
coupled receptor member of the melanocortin family.
15
 MC1R is expressed on 
melanocyte and melanoma cells where it plays a role in pigmentation, but it is also 
expressed on a variety of other cell types relevant to skin (keratinocytes, fibroblasts,…) 
as well as in other organs (e.g. in the testis and the periaueductal grey matter in brain).
16
 
After UV-R exposure, melanocytes increase their expression of proopiomelanocortin, 
the precursor of  melanocytes stimulating hormone (-MSH).17,18 The ligand -MSH, 
via activation of MC1R, stimulates adenylyl cyclase, leading to an increase in cAMP 
(cyclic adenosine monophosphate), which in turn causes transcription of a number of 
enzymes, notably members of the tyrosinase family, important in melanin 
biosynthesis.
16
 In animals such as the mouse, overexpression of agouti, a peptide that 
acts as an inverse agonist at MC1R, results in a reduction in eumelanin production and 
an increase in the synthesis of pheomelanin.
19
 Although there is evidence that agouti 
signaling peptide, the homologue of agouti, is expressed in human skin, its role in 
human pigmentation remains unclear.
20
  
The MC1R is encoded for within a single exone of the MC1R gene on chromosome 
16q24.3. The observation by Robbins et al.
21
 that alterations in the murine Mc1r gene 
resulted in different code colours in mice led to the hypothesis that part of the variation 
of normal human pigmentation within and between populations may arise from 
polymorphisms/variants in the human MC1R gene. Several association and population 
genetic studies have shown this to be the case over 30 variants in this gene identified to 
date.
16,22
 In general, black-skinned populations have two wild-type MC1R alleles, as do 
a number of Asian and darker skins Caucasian. However, within Caucasian populations, 
a single variant MC1R allele is associated with fairer skin type and an inability to tan, 
whereas two variant MC1R alleles are associated with a red hair phenotype.
22
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Many of the reported changes, causally associated with a particular phenotype, are not 
complete loss-of-function mutations but rather show diminished function of signaling to 
varying degrees; that is, they show quantitative reduction of function rather than 
absence signaling activity. Although the number of partial loss-of-function mutations at 
the MC1R is large, three are relatively common in Northern European populations: the 
p.R151C, the p.R160W, and the p.D294H.
16,22-25
 These sequence variants are not 
however, functionally equivalent.
22,26
 
Recently the complete loss of function mutant MC1R alleles, as c.86_87insA and 
c.534_538insC, with insertion/deletion frameshift or premature stop codon, were 
studied. They are extremely rare, but Sturm et al. were able to find one case in the 
homozygote state, actually heterozygote for two rare insertions, that was the first case of 
MC1R null individual, showing red hair and fair skin.
27
  
On this basis, several studies have been focused at assessing the relationship of 
genotype with measurements of the type and amount of melanins in hair, as determined 
by quantitation of melanin markers. This approach will not only allow assessment of the 
quantitative contribution of a locus to variation, but also identification of those 
variations which have not so far been considered.
26
 
 
 
1.1.4. Structure and biosynthesis of pheomelanin 
 
Within melanosomes, at least three enzymes are definitely required to synthesize 
different types of melanin. While tyrosinase is responsible for the critical steps of 
melanogenesis, tyrosinase-related protein 1 and dopachrome tautomerase are further 
involved in modifying the melanin into different types. Besides these, melanosomes 
contain other melanocyte-specific proteins that have structural functions or probably are 
involved in regulating the pH within melanosomes. 
Eumelanin and pheomelanin both derive from the common precursor dopaquinone 
(DQ) formed by hydroxylation and oxidation of the common amino acid L-tyrosine by 
tyrosinase (Fig. 2).  
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DQ, through intramolecular addition of the amino group of the alanyl side chain and 
further oxidation steps, leads to 5,6-dihydroxyindole intermediates, which in turn give 
rise to eumelanin by oxidative polymerization.
4
 
The biosynthesis of pheomelanin proceeds through several steps at the monomer levels 
(Fig. 2). The process is initiated by the conjugation of cysteine to DQ leading to 5-S-
cysteinyldopa (5SCD) (74%) as main product, with small amount of 2-S-cysteinyldopa 
(2SCD) (14%) and other isomers.
28,29
 
Under physiologically relevant conditions, the major pheomelanin precursor 5SCD is 
converted to  cysteinyldopa-quinone (CDQ) via a redox exchange with DQ, followed by 
cyclization and dehydration of CDQ to form the ortho-quinonimine (QI).
30
 
Rearrangement with or without decarboxylation of transient QI leads to 7-(2-amino-2-
carboxyethyl)-5-hydroxy-2H-1,4-benzothiazine (BTZ) and 7-(2-amino-2-carboxyethyl)-
5-hydroxy-2H-1,4-benzothiazine-3-carboxylic acid (BTZCA).
31-33
 BTZ and BTZCA are 
the ultimate monomer precursor of pheomelanin. Before being incorporated into 
pheomelanin, a minor part of the benzothiazines may undergo a structural modification 
to form 7-(2-amino-2-carboxylethyl)-5-hydroxy-3-oxo-3,4-dihydro-2H-1,4-
benzothiazine (ODHB) and 6-(2-amino-2-carboxyethyl)-4-hydroxy-benzothiazole (BT). 
The four monomeric units, BTZ (and BTZCA), ODHB, and BT, are eventually 
polymerized to form pheomelanin (Fig. 2).
5,33,34
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Figure 2. Eumelanogenesis and pheomelanogenesis pathways. 
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Most of the studies on pheomelanin beyond the monomer level were carried out on 
5SCD, the main precursor. In studies carried out in the nineties, the evolution pathways 
of benzothiazine intermediates were investigated by analysis of the oxidation of 5SCD 
under biomimetic conditions. The couple peroxidase/H2O2, an enzyme involved in 
pheomelanogenesis in vivo, but extremely more efficient than tyrosinase in the 
oxidation of cysteinyldopas,
31
 was chosen as oxidant system. In the early stages of the 
oxidation BTZ is mainly formed, that rapidly evolves leading to a complex pattern of 
oligomeric compounds, the major of which was isolated after reductive treatment with 
10% yields and characterized as the dimer I shown, while other minor compounds were 
identified as the related trimers II and III (Fig. 3).
35
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Figure 3. Oligomer compounds arising from oxidation of 5SCD by the peroxidase/H2O2 
couple. 
 
All the oligomeric structures are characterized by C-C and C-O bonds between the 
benzothiazine units, suggesting that the polymerization proceeds through phenolic 
coupling of aryloxy radicals generated by an initial monoelectronic oxidation of 5SCD. 
In addition to enzymatic factors some metal ions, particularly zinc and iron, are shown 
to profoundly affect the kinetics and course of fundamental steps of 
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pheomelanogenesis.
36
 5SCD is shown to form strong complexes with a series of metal 
ions including Zn
2+
, Cu
2+
, Fe
3+
, Al
3+
, Co
2+
, Cd
2+
. Some of these, and particularly the 
5SCD–zinc complex, undergoes oxidation at higher rates with respect to free 5SCD, 
leading to BTZCA.
37
  
This finding is of particular interest as it provides a clue to the formation of 
trichochromes, a group of low molecular weight pigments, isolated from red feathers, 
featuring a peculiar pH dependent chromophore, which could unambiguously be 
formulated as 2,2‟-bibenzothiazines(Fig. 4).38 
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Figure 4. Structures of trichochromes isolated from red avian feathers. 
 
Indeed, Trichochrome C, the most abundant trichochrome isolated in red hair, was 
obtained when BTZCA was allowed to stand in air in the presence of acids by the 
intermediacy of 2,2‟-bi(3-carboxy-1,4-benzothiazine), BTZCA-dimers (actually a pair 
of diasteromers), derived by coupling at two position of BTZCA (Fig. 5).
37
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Figure 5. Formation of Trichochrome C by oxidative dimerization of BTZCA in the 
zinc-catalyzed oxidation of 5SCD. 
 
 
1.1.5. Chemical degradation studies  
 
Direct investigation of the natural pigments was largely based on chemical degradation 
studies. Chemical degradation has the advantage to allow direct analysis of melanins 
from natural sources, which is different from the biogenetic type approach so far 
illustrated. Yet, exposure to the degradation agent, often an efficient oxidant in strong 
alkaline or acid media, may produce artifactual alterations of the pigment backbone 
which are reflected in the structure of the final products. This is indeed a major 
limitation unless the chemical reactivity of the monomer units of the pigment polymer 
under the degradation conditions is well characterized and taken into account in the 
structural interpretation. Thus, when combined with the results of the biogenetic studies, 
chemical degradation is a valuable tool not only for structural determination but also for 
identification of melanins in tissues. Indeed, the specificity of the degradation products 
makes isolation of the pigments from tissues generally not needed, and allows 
straightforward discrimination of true pheomelanins from pheomelanin-looking 
pigments, e.g. light brown eumelanins. 
Different useful degradation methodologies has been set up. One is the reductive 
hydrolysis with HI, which produces 4-amino-3-hydroxyphenylalanine (4-AHP) and 3-
amino-4-hydroxyphenylalanine (3-AHP).
34
  
The second one is the oxidation by alkaline hydrogen peroxide, that gives 6-(2-amino-2-
carboxyethyl)-2-carboxy-4-hydroxybenzothiazole (BTCA), thiazole-4,5-dicarboxylic 
acid (TDCA) and thiazole-2,4,5-tricarboxylic acid (TTCA) (Fig. 6).
39
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Figure 6. Main chemical degradation products of pheomelanins. 
 
An advantage of this oxidative degradation is that pheomelanin degradation products 
are produced together with degradation products arising from eumelanin, pyrrole-2,3,5-
tricarboxylic acid (PTCA) and pyrrole-2,3-dicarboxylic acid (PDCA). This allows to 
estimate relative ratios of pheomelanin to eumelanin in tissue samples (Fig. 7).
39,40
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Figure 7. Products from alkaline hydrogen peroxide oxidation of eumelanins. 
 
An intriguing, and so far overlooked, structural issue relates to the identification in an 
early seminal paper
41 
 of a series of pyridinecarboxylic acids, including pyridine-2,3,4,6-
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tetracarboxylic acid and 2-[2‟-(4‟,5‟-dicarboxythiazolyl)]-3,4,6-pyridinetricarboxylic 
acid (TPCA), by permanganate degradation of pheomelanin isolated from red chicken 
feathers (Fig. 6). This oxidative degradation lead also to TDCA and TTCA.
42
  
Identification of pyridine fragments allowed the authors to postulate the presence of 
isoquinoline units in natural pheomelanins, but this hypothesis has remained so far 
unverified (Fig. 8). In fact, pyridine-yielding units have never been demonstrated in 
human red hair pheomelanin or synthetic pheomelanins, the origin of the main pyridine-
containing degradation products has never been elucidated since the original study and 
no isoquinoline derivative has ever been isolated or detected spectroscopically in model 
chemical studies of pheomelanin synthesis.
5
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Figure 8. Proposed structural model of pheomelanin.
41
 
 
These considerations prompted us to re-examine the structure of pheomelanins. 
Furthermore more attention was given to the contribution of 2SCD, a minor 
pheomelanic precursor, in pigment construction. 
 
 
1.1.6. Casing model for mixed melanogenesis 
 
Over the past 30 years, chemical analyses have been performed that enable the 
quantification of the amount of eumelanin and pheomelanin present in a naturally 
occurring sample of melanin.
43
 These works collectively reveal that more often than not, 
natural melanin pigments consist of both eumelanin and pheomelanin in varying 
ratios.
26,44,45
 Thus, rather than focus just on the structural and functional properties of 
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pure eumelanin or pheomelanin, there is a need to understand how “mixed melanins” 
are made, and how their molecular and functional properties differ from those of pure 
melanins.
5
 
By use of  advanced technologies, in particular photoelectron emission microscopy 
(PEEM) coupled to a free-electron laser (FEL),
46,47
 it was shown that human 
eumelanosomes from black hair have a surface oxidation potential of -0.2 V vs. the 
normal hydrogen electrode. On the other hand, human melanosomes from red hair 
contain a mixture of eumelanin and pheomelanin, which is reflected by oxidation 
potentials of -0.2 and +0.5 V, respectively. Because FEL–PEEM is a surface technique, 
the results indicate that melanosomes from red hair have both types of melanin on or 
near their surface.
48
 
Wakamatsu et al. recently reported the eumelanin/pheomelanin ratios for uveal 
melanocytes isolated from eyes of varying color.
49
 A variety of spatial imaging studies 
of the melanosomes isolated from the stroma of blue-green (hazel) and dark brown 
irides, which are characterized by eumelanin:pheomelanin ratios of 1.3 and 14.8, 
respectively, were performed.
50
 The photoemission image only reveals the presence of 
eumelanin on the surface of the melanosome. 
Therefore, an explanation is needed for how eumelanin grows on pheomelanin. 
Recently a three-step pathway for the mixed melanogenesis has been proposed.
51,52
 
After DQ production, the first stage is the production of cysteinyldopas, which 
continues as long as the cysteine concentration is above 0.13 M. The second stage is 
the oxidation of cysteinyldopas to produce pheomelanin, which continues as long as 
cysteinyldopas are present at concentrations above 9 M. The third stage is the 
production of eumelanin, after most cysteinyldopas and cysteine are depleted.
53
 The 
morphological consequence of this „casing model‟ for the chemistry/biochemistry and 
time course of mixed melanogenesis is schematically represented in Figure 9, in which 
the assembly of the pigment involves a pheomelanin core surrounded by a eumelanin 
outer coat.  
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Figure 9. Schematic representation of the casing model for mixed melanogenesis. 
 
This organization has been proved for neuromelanin, a dark pigment present in the 
substantia nigra and some other regions of the brain, consisting of dopamine with some 
incorporation of cysteinyldopamine
54-56
 and iridal stroma melanosomes, both resulting 
from mixed melanogenesis, suggesting that the casing model may be independent on the 
tissue type. However, this model has still to be proved for skin and hair pigment with 
interesting consequences. Indeed, oxidative damage of the eumelanic surface could 
expose pheomelanin, which can lead to additional oxidation stress. Subsequent 
exposure of the photoreactive and pro-oxidant pheomelanin coupled to the lower total 
amount of melanin in lighter colored tissues could critically contribute to the observed 
tendency to actinic damage and skin cancers of fair complexioned individuals. 
 
 
1.1.7. Photochemical properties of pheomelanin 
 
A commonly held view is that pheomelanins may act as potent UV photosensitizers 
leading to intense production of reactive oxygen species (ROS) which contribute 
directly to the increased susceptibility of red haired individuals to actinic damage and 
skin cancer. This concept was pioneered by Chedekel et al.,
57
 and has spurred unabated 
interest in the photochemical and photobiological properties of pheomelanins.
58-61
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Experiments on congenic mice of black, yellow, and albino coat colors after exposure to 
predominantly UVB (280–320 nm) or UVA (320–400 nm) radiation have shown that 
pheomelanin had 3-fold greater specific activity in photosensitizing adjacent cells to 
caspase-3 independent apoptosis, and this occurs at a frequency greater than the 
apoptosis induced by UV absorption on DNA.
61
 
Simon and coworkers demonstrated that different molecular components may be 
involved in the transient absorption, emission and oxygen photoconsumption responses 
of pheomelanin.
62-64
 Moreover, pheomelanin-containing melanosomes from human hair 
were shown to display low photo-ionization threshold values relative to eumelanins
65
 
supporting a possible role of pheomelanins in the onset of UV-induced skin cancer in 
redheads. 
In this framework the implication of oxidant and photo-oxidant properties of 
pheomelanins in mixed melanogenesis and in the proposed casing model has not so far 
been clarified. 
 
 
1.1.8. Melanoma and melanosis 
 
Melanoma, one of the most widely spread cancers, is derived from pigment-producing 
melanocytes. There is accumulating evidence that constitutive pigmentation is highly 
involved in the development of melanoma, with the highest risk being associated with 
pheomelanic pigmentation.  
Diffuse melanosis is a rare condition which may occur in metastasizing melanoma and 
is associated with a very poor prognosis. The median survival after the appearance of 
diffuse melanosis is only about six months, with a range of a few days to one year.
66
 
The process of diffuse melanosis may involve the total skin, mucous membranes and 
internal organs, resulting in a characteristic slate-gray discoloration. The color of the 
patients' urine is dark brown when freshly voided. In 1864 the German pathologist 
Ernest Wagner was the first to describe a 30-year-old patient with a melanoma arising in 
a congenital nevus who subsequently acquired a generalized bluish-gray discoloration.
67
 
Despite various explanations for the diffuse melanosis,
67-70
 the process resulting in 
diffuse melanosis from metastatic melanoma is still unknown.
71
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The formation of cysteinyldopa in melanocytes was proven by their occurrence in 
melanoma and epidermal tissues
72
 but also in biological fluids such as urine and 
serum,
73,74
 where they are found at ratios that compare fairly well with those obtained 
during in vitro pheomelanogenesis (5:1).
29,33
 Of particular interest in this connection is 
the rise of urinary and serum levels of cysteinyldopas in melanoma patients.
74
 Studies 
carried out on thousands of patients have indicated that determination of 5SCD levels is 
a powerful tool for monitoring melanoma progression and prognosis, but it appears also 
as a sensitive and specific predicting factor of distant metastases.
75
 
BTCA obtained from oxidative degradation of 5SCD derived units
40
 proved to be a 
specific structural marker for the analysis of pheomelanin containing tissues together 
with AHPs.
76,77
 The conditions for chemical degradation and analysis of these 
compounds were recently improved by introduction of wettable octadecylsilane 
columns
39
 simpler eluents, hydrophilic interaction liquid chromatography (HILIC)
78
 and 
GC/MS analysis.
79
 Using the latter methodologies evidence was obtained for the 
presence of pheomelanin pigments in the urine of melanoma patients.
77
 
1,4-Benzothiazole compounds were obtained in melanoma patients on HI degradation 
of urinary pigments followed by ethyl chloroformate derivatization and GC/MS 
analysis.
79
 The presence of an active pheomelanogenic pathway associated with 
melanoma was also indicated by the occurrence of trichochromes in the urine of 
melanoma patients
80
 particularly when diffuse melanosis occurs in metastasizing 
melanoma.
81
 
However  the pheomelanogenic pathway associated with melanosis of melanoma is still 
poorly unknown. 
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1.2 . Thioconjugates from dietary polyphenols of plant origin 
 
 
1.2.1. Classification and occurrence of dietary polyphenols 
 
Dietary polyphenols are the most abundant antioxidants in human diets. With over 
8,000 structural variants, they are secondary metabolites of plants and denote many 
substances with aromatic ring(s) bearing one or more hydroxyl moieties. They are 
ranked into groups (Fig. 10) based on the number of phenolic rings and of the structural 
elements that connect these rings:
82
 (1) the phenolic acids with the subclasses derived 
from hydroxybenzoic acids such as gallic acid and from hydroxycinnamic acid, 
containing caffeic, ferulic, and coumaric acid; (2) the large flavonoid subclass, which 
includes flavonols, flavones, isoflavones, flavanones, anthocyanidins, and flavanols; (3) 
the stilbenes; (4) the lignans and the polymeric lignins. 
The main dietary sources of polyphenols include some common fruits, vegetables and 
beverages (fruit juice, wine, tea, coffee, chocolate and beer) and, to a lesser extent, dry 
legumes and cereals. Phenolic acids account for about one third of the total intake and 
flavonoids account for the remaining two thirds. The most abundant flavonoids in the 
diet are flavanols (catechins plus proanthocyanidins), anthocyanins, glycosylated 
derivative of anthocyanidin, present in highly pigmented flowers and fruits, and their 
oxidation products.
83
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Figure 10. Classification of dietary polyphenols. 
 
 
1.2.2. Reactive oxygen species (ROS) and bioactivities of dietary polyphenols 
 
Oxidative stress is a condition of over-production of reactive oxygen species (ROS) and 
is considered to play a pivotal role in the pathogenesis of aging and several degenerative 
diseases, such as atherosclerosis, cardiovascular disease, type II diabetes and cancer.
84-86
   
ROS are products of normal cellular metabolism and are well recognised for being both 
deleterious and beneficial species, since they can be either harmful or beneficial to 
living systems.
87-91
 Beneficial effects of ROS occur at low/moderate concentrations and 
involve physiological roles in cellular responses to noxious stimuli as, for example, in 
defence against infectious agents and in the functioning of a number of cellular 
signalling systems. 
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The harmful effect of free radicals occurs in biological systems when there is a 
deficiency of enzymatic and non-enzymatic antioxidants to readily detoxify the reactive 
intermediates or to repair the resulting damage.
88
 The excess ROS can damage cellular 
lipids, proteins or DNA inhibiting their normal function. 
Oxidative stress is the result of the metabolic reactions that use oxygen and represents a 
disturbance in the equilibrium status of prooxidant/antioxidant reactions in living 
organisms. Because of this, oxidative stress has been implicated in a number of human 
diseases as well as in the ageing process. Free radicals can be defined as molecules or 
molecular fragments containing one or more unpaired electrons in atomic or molecular 
orbitals.
92
 This unpaired electron(s) usually gives a considerable degree of reactivity to 
the species. The addition of one electron to dioxygen forms the superoxide anion radical 
(O2·
-
),
93
 which is generated mostly within mitochondria. Superoxide anion, arising 
either through metabolic processes or following oxygen “activation” by physical 
irradiation, is considered the “primary” ROS, and can further interact with other 
molecules to generate “secondary” ROS, prevalently through enzyme- or metal-
catalysed processes.
90 
Superoxide can disproportionate by action of superoxide 
dismutase to yield hydrogen peroxide (H2O2). In the presence of partially reduced metal 
ions, in particular iron, hydrogen peroxide is subsequently converted through Fenton 
and Haber-Weiss reactions to a hydroxyl radical (·OH) according to equations below:  
 
O2 
e-
O2
-. 
2O2
-. + 2H+ H2O2 + O2
H2O2 + Fe
2+ .OH + -OH + Fe3+ (Fenton reaction)
O2
-. + H2O2 
Fe3+
O2 + 
.OH + -OH (Haber-Weiss reaction)
 
 
The hydroxyl radical has a high reactivity, making it a very dangerous radical with an 
exceedingly short in vivo half-life of approx. 10
-9
s,
94
 that is near diffusion rate. Thus 
when produced in vivo ·OH reacts close to its site of formation and can interact with 
nucleic acids, lipids, and proteins. The hydroxyl radical is known to react with all 
components of the DNA molecule, damaging both the purine and pyrimidine bases and 
also the deoxyribose backbone.
90
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Oxygen consumption in peroxisomes leads to H2O2 production, which is then used to 
oxidize a variety of molecules. These organelles also contains catalase, which 
decomposes hydrogen peroxide and presumably prevents accumulation of this toxic 
compound. When peroxisomes are damaged and their H2O2-consuming enzymes 
downregulated, H2O2 is released into the cytosol which significantly contributes to 
oxidative stress.  
Additional reactive radicals derived from oxygen that can be formed in living systems 
are peroxyl radicals (ROO·). The simplest peroxyl radical is ·OOH, which is the 
protonated form of superoxide (O2·
-
) and is termed hydroperoxyl radical. It has been 
demonstrated that hydroperoxyl radical initiates the process of lipid peroxidation in 
vivo, a process that generates a variety of products including reactive electrophiles such 
as epoxides and aldehydes.
95
 
In order to cope with an excess of free radicals produced upon oxidative stress, humans 
have developed endogenous and exogenous mechanisms in order to maintain redox 
homeostasis. Among these, dietary polyphenols have been largely studied for their 
strong antioxidant capacities and other properties by which cell activities are 
regulated.
83
 
In literature several data are reported about the mechanisms with which dietary 
polyphenols exhibit their antioxidant activities.
96,97
 In particular, it was shown that they, 
thanks to the o-diphenol function, are able to chelate metal ions such as Fe
2+
 and Cu
2+
 
involved in Fenton-type oxidation processes. They can also act as hydrogen donors, 
interrupting, for example, the processes of chain propagation in lipidic peroxidation
98
 
and can act as a scavenger of radical species.
99
 
In the following sections the characteristics of the main classes of polyphenols will be 
discussed in more details. 
 
 
1.2.3. Polyphenolics of olive oil. Hydroxytyrosol 
 
Hydroxytyrosol (2-(3,4-dihydroxyphenyl)ethanol, HTYR) and related polyphenolic 
constituents of extra virgin olive oil are endowed with several biological properties that 
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may contribute to the reduced risk of cardiovascular diseases and malignant neoplasms 
in the populations of Mediterranean countries.
100-102
  
 
OH
OH
OH
OH
OH
tyrosol hydroxytyrosol  
 
The beneficial role of olive phenols in cancer prevention is ascribed to their potent 
antioxidant properties enabling them to counteract the geno- and cytotoxic effects of 
ROS generated in settings of oxidative stress.
96,97
 Extra virgin olive oil constituents can 
contribute to lower the incidence of coronary hearth diseases as well as of prostate and 
colon cancer.
100
 HTYR and related (poly)phenolic components can also inhibit the 
formation of carcinogenic and mutagenic heterocyclic amines.
103
 The scavenging 
potential of HTYR towards ROS has recently been determined.
104
 
The marked 
antioxidant properties of HTYR are also exemplified by its ability to inhibit the copper 
sulphate induced oxidation of low density lipoproteins as shown by the reduced short 
chain aldehydes formation, sparing of vitamin E and decrease of the levels of 
malondialdehyde-lysine and 4-hydroxynonenal-lysine adducts indicating protection of 
the apoprotein layer.
105
 
Another mechanism by which HTYR may exert its effects is 
metal chelation, particularly Cu
2+
and Fe
2+
 ions which are able to promote 
peroxyl/hydroxyl formation by decomposition of hydroperoxides by the Fenton and 
Haber-Weiss reactions. The ability of HTYR to chelate ferric ions accounts for the 
marked inhibition of hydroperoxide formation promoted by enzymatic and non 
enzymatic process including lactoferrin and iron in liposomes and oil-in-water 
emulsions
106
 
or hemoglobin, enzymatic NADH-iron and non enzymatic ascorbate-
iron.
107
 Free iron sequestering by HTYR may therefore represent an important route by 
which this compound exerts the documented beneficial effects towards those 
pathological conditions and chronic diseases associated with oxidative stress.
108
  
The concentration of phenols in extra virgin olive oil varies from 50 to 800 mg/Kg, with 
a mean value for commercial oil of 180 mg/kg;
97,109
 a daily consumption of 50 g olive 
oil (a mean value in the Mediterranean countries) would therefore result in an intake of 
about 9 mg of olive oil phenols per day, of which it is estimated that 1 mg is derived 
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from HTYR and tyrosol and about 8 mg from the aglycones of oleuropein and 
ligstroside. Extra virgin olive oil is also rich in the antioxidant compound -tocopherol, 
whose concentration varies between a few ppm to 350 ppm.  
 
O
O
O
OH
O
O
OH
R
R= OH oleuropein
R= H    ligstroside  
 
HTYR was reported to be absorbed by 66%: this would lead to a maximum 
concentration of 0.06 M of this compound in plasma after a 50 g intake of olive oil.109 
Although low molecular weight phenols are found in virgin olive oil, a high percentage 
is discarded in olive mill wastewaters (OMW), a by-product of the extraction process of 
olive oil. Most OMW are accumulated over a short period (typically November–
December) then spread over fields or dumped into rivers, thus causing pollution of soils 
and aquatic area. Olive phenols are partially responsible for this pollution due to their 
toxicity to plants, bacteria and aquatic organisms. Hence, chemical and biotechnological 
processes (e.g., Fenton reaction or oxidation catalyzed by fungal enzymes) have been 
developed to degrade OMW phenols. An interesting alternative could be the extraction 
of phenols from OMW and their valorization as antioxidants in the food and 
pharmaceutical industries.
110
 
 
 
1.2.4. Hydroxycinnamate compounds 
 
The total polyphenol intake has been reported to reach 1 g/d in people who eat several 
servings of fruit and vegetables per day. Hydroxycinnamate compounds, including p-
coumaric acid, ferulic acid, caffeic acid and its ester chlorogenic acid (5-caffeoyl-D-
quinic acid), are widely diffused at relatively elevated levels in various agricultural 
products and contribute significantly to the total polyphenol intake: for example, 
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chlorogenic acid is present in quantities of 3.4-14 mg/100 g fresh weight in potatoes, 60 
mg/kg in broccoli, 12-31 mg in 100 mL of apple juice, 89 mg/100 g in dry tea shoots, 
and 70-350 mg in a cup of coffee. Caffeic acid is present in fruit such as pears (19 
mg/g) and apples (1.3 mg/g), while ferulic acid is the most abundant phenolic acid 
found in wheat grain (0.8-2 g/kg dry weight).
111
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Hydroxycinnamic acids have been suggested to play a role in the apparent association 
between the regular consumption of polyphenol-rich foods and beverages and the 
prevention of inflammatory and proliferative diseases. In particular, chlorogenic acid 
reportedly prevents type 2 diabetes mellitus by inhibiting intestinal glucose 
absorption
112
 and exerts anticarcinogenic effects by attenuating injury from 
carcinogenic N-nitroso compounds and DNA damage.
111,113,114
 However, ~33% of 
chlorogenic acid is absorbed in the intact form intestinally, with the remaining 67% 
being metabolized to caffeic acid in the colon.
111
 In contrast, ~95% of caffeic acid is 
absorbed intestinally. These bioavailability data suggest that the biological effects of 
chlorogenic acid in the body would manifest after it has been metabolized to caffeic 
acid. 
Caffeic acid is a selective inhibitor for biosynthesis of leukotriene, involved in 
immunoregulation and in a variety of diseases, including asthma, inflammation and 
various allergic conditions. In addition, caffeic acid is a strong and selective activity and 
transcription inhibitor of matrix metalloproteinase, that are directly involved in human 
hepatic tumorigenesis and metastasis.
115
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1.2.5. Red wine stilbenes 
 
Resveratrol (5-[2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol) is the most well-known 
and well-characterized stilbene. Primarily found in peanuts, red wine, and grapes,
116,117
 
resveratrol is a polyphenolic phytoalexin produced by various plants in response to 
microbial attack, excessive ultraviolet exposure and disease.
118
 Currently, has been 
shown how resveratrol can act as a potent anti-inflammatory, anti-cancer and 
chemoprotective agent.  
 
OH
OH
OH
OH
OH
OH
OH
resveratrol piceatannol  
 
Stilbenes (diarylethenes) exist as stereoisomers in E and Z forms, but naturally 
occurring stilbenes exist in the E (trans) form. Research has revealed the E form to 
exhibit more potent activity compared to the Z form across various anti-cancer and anti-
oxidant assays.  
Studies of structure-activity relationships indicate that the antioxidant activity of 
resveratrol stems from the peculiar oxygenation pattern on the planar stilbenic skeleton, 
featuring as a crucial determinant of the radical scavenger activity the 4‟-OH group, 
synergistically supported by the 3- and 5-OH groups on the resorcin moiety. The 
efficiency of the 4‟-OH group as a hydrogen donor is enhanced by the trans double 
bond, which increases both its acidity
 
and the resonance stabilization energy of the 
phenoxyl radical derived from H-atom abstraction.
119,120
 
Based on encouraging therapeutic evidence, resveratrol research has fuelled a great deal 
of interest in characterizing structurally similar stilbene compounds and in synthesizing 
modified stilbenes substituted with various functional groups. Among these one of the 
best known is piceatannol (4-[2-(3,5-dihydroxyphenyl)vinyl]benzene-1,2-diol).  
Piceatannol is synthesized in response to fungal attack, ultraviolet exposure, and 
microbial infection. Induction of piceatannol synthesis is also evident during the 
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ripening of grapes and increases during the fermentation process of wine production due 
to β-glucosidase activity of bacteria. Constitutive piceatannol has also been identified in 
white tea, sugar cane, rhubarb, and some varieties of berries.
121
 
Resveratrol and piceatannol have been detected in red wine and have long been 
associated with cardioprotection. The “French paradox” was described as an anomaly in 
which southern French citizens, who smoke regularly and enjoy a high-fat diet, boast a 
very low mortality rate of coronary heart disease. Scientists have attributed this unlikely 
relationship to moderate consumption of the anti-inflammatory and anti-oxidant 
polyphenolic compounds, such as piceatannol and resveratrol, in red wine.
122,123
 
Piceatannol and resveratrol have been shown to elicit a number of cardioprotective 
activities including inhibition of low-density lipoprotein (LDL) oxidation, mediation of 
cardiac cell function, suppression of platelet aggregation, and attenuation of myocardial 
tissue damage during ischemic events.
83
  
It has been estimated that the concentration of resveratrol in wine ranges from as little 
as 0.2 mg/L up to 10.6 mg/L, depending largely on grape type and environment while 
that of piceatannol is about 0.45 mg/L.
124
 
One study employing human liver microsomes found that trans-resveratrol metabolism 
produces two main metabolites, with one being piceatannol. The rate of resveratrol 
hydroxylation forming piceatannol was rapid, leading investigators to postulate that 
resveratrol may act as a pro-drug for production of piceatannol and other stilbenes.
125
  
Piceatannol is an antagonist of the aryl-hydrocarbon receptor, implicated in dioxin 
toxicity. Due to its estrogen structural similarity piceatannol acts as a selective estrogen 
receptor modulator in human breast cancer cell lines.
 
Further investigations revealed 
piceatannol to be a potent superoxide scavenger. Recent researches have shown 
piceatannol to be a more effective scavenger of nitric oxide and hydrogen peroxide and 
significantly more potent in inhibiting Cu
2+
 induced lipid peroxidation in low-density 
proteins compared to resveratrol. It is commonly believed that the additional hydroxyl 
group of piceatannol makes it more reactive and is therefore a more potent free radical 
scavenger compared to resveratrol.
83
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1.2.6. Thioconjugates of polyphenols with dihydrolipoic acid 
 
In the field of antioxidants research, development of new antioxidants with enhanced 
activity and lower toxicity is highly desirable for the prevention and/or treatment of a 
number of diseases and, in food chemistry, for better food preservation.  
In particular recent efforts are direct to the preparation and properties evaluation of 
thioconjugates of polyphenols from natural sources.  
It was shown that conjugation of cathechins with cysteine generates compound with 
higher antiradical capacity and enhanced neuroprotective activity than their 
underivatised counterparts.
126
  
In a recent paper it was elucidated that the presence of an alkylthio group in para-
position of phenolic systems produces a marked enhancement of the chain breaking 
antioxidant activity, by decreasing the bond dissociation enthalpy of the OH group and 
affecting the reaction rate with peroxylic radicals.
127
 Nevertheless, it is not yet clear the 
effect of an alkylthio group in ortho-position of phenolic systems on their antioxidant 
activity and on the reactivity of ortho-catechols. 
All naturally occurring antioxidant are strongly hydrophilic and this makes their 
incorporation into fat and oil matrices difficult. To overcome this problem in recent 
years preparation of lipophilic antioxidants from natural sources, as clovamide 
derivatives, poly(lauroyl(+)-catechin)s or hydroxytyrosol fatty acid esters, as the 
hydroxytyrosol acetate, palmitate, oleate and linoleate has largely been pursued.
128-130
 
Yet, improvement of the antioxidant activity of polyphenols through modification of the 
catecholic nucleus has scarcely been pursued, the only derivatives so far prepared being 
esters at the phenolic or alcoholic functionality.  
With this in mind new experiments were directed to the synthesis of a new derivative of 
polyphenols by conjugation with dihydrolipoic acid (DHLA) and evaluation of its 
antioxidant properties.  
Lipoic acid (1,2-dithiolane-3-pentenoic acid, LA) and its reduced form dihydrolipoic 
acid (DHLA) are naturally occurring compounds. 
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LA has long been known as a coenzyme of multienzymatic mitochondrial complexes 
catalyzing oxidative decarboxylation of α-ketoacids.131 Therapeutic action of LA is 
based on unique antioxidant properties of LA/DHLA system, which possesses one of 
the lowest standard biological redox potentials (E0=-0.29 V). Thus, DHLA is able to 
reduce not only ROS but also the oxidized forms of other antioxidant.
132
 It is worth 
remembering that LA has antioxidant properties as well. Owning to its easy absorption 
from the gastrointestinal tract and ability to cross the blood-brain barrier, exogenous LA 
can reach the majority of tissues. Moreover, LA and DHLA are easily soluble both in 
fats and water, which is a unique features among antioxidants, and are therefore active 
both at membrane level and in aqueous phases of cytoplasm.  
Due to its unique properties, LA has also been administered in the treatment of various 
oxidative stress related diseases such as alcoholic liver disease, heavy metal poisoning, 
mushroom poisoning, diabetes, glaucoma, ischemia/reperfusion injury of heart and 
neurodegenerative disorders.
133
 The most important exogenous source of LA are 
potatoes, spinach and red meats.  
Examples of conjugate of DHLA with polyphenols have been reported in literature e.g. 
the 5-S-lipoyl-DOPA, obtained by the reaction of DHLA with 3,4-
dihydroxyphenylalanine (DOPA), which was found to act as inhibitor of DOPAchrome 
formation, with possible applications as depigmentating agent for skin.
134
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2. Results and discussion 
 
 
 
2.1. Isomeric cysteinyldopas provide a (photo)degradable bulk 
component and a robust structural element in red human hair 
pheomelanin 
 
 
Traditional models of pheomelanogenesis postulated a major involvement of 5SCD in 
pigment build-up, whereas 2SCD was usually dismissed as a minor side product in the 
process. Borges et al.,
135
 however, recently analyzed melanin composition in various 
human hair samples using 4-AHP and 3-AHP as markers, and reported that the 
pheomelanin component of the total melanin pool consisted mainly of 2SCD-derived 
units, up to 80%. Though apparently confirmed in subsequent studies,
76
 this observation 
passed virtually unnoticed because of the questionable reliability of 3-AHP as a marker 
of 2SCD due to a possible background contribution from 3-nitrotyrosine in proteins. 
 
2.1.1. Identification of a new structural marker  
 
Analysis of red hair was carried out according to a recently improved procedure based 
on alkaline hydrogen peroxide degradation of pheomelanin followed by HPLC 
determination of BTCA, a marker of 5SCD-derived units.
40
 The peak area ratio at 254 
and 280 nm (A(280)/A(254) for BTCA = 0.6) was a valuable parameter for reliable 
identification of this structural marker even in the most complex degradation mixtures. 
Figure 11 shows HPLC/UV traces of degradation mixtures from red human hair and 
isolated pheomelanin from red human hair, as well as black human hair and albino hair 
as controls. Inspection of the chromatographic trace from red hair revealed the 
formation, besides BTCA (RT 52 min), of an additional major peak (RT 45 min) not 
detectable in black and albino hair samples. This component was also well 
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distinguishable in the pigment isolated from red human hair by a mild proteolytic 
procedure.
39
 Both peak area ratio (A(280)/A(254)= 0.6) and pseudomolecular ion peak 
of the product by LC-MS analysis with electrospray ionization in the positive ion mode 
(ESI+) ([M+H]
+
, m/z= 283) were identical to those of BTCA, suggesting an isomer. 
 
 
 
Figure 11. HPLC/UV (254 nm) traces of the degradation mixtures of black human hair 
(A), red human hair (B), pheomelanin isolated from red human hair (C), and albino 
human hair (D). Elutographic profiles are shown with different intensities. 
 
On this basis, a likely candidate was a benzothiazole carboxylic acid arising from an 
isomeric cysteinyldopa. To check this hypothesis, a synthetic pheomelanin from 2SCD 
was prepared by tyrosinase catalyzed oxidation of 2SCD under oxygen with catalytic 
dopa.
136
 The pigment thus obtained was subjected to chemical degradation with 
H2O2/NaOH. HPLC analysis of the reaction mixture (Fig. 12) indicated the presence of 
the same peak found in red hair mixtures, but no detectable BTCA. Moreover, the peak 
was clearly missing in the oxidation mixture from 5SCD and was much lower in 
synthetic pheomelanin from dopa and cysteine. 
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Figure 12. HPLC/UV traces of the degradation mixtures of a synthetic pheomelanin 
from 2SCD (A), 5SCD (B) and dopa + cysteine (C). Elutographic profiles are shown 
with different intensities. 
 
The product eluted under the unknown peak was then isolated by oxidative degradation 
of a large sample of synthetic pheomelanin from 2SCD and was identified as 7-(2-
amino-2-carboxyethyl)-2-carboxy-4-hydroxybenzothiazole (2-BTCA) by extensive 
spectral analysis (Table 1). 
 
Table 1. 
1
H and 
13
C
 
NMR data (D2O/DCl) of 2-BTCA.  
  
S
N
NH
2
OH
COOH
COOH
1
2
3
4
5
6
7
7a
3a
 
 
 
 
 
 
 
 
 
           
 *Chemical shift values are given in ppm. 
 
 
The identity of the 2-BTCA with the species eluted under the new peak in the red hair 
degradation mixture was secured by LC-MS with single ion monitoring (SIM) detection 
 H (multiplicity, J, Hz)* C* 
2  158.0 
C-2-COOH  163.2 
3a  142.4 
4  151.9 
5 6.65 (d, 8.0) 114.2 
6 7.13 (d, 8.0) 132.6 
7  120.5 
7a  139.6 
-CHCH2 3.11 (dd 15.2, 10.4) 
3.38 (dd 15.2, 4.4) 
36.8 
-CHCH2 4.50 (dd 10.4, 4.4) 54.4 
-CHCOOH  172.4 
0 
0 
10 20 30 40 50 min 
50 
100 
mAbs 
C 
A 
B 
B
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(Fig. 13). The identification of 2-BTCA by degradation of isolated, partially purified 
natural pheomelanin and its lack in control experiments on white hair (Fig. 11) and pure 
2SCD would rule out any artifactual formation from free 2SCD into the pigment 
sample.  
 
 
 
Figure 13. LC-MS profiles with SIM detection at m/z 283 of the degradation mixtures of 
a synthetic pheomelanin from 2SCD (A) or 5SCD (B) and of pheomelanin isolated from 
red human hair (C). Elutographic profiles are shown with different intensities. 
 
The structures of BTCA and 2-BTCA and their relationships with 5SCD- and 2SCD-
derived structural components are illustrated in Figure 14. 
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Figure 14. Origin of BTCA and 2-BTCA from degradation of 5SCD- and 2SCD-derived 
units in pheomelanin. 
 
2-BTCA, as novel structural marker of pheomelanins, does not suffer from the afore 
mentioned ambiguities related to 3-AHP determination,
76
 and provides definite 
evidence of the involvement of 2SCD in pheomelanogenesis. 
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2.1.2. Pheomelanin analysis 
 
The simultaneous determination of BTCA and 2-BTCA was assessed through a series 
of control experiments with a view to setting up an improved methodology for 
pheomelanin analysis. It was shown that 1) the rate of formation of BTCA and 2-BTCA 
are comparable under the degradation conditions adopted, and plateau after 24 h in line 
with results of previous studies
40
 (Table 2); 2) exposure of BTCA and 2-BTCA at 250 
M to the degradation conditions resulted in a comparable decay of about 30% after 24 
h; 3) oxidation of 5SCD and 2SCD gives the corresponding pigments in similar yields 
(approx 60% on a w/w basis), indicating the same degree of conversion to pigment 
polymers; and 4) the amounts of BTCA and 2-BTCA obtained by hydrolytic treatment 
of synthetic pheomelanins from 5SCD or 2SCD under non-oxidative conditions that is 
on exposure to 1 M sodium hydroxide with exclusion of oxygen for 24 h did not exceed 
15% of those obtained under the standard degradation conditions. No significant 
reactivity of either BTCA or 2-BTCA was observed under different oxidation 
conditions including prolonged exposure to oxygen at alkaline pHs and ferricyanide 
oxidation. 
 
Table 2. Yields of formation of BTCA and 2-BTCA from 5SCD and 2SCD 
pheomelanins, respectively  at different degradation times. 
 
 
 
 
 
 
 
 
 
 
 
*Shown are the mean values for three separate 
experiments with SD ≤ 10%. 
 
On this basis, pheomelanin containing tissues of different origin and a synthetic sample 
were analyzed with the novel methodology. For comparison, pheomelanin analysis was 
repeated on the same samples using the classic reductive method based on HI reduction 
Time (h)  Yields (g/mg)*    
 BTCA 2-BTCA 
1 71 85 
5 119 131 
10 137 145 
24 151 165 
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followed by determination of 4-AHP and 3-AHP as markers of 5SCD and 2SCD 
derived units, respectively.
76
 
Data in Table 3 show that all natural pheomelanins provide in addition to BTCA 
substantial amounts of 2-BTCA. Recessive and lethal yellow mouse hair, chicken 
feathers and synthetic dopa-cysteine pheomelanin gave yields of BTCA and 2-BTCA at 
ratios that reflected the formation ratio of 5SCD to 2SCD as observed by tyrosinase 
oxidation of dopa in the presence of cysteine.
29
 By contrast, the yields of BTCA and 2-
BTCA from red human hair were in an approximate 1.5:1 ratio. 
 
Table 3. Yields of degradation products from pigmented tissues and synthetic pigments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                           a
Shown are the mean values for three separate experiments  
with SD ≤ 10%. 
b
 The sample was taken from the tip of the lock 
at about 7 cm from the scalp. 
 
A key to the “anomalous” BTCA/2-BTCA values from human hair came from analysis 
of a very short red hair sample (ca. 5 mm from scalp) which gave a BTCA/2-BTCA 
ratio close to 5:1 differently from the hair sample shown in the Table 3 that was taken 
from the tip of the lock at a distance of about 7 cm from the scalp. On the other hand 
murine hairs (approximately 1 cm long ) were analysed as a whole. Based on this 
observation BTCA and 2-BTCA values were determined in different segments of red 
hair locks taken at various distances from the scalp from 19 subjects. 
Sample Yields (ng/mg)
a
 
 BTCA 2-BTCA 4-AHP 3-AHP 
Red human 
hair 
b
 
600 420 600 330 
Recessive 
yellow mouse 
hair 
4000 830 1370 380 
Lethal yellow 
mouse hair 
3200 700 1640 480 
Chicken 
feathers 
7700 1400 3100 840 
Dopa/cys 
pheomelanin 
285500 51000 205000 32500 
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The results, summarized in Figure 15, showed in all cases in spite of a significant 
individual variability an abrupt drop of BTCA yields on passing from the segment near 
the root to the tip of the hair, whereas 2-BTCA values remained virtually constant 
throughout the entire hair length. Such trend was well apparent in a representative long 
(ca 30 cm) red hair lock (see Inset in Figure 15). 
 
 
 
Figure 15. Yields of BTCA (left) and 2-BTCA (right) from degradation of different 
segments of hair locks taken at various distances from the scalp for 19 red haired 
individuals. ▲ = 25th percentile; ♦ = median; ■ = 75th percentile; horizontal bars = 
minimum and maximum values. (Inset) BTCA (■) and 2-BTCA (∆) yields from 
degradation of 4 cm segments of a representative red hair lock. Values on the x axis 
refer to the distance from scalp of the start of each segment. 
 
Analysis of 4-AHP and 3-AHP showed a closely similar trend. Figure 16 compares the 
yields obtained for the four markers in a hair lock long enough to allow obtaining 
segments at very different distances from the scalp. A significant decrease of the yields 
of BTCA and 4-AHP with increasing the distance from the scalp is observed whereas 2-
BTCA and 3-AHP yields are not changed significantly.  
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Figure 16. Yields of BTCA (black bars), 4-AHP (light grey bars), 2-BTCA (dark grey 
bars) and 3-AHP (open bars) from degradation of 4 cm-segments of a representative 
hair lock. 
 
Data for other hair samples examined are reported in Table 4 along with the yields 
obtained for TTCA, another typical degradation product of pheomelanin.
40
 Data show a 
marked increase of TTCA yields with increasing distance from the scalp, whereas the 
yields of the other markers confirm the trend observed and shown in Figure 15 and 16. 
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Table 4. Yields of pheomelanin markers from degradation of red human hair locks 
taken at various distances from the scalp. 
 
 
 
 
 
 
 
 
 
 
 
 
*Shown are the mean values for three separate experiments with SD ≤ 10%. 
 
Exposure of three locks from different individuals to intense sun light over 2 weeks (ca 
140 h exposure) resulted in a decrease of BTCA while 2-BTCA remained almost 
unchanged, with a well apparent lightening of the red color. Figure 17 shows the 
changes occurring at different distances from the scalp of a representative hair sample 
after sun exposure.  
 
 
 
Figure 17. Yields of  BTCA (black bars) and 2-BTCA (open bars) obtained by 
degradation of a representative red hair lock at (I) 1-3 cm and (II) 7-9 cm from the 
scalp before (A) and after (B) 140 h exposure to sun light. Shown are the mean values 
of experiments run in triplicate with SD ≤ 10%. 
 
Sample 
# 
Distance from 
the scalp (cm) 
  Yields 
(ng/mg)
*
 
  
  BTCA 2-BTCA 4-AHP 3-AHP TTCA 
1 1-3 618 159 1052 266 230 
 7-9 324 176 616 223 245 
2 3-6 612 421 602 331 258 
 18-20 / 335 141 196 614 
3 1-5 1239 331 1415 353 266 
 21-25 125 306 324 265 477 
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A similar trend was observed for the other two locks examined, with individual 
variability in the yields of BTCA and 2-BTCA at the root and tip of hair as apparent 
also from data of Figure 15. In all cases BTCA yields significant decreased (at least 
halving of the initial value) following solar exposure. These data confirmed the relative 
stability of the 2SCD component even under conditions favoring photodegradation 
processes. Prolonged storage of red hair samples over periods of months, on the other 
hand, did not affect BTCA and 2-BTCA values. Reproducible BTCA values were 
determined on red hair samples that had been stored in the dark for more than three 
years. 
 
 
2.1.3. Model chemical studies 
 
A vis-à-vis analysis of the oxidative conversion of 5SCD and 2SCD to pheomelanin 
was carried out with a view to gaining an insight into the different behavior of the two 
main pheomelanin components. Autoxidation in phosphate buffer at pH 9.0 was 
selected as the model reaction to compare the intrinsic reactivity of the substrates 
independent of the oxidizing system used. HPLC monitoring of the oxidation mixtures 
with substrates at 200 M showed comparable rates of substrate consumption with a 
decay > 90% after 4 h. Spectrophotometric analysis however revealed quite different 
reaction courses: whereas 2SCD gave after 2 h a broad absorption at 400 nm suggesting 
extensive benzothiazine formation and after 4 h significant melanization, 5SCD was 
poorly melanized after 4 h (Figure 18).  
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Figure 18. Spectophotometric analysis of the mixture of autoxidation of (I) 2SCD and 
(II) 5SCD at 200 M in 0.1 M phosphate buffer pH 9.0 at various times. 
 
These results clearly show that oxidation of isomeric cysteinyldopas proceeds with 
different chromophoric changes during the early phases, but leads eventually (24 h) to 
pheomelanin-like pigments with similar absorption properties.  
In further experiments 5SCD and 2SCD were allowed to autoxidize at 1:1 molar ratio 
and the pigment that separated from the mixture in the very early stages was subjected 
to chemical analysis. The results at 24 h showed a BTCA/2-BTCA ratio of 1:1 whereas 
after 72 h the ratio decreased to 0.5:1, indicating a substantial oxidative degradation of 
the pheomelanin constituents leading to BTCA. No appreciable amounts of either 
BTCA or 2-BTCA were obtained from degradation of the supernatants after pigment 
separation at different times. 
Finally, a typical experiment of pheomelanogenesis in vitro was carried out in which a 
dopa-cysteine reaction promoted by tyrosinase was monitored at various intervals of 
time to probe the relative stability of the 5SCD and 2SCD components. At 9 h reaction 
time an approximately 5:1 BTCA/2-BTCA ratio was observed which dropped to nearly 
3:1 after two  week (Fig. 19). After an additional week  the ratio was not significantly 
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changed (not shown). 2-BTCA yields varied less than 10% over the whole experimental 
time, suggesting an intrinsic chemical instability of the BTCA-forming structures.  
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Figure 19. Ratios of BTCA/2-BTCA yields from degradation of an oxidation mixture of 
dopa and cysteine at different times of incubation in air. 
 
 
2.1.4. BTCA/2-BTCA as aging- and UV- index 
 
In this study it was demonstrated that 2SCD provides human pheomelanin with a stable 
structural constituent, whereas the bulk 5SCD-derived component is degraded during 
hair growth and represents an index of pigment aging. 
The noticeable persistence of the 2SCD component during red hair growth might reflect 
an intrinsic stability to ROS attack or UV-induced degradation, which appear to affect 
preferentially the dominant 5SCD component. 
The marked drop in BTCA yields indicates an irreversible change in pheomelanin 
structure which occurs in hair with aging. The high BTCA/2-BTCA values in mouse 
hair, approximating those in native pheomelanin set by the 5SCD/2SCD formation ratio, 
can be explained considering the short hair cycle (about 3 weeks)
137
 compared to the 
human case (years).  
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In spite of a marked individual variability in the yields of either the BTCA/2-BTCA or 
the 4-AHP/3-AHP markers obtained at the hair root or tip the general trend was 
confirmed in all the red haired subjects examined. 
The age (and UV)-dependent change of components giving BTCA (and 4-AHP) may be 
interpreted in terms of bond formation involving the benzene moiety. In this connection, 
it should be mentioned that 5SCD-derived benthiazine/bentothiazole components have 
ortho- and para-positions to the hydroxyl group intact while 2SCD-derived counterparts 
have only ortho-position intact. Other possibilities accounting for the decrease of BTCA 
include degradation of the alanyl moiety
138
 and oxidative fission of the benzene moiety 
of benzothiazine/benzothiazole structural components. The latter process is compatible 
with the increased yields of TTCA. 
Pheomelanin degradation is likely to be the consequence of photodegradation processes. 
However, the abrupt decrease in BTCA yield observed in hair segments near to the 
scalp and supposedly little exposed to direct sunlight suggests that other mechanisms, 
probably related to oxidative stress, may be also involved. An attractive hypothesis 
implicates the abnormal accumulation of iron in red hair pheomelanin as a possible 
vulnerability factor.
139
 Pheomelanin precursors and components are strong transition 
metal chelators
37,140
 and may cause a “lens effect” enhancing site-directed Fenton-type 
reactions with hydrogen peroxide on the pigment granules and their immediate 
environment.
60,141
 
A major implication of the present results is in relation to pheomelanin roles and fate in 
the skin of red haired individuals. As pointed out by Slominski et al.,
142
 hair shaft 
melanin components are a long-lived record of precise interactions in the hair follicle 
pigmentary unit involving follicular melanocytes, keratinocytes, and dermal papilla 
fibroblasts. Melanin synthesis and transfer to bulb keratinocytes are regulated by signal 
transduction pathways intrinsic to skin and hair follicle. In an oxidative stress setting 
with elevated ROS production, e.g. in sunburn, extensive degradation of the 5SCD 
component of pheomelanin may be a significant event accompanying the inflammatory 
response. In this context, the 2SCD-derived component might survive ROS attack 
during aging or sun exposure, providing a stable (photo)protective effect even after the 
5SCD portion of pheomelanin is degraded. 
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2.2. A melanin-inspired pro-oxidant system for aerial catechol(amine)- 
polymerization: implementing a non-enzymatic mimic of the natural 
casing model 
 
 
According to a currently accepted kinetic model, assembly of pigment-containing 
organelles, the melanosomes, occurs by a casing process in which a pheomelanin core is 
initially formed and is then encapsulated into a eumelanin coating (Fig. 9).
48
 Support to 
this model came from photoemission electron microscopy imaging studies of iridial 
melanosomes and neuromelanin granules indicating eumelanin-type surface properties 
despite a large pheomelanin content.
46,50,143
 Recently, eumelanins have attracted 
increasing interest because of their intriguing physico-chemical properties, including 
broad band monotonic absorbance, extremely low radiative quantum yield, and 
condensed phase electrical and photoconductivity, that suggested possible applications 
as bio-inspired high-tech materials for bioelectronics, chemical sensing, photon 
detection and radioprotection.
144-149
 Several papers have also reported use of 
catecholamines such as dopamine, dopa and epinephrine for the preparation of 
eumelanin-like multifunctional coatings and adhesive films that stick to a broad variety 
of organic and inorganic surfaces, e.g. silica, dimethyldiethoxysilane emulsions, 
nanotubes, etc.
150-158
 In most of these surface modification systems, however, 
catecholamine polymerization is obtained through a lengthy oxygen-induced process 
(autopolymerization) subject to substrate and oxygen availability as main determinants 
of coat thickness.
159,160  
 
 
2.2.1. Pheomelanin promoted oxidative polymerization of catechol(amines) 
 
A peculiar redox system based on pheomelanin that implements a non-enzymatic mimic 
of the natural casing process of  melanin pigments was observed which enables efficient 
deposition of eumelanin-like coatings. The new system is built upon the discovery that a 
finely suspended, partially solubilized pheomelanin-type polymer obtained by oxidation 
of 5SCD (5SCD-pheomelanin) markedly accelerates the oxygen-dependent 
 - 49 - 
 
 
polymerization of catecholamines at pH 7.4 leading to a faster eumelanin coating 
formation. The catecholamines object of this studies were DOPA and 5,6-
dihydroxyindole-2-carboxylic acid (DHICA), intermediates of eumelanin, dopamine 
(DA), the main precursor of neuromelanin and epinephrine (EN), a neurotransmitter.  
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Figure 20. Catechol(amine) oxidation promoted by synthetic 5SCD-pheomelanin. a) 
Time course of 1 mM DOPA oxidation in the presence (▲) and in the absence (■) of 
pheomelanin (5:1 w/w). b) As in a), with DA. c) As in a) but with DHICA. d) As in a) 
but with EN. e) DOPA consumption at 6 h as a function of the amount of 5SCD-
pheomelanin added. Shown are the mean values for three separate experiments with 
SD≤5%. f) Color changes of DOPA solutions after 24 h without (A) or with (B) added 
pheomelanin (5:1 w/w). 
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The key observation underpinning this study is provided in Figure 20. The rate of 
oxidation of various catechol substrates at 1 mM concentration in air-equilibrated 
phosphate buffer at pH 7.4 is markedly increased in the presence of 20% (w/w) 5SCD-
pheomelanin (panels a-d), leading to dark insoluble eumelanin-like polymers visually 
identical to those obtained by spontaneous oxidation (panel f). Despite differences in the 
relative rates of catechol oxidation, the accelerating effect was significant in all cases 
examined, being higher with DHICA and DOPA, and varies with the added amount of 
pheomelanin (panel e), doubling on passing from a 1:15 to 1:1 w/w pheomelanin/ 
DOPA ratio. 
Separate experiments (not shown) indicated that: a) catechol(amine) consumption is not 
affected by SOD and catalase under the usual conditions for inhibition experiments; b) 
the process is virtually inhibited under an argon atmosphere; and c) synthetic 
eumelanin, obtained by oxidation of DOPA (DOPA-eumelanin) has no detectable effect 
on DOPA oxidation. From these data, it was concluded that catechol(amine) 
consumption is due to an oxygen-dependent process, but is not mediated to any 
significant degree by superoxide and hydrogen peroxide and is not associated to 
physical adsorption phenomena.  
 
 
2.2.2. Analysis of pheomelanin-induced oxidation of dopa and dopamine 
 
Figure 21a, panel a, reports the decay profile of 1 mM DOPA after multiple additions 
to the pheomelanin-containing buffer at pH 7.4. When all of the DOPA from the 
oxidation reaction was consumed (24 h), addition to the mixture of a fresh solution of 
DOPA at the same initial concentration resulted in a markedly slower consumption rate. 
No significant accelerating effect was eventually observed following a third addition of 
freshly prepared DOPA (48 h), indicating complete inactivation of the pheomelanin 
system. Based on these data, it was estimated that the system can promote oxidation of 
up to 4.5 mg of DOPA/mg of pheomelanin at a 6.5:1 w/w initial ratio before 
inactivation, the remainder of DOPA being consumed by the concurrent slower 
spontaneous autoxidation (dashed line panel a).  
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Figure 21a. a) Kinetic profile of DOPA decay following repeated addition to 5SCD-
pheomelanin solution (initial condition: DOPA/pheomelanin 5:1 w/w; at time 0, 24 h 
and 48 h DOPA concentration is taken to 1 mM); dashed line: 24 h DOPA decay in 
absence of 5SCD-pheomelanin added, reported in the range 48-72 h. Shown are the 
mean values for three separate experiments with SD≤5%. b) SEM image of 5SCD-
pheomelanin; c) as b) but 24 h after addition of the same weight amount of DOPA; d) 
as b) but 24 h after oxidation of a 10-fold weight excess of DOPA. 
 
The polymer produced by pheomelanin-promoted oxidation of DOPA was then 
investigated by scanning electron microscopy (SEM). The morphological features of 
5SCD-pheomelanin are shown in Figure 21a, panel b. The image reveals compacted 
grains which generate a well defined continuous structure. Interestingly, a globe-like 
morphology became apparent in the case of polymers obtained by 5SCD-pheomelanin 
promoted oxidation of DOPA (1:1 w/w, panel c), which was much more pronounced 
with a 10-fold weight excess of the catechol (panel d). The latter images indicated a 
close similarity of the polymer morphology with that of a pure DOPA-eumelanin, 
suggesting encasement of the 5SCD-pheomelanin component into the DOPA-eumelanin 
coating (Fig. 21b). 
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Figure 21b. a) SEM image of 5SCD-pheomelanin b) as a) but 24 h after addition of the 
same weight amount of DOPA; c) as a) but 24 h after oxidation of a 10-fold weight 
excess of DOPA; d) DOPA-eumelanin. 
 
The casing process was confirmed by additional experiments in which the polymer 
obtained by pheomelanin-induced oxidation of DOPA (DOPA/pheomelanin 5:1 w/w) 
was washed sequentially on a filter with phosphate buffer pH 8, pH 9, and with 1 M 
NaOH, (4 times each), and the washings were separately analyzed for melanin content 
by the alkaline H2O2 degradation protocol
39
 in comparison with the untreated material 
(Fig. 22).  
 
 
 
 
c) 
a) b) 
d) 
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Figure 22. Yields of PTCA (black bars) and BTCA (open bars) from alkaline oxidative 
degradation of eluates deriving from washing with phosphate buffer pH 8, pH 9 and 
NaOH 1 M of polymer obtained by pheomelanin-induced oxidation of dopa (panel A) 
and of 5SCD-pheomelanin (panel B). In panel A the degradation of the insolubilized 
material is reported. Shown are the mean values for three separate experiments with SD 
≤10%. 
 
HPLC determination of eumelanin and pheomelanin markers, PTCA and BTCA, 
consistently indicated an approximately 2.5:1 eumelanin/pheomelanin ratio in both the 
crude and washed polymers, but no trace of pheomelanin or eumelanin released into the 
washings. Since in control experiments pure 5SCD-pheomelanin was completely 
released from the filter following washing with alkali, it was concluded that all of the 
pheomelanin component was encased and preserved from alkali-induced solubilization 
by the insoluble polycatecholamine coating.  
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Table 5. Yields of PTCA and BTCA from alkaline oxidative degradation of eluates 
deriving from washing with phosphate buffer pH 8, pH 9 and NaOH 1 M of polymer 
obtained by pheomelanin-induced oxidation of dopa and of 5SCD-pheomelanin. The 
yields of the melanin markers from degradation of the pigments not subjected to 
solubilization treatments are reported. 
 
 Polymer by pheomelanin-induced 
oxidation of dopa 
Yields (g/mg pigment)* 
5SCD-pheomelanin 
Yields (g/mg pigment)* 
 PTCA BTCA PTCA BTCA 
pH 8 / / 22.39 55.25 
 / / 5.29 16.79 
 / / 4.84 15.36 
 / / 4.55 13.31 
pH 9 / / 3.89 13.50 
 / / 1.47 5.49 
 / / 1.15 3.64 
 / / 0.24 0.95 
NaOH 1M 1.52 5.52 0.76 2.09 
 2.68 3.97 0.64 1.29 
 0.59 0.98 0.21 0.81 
 0.39 0.63 0.12 0.66 
Filter 
(insolubile material) 
102.93 27.40 / / 
Pigment without 
washings 
99.2 43.5 56.2 104.6 
*Shown are the mean values for three separate experiments with SD ≤ 10%. 
 
Overall, the above data would suggest that catecholamine oxidation and coating 
formation is an oxygen-dependent process occurring on the surface of the finely 
dispersed 5SCD-pheomelanin, e.g. via redox cycling of benzothiazine units
5
 sustained 
by oxygen (Fig. 23). The proposed redox mechanism is compatible with the oxidation 
potentials of eumelanosomes and pheomelanosomes (−0.2 V and +0.5 V, respectively, 
vs normal hydrogen electrode),
47,161
 indicating that pheomelanin, but not eumelanin, 
may be competent to act as an oxidizing system. Unfortunately, current gaps in the 
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Eumelanin from DOPA  
Pheomalanin from 5SCD 
knowledge of pheomelanin structure and the heterogeneous character of the pigment 
prevent a more detailed characterization of the redox system at this time.  
 
 
 
Figure 23. Left panel: SEM image of 5SCD-pheomelanin;Right panel: SEM image of 
5SCD-pheomelanin plus a 10-fold weight excess of DOPA (at 24 h reaction time). In the 
middle: proposed redox mechanism of 5SCD-pheomelanin oxidation of DOPA and 
eumelanic coating formation. 
 
Assuming a 4.5:1 eumelanin/pheomelanin ratio as indicated above and a uniform 
density for the fundamental cased aggregates, it could be predicted that the thickness of 
the eumelanic exterior formed by deposition of polymerized DOPA is about 0.75 times 
the radium of the pheomelanic core (Fig. 24).  
 
 
 
Figure 24. Schematic illustration of eumelanic coating on pheomelanic core. 
 
This value falls within within the recently reported range for iridal melanosomes.
50
 
These results may be relevant to the origin of the casing architecture in the DA-derived 
neuromelanin of human substantia nigra. Based on preliminary data, it can be 
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speculated that a 5-S-cysteinyldopamine-derived melanin, generated under an oxidative-
stress condition in dopaminergic neurons,
48
 may trigger DA polymerization and 
neuromelanin accumulation without enzymatic assistance (Fig. 25). The similarity in 
organization of neuromelanin granules and iridial stroma melanosomes suggests that the 
morphological consequence of mixed melanogenesis may be independent of tissue type, 
biosynthetic origin, time scale of synthesis and enzymatic assistance. 
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Figure 25. Time course of 1 mM dopamine oxidation in the presence (▲) and in the 
absence (■) of 5-S-cysteinyldopamine-pheomelanin (5:1 w/w). Shown are the mean 
values for three separate experiments with SD ≤5%. 
 
On this basis it is tempting to speculate that the casing mechanism is a consequence of 
the intrinsic chemical reactivity during melanization in any mixed 
eumelanin/pheomelanin-forming system. Besides the biological relevance, the results 
disclosed herein may be of interest in relation to the potential utility of added oxidants 
for improved polycatecholamine coating methodologies. So far, this aspect has been 
little investigated, though certain limitations of chemical oxidants have been recently 
highlighted. To this aim, the technological  prospects deriving from inclusion in 
catecholamine polymerization protocols of a pheomelanin-inspired non-enzymatic 
system enabling controlled coating formation
162
 are worthy of further attention.  
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2.3. Oxidative chemistry of cysteinyldopas and properties of related 
synthetic pheomelanins 
 
As illustrated in the paragraph 2.1, it was demonstrated that 2SCD provides human 
pheomelanin with a stable structural constituent, whereas the bulk 5SCD-derived 
component is degraded during hair growth and represents an index of pigment aging. To 
give a molecular interpretation to this phenomenon, the oxidative reactivity of 2SCD 
was examined in biomimetic condition, also in comparison with the more extensively 
investigated 5SCD isomer. The pro-oxidant properties of 5SCD-pheomelanin in 
promoting catecholamine oxidation (paragraph 2.2) were studied also for 2SCD-
pheomelanin, in the oxidation of the catecholamine pheomelanic precursors themselves, 
5SCD and 2SCD. Model experiments led to formulate a pheomelanic casing model as 
interpretation of the instability of 5SCD-derived components observed in hair growth. 
 
 
2.3.1. Oxidative chemistry of 2SCD 
 
In order to assess possible differences in the reactivity between 2SCD and 5SCD, and 
then the relative tendency to take part in the formation of pheomelanic pigment, a first 
stage of this work was directed at investigating the oxidative chemistry of 2SCD under 
the conditions typically used to prepare synthetic pigments.
40,163
 This analysis showed 
in all cases a marked tendency of 2SCD to oxidation. Particular attention was focused to 
reaction carried out with tyrosinase in the presence of L-DOPA in phosphate buffer pH 
6.8, bubbled with O2. At 30 minutes reaction time, the reverse-phase HPLC analysis of 
the mixture, after reductive treatment with NaBH4, showed the presence of three main 
products: one poorly retained with tR 12 min and two eluted between 30 and 40 min. 
The reaction was then carried out on 50 mg of 2SCD. The mixture was reduced after 30 
min, lyophilized, the residue was taken up in water and eventually purified by semi-
preparative HPLC-RP. 
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Figure 26. HPLC/UV traces of the reaction oxidation mixture of 2SCD, after reductive 
treatment with NaBH4 at 30 min reaction time. 
 
1
H NMR analysis and ESI(+)-MS analysis of the product eluted at 11.2 min allowed its 
identification as 8-(2-amino-2-carboxyethyl)-5-hydroxy-3,4-dihydro-1,4-benzothiazine 
(1), while the two components eluted at 32.3 and 36.6 min showed very similar proton 
spectra and were identified as two diastereoisomers of 8-(2-amino-2-carboxyethyl)-3-
carboxy-5-hydroxy-3,4-dihydro-1,4-benzothiazine (2 and 3). The products isolated 
likely derived from reduction of the 2H-1,4-benzothiazine and the 3-carboxy derivative, 
respectively, arising from intramolecular cyclization of 2SCD. This was confirmed also 
by the 1:1 formation ratio of two diastereoisomers produced by borohydride reduction 
(Fig. 27). 
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Figure 27. Products arising from the early stages of 2SCD biomimetic oxidation, after 
reductive treatment. 
 
The analysis of the reaction mixture after 24 h after reductive treatment showed the 
disappearance of the benzothiazines initially formed and the presence of a complex 
pattern of products (Fig. 28). However, all the attempts to isolate the main components 
in sufficient quantities to carry out the spectroscopic characterization failed because of 
the extreme instability of these species, that after chromatographic fractionation of the 
mixture and removal of the solvent (even by lyophilization) were converted into several 
other species. 
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Figure 28. HPLC/UV traces of the reaction oxidation mixture of 2SCD, after reductive 
treatment with NaBH4 at 24 h reaction time. 
 
Overall, this preliminary investigation showed that the early stages of biomimetic 
oxidation of 2SCD are quite similar to those characterized in detail in the case of 5SCD. 
 
 
2.3.2. Aerial oxidation of 5SCD and 2SCD 
 
In a subsequent series of experiments a direct comparison between the tendency to 
oxidation of 2SCD and 5SCD was carried out. To avoid effects due to substrate 
specificity of the isomers, as observed in the case of tyrosinase (which operates more 
effectively on 5SCD than on 2SCD), it was preferred not to use enzymes as oxidizing 
systems. Aerobic oxidation was therefore chosen and the reaction was carried out using 
solutions of the two isomers at 0.5 mM under conditions of neutral pH of physiological 
relevance (phosphate buffer, pH 7.4), kept under vigorous stirring. The consumption 
rate was determined by monitoring the reaction mixtures by HPLC at 30 min intervals. 
For both compounds a relatively low and comparable consumption rate was observed: 
after 24 h the residual compounds were up to 80%. 
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2.3.3. Oxidation of 5SCD and 2SCD in the presence of synthetic and natural 
pheomelanins 
 
Due to the similarity in the reactivity between 5SCD and 2SCD, the research work was 
directed toward examination of the properties of pigments obtained from cysteinyldopa 
isomers. Preliminary, pheomelanins were prepared by treating a 12 mM solution of the 
substrate (5SCD or 2SCD) with the oxidizing system peroxidase/H2O2 for 2 h according 
to a procedure previously developed.
40,163
 The pigment formed was precipitated by 
cautious acidification, recovered by centrifugation (7000 rpm, 30 min, 4°C), washed 
three times with 1% acetic acid, once with H2O and lyophilized. 
The pheomelanic pigments prepared, together with the one synthesized by oxidation of 
DOPA with cysteine by the enzyme tyrosinase,
136
 commonly considered as the 
reference pheomelanin, were used in all experiments described below. 
1 mM solutions of 5SCD or 2SCD in phosphate buffer at pH 7.4 were taken under air 
stirring, in the presence and in the absence of the pigments, with w/w ratio 
cysteinyldopa/pigment of 5:1. Cysteinyldopas consumption was followed by HPLC-RP. 
Data in Figure 29 show the significant increase in the rate of cysteinyldopa decay in the 
presence of the pigment: after 4 h the consumption of cysteinyldopas was complete, 
while in the absence of the pigment was not detectable. In the case of 2SCD the effect 
of the pigment was more pronounced, but the type of precursor from which the 
pigments were obtained did not affect the oxidation to a significant extent (data not 
shown). The effect observed in the case of pheomelanic promoted oxidation of 
cysteinyldopas was much more apparent than in the case of the previously studied 
catecholamines (paragraph 2.2). 
 - 62 - 
 
 
0
20
40
60
80
100
0 1 2 3 4 5
Tìme (h)
D
e
c
a
y
 (
%
)
 
 
Figure 29. Time course of 1 mM 5SCD oxidation in the presence (♦) and in the absence 
(■) of synthetic pheomelanin (5:1 w/w) and of 1 mM 2SCD oxidation in the presence (-) 
and in the absence (Δ) of synthetic pheomelanin (5:1 w/w). Shown are the mean values 
for three separate experiments with SD ≤5%. 
 
The same experiments were carried out in the case of 5SCD in the presence of natural 
melanin isolated from red hair and black hair. 
The effect of natural pheomelanin in the oxidation of 5SCD, at 5SCD/pigment ratio of 
1:2, was significantly higher than that observed for synthetic pigment (Fig. 30). It is 
important to consider that in the natural pigment even after purification there is a 
relevant contribution of the matrix protein, so the weight corresponds to a smaller 
quantity of pheomelanin. 
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Figure 30. Time course of 1 mM 5SCD oxidation in the presence of synthetic 
pheomelanin (+), natural pheomelanin from red hair (▲), or in the absence of pigment 
(■) (5SCD/pigment ratio 1:2 w/w). Shown are the mean values for three separate 
experiments with SD ≤5%. 
 
The eumelanin isolated from black hair did not effect the oxidation of 5SCD, using the 
same 5SCD/pigment ratio of 1:2 (Fig. 31), as previously observed for the pheomelanic 
promoted oxidation of a series of catecholamines (paragraph 2.2.1). 
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Figure 31. Time course of 1 mM 5SCD oxidation in the presence of natural 
pheomelanin from red hair (▲), natural eumelanin from black hair (+), or in the 
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absence of pigment (■) (5SCD/pigment ratio 1:2  w/w). Shown are the mean values for 
three separate experiments with SD ≤5%. 
 
 
2.3.4. Proposed mechanism of growth of synthetic pheomelanins from 2SCD and 
5SCD 
 
To explain the different trend to (photo) degradation observed for the components of the 
pheomelanic pigment of red hair, it was initially hypothesized that 2SCD and 5SCD 
might exhibit a different oxidative chemistry, leading to different pigments with 
different structural characteristics and hence diverse susceptibility to (photo) 
degradation. This hypothesis, however, was not supported by the results of the 
comparative examination of the oxidation reactivity of the two isomers, that showed a 
broad similarity of the course of early stages of the process.  
A similar photoreactivity of 2SCD- and 5SCD-pigments was also shown recently by 
electron paramagnetic resonance (EPR) oximetry and EPR-spin trapping experiments 
indicating that either pigments had a pronounced but comparable tendency to reduce 
molecular oxygen to ROS.
164
  
The possibility was then considered that the two pigments are differently exposed to 
sunlight and air, as a result of the intervention of a  coating mechanism during pigment 
growth closely parallel to that proposed in the case of eumelanin and pheomelanin 
(paragraph 2.2).  
To test this hypothesis, an experimental protocol was designed based on the preparation 
of two different synthetic pheomelanins, termed mixed because containing both 5SCD 
units and 2SCD units. 
The mixed pheomelanin A was prepared by peroxidase/H2O2 oxidation of a solution of 
5SCD in 0.01 M phosphate buffer at pH 6.7 in the presence of pheomelanin from 2SCD 
previously synthesized, while the mixed pheomelanin B derived from oxidation of a 
solution of 2SCD in the presence of pheomelanin from 5SCD. In both cases the ratio of 
2SCD (or its pheomelanin) and 5SCD (or its pheomelanin) was 1:5, reflecting the 
formation ratio of cysteinyldopas in vivo.
29
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It was then assumed that the pigments thus prepared were made, in the first case, of a 
core of pheomelanin from 2SCD and a surface of pheomelanin from 5SCD (mixed 
pheomelanin A), while the latter, had a pheomelanin core from 5SCD and a surface of 
pheomelanin from 2SCD (mixed pheomelanin B) (Fig. 32). 
 
 
 
 
Figure 32. Schematic illustration of mixed pheomelanin A and mixed pheomelanin B. 
 
The pheomelanic pigments are slightly soluble in dilute alkali, under which conditions 
they do not undergo structural changes. On this basis, in order to assess a possible 
stratification between the two components, each mixed pheomelanin was subjected to 
the following steps: 2 mgs of dry sample were loaded on a nylon filter (Millex-GV, 0:22 
mm) and dissolved by the rapid treatment with solutions at increasing pHs, including 4 
aliquots of H2O, 4 aliquots of phosphate buffer at pH 8, 4 aliquots of phosphate buffer 
at pH 9 and 4 aliquots of NaOH 1 M (each aliquots of 200 L). Each eluate was then 
subjected to oxidative degradation with NaOH/H2O2 and degradation products analyzed 
by HYDRO-RP HPLC-UV. The solubilized components present in each sample were 
identified by the amounts of BTCA and 2-BTCA arising from the degradation reaction . 
For each pheomelanin the oxidative degradation of the pigment without washings was 
carried out, in order to determine the ratio of the 2SCD-units and 5SCD-units "in the 
whole pigment”. 
Initially mixed pheomelanin A was studied. Analysis of the degradation mixture of the 
entire pigment showed a BTCA/2-BTCA ratio of 5:1 (grey dashed line, Fig. 33, panel 
2SCD-units  
5SCD-units 
Mixed pheomelanin A Mixed pheomelanin B 
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b). When pheomelanin A was subjected to the solubilization treatment degradation of 
the eluates showed that 5SCD- and 2SCD-derived components were solubilzed 
differently, in particular at lower pHs only the 5SCD-derived units were solubilized 
(Fig. 33, panel a). 
In the eluates obtained at lower pHs a BTCA/2-BTCA ratio of about 10:1 was obtained 
which decreased up to 3:1 in the NaOH eluates (Fig. 33, panel b). It is worth noting that 
in the absence of any coating the BTCA/2-BTCA ratio should remain constant at a 
value of 5:1. 
 
 
 
Figure 33. Yields of BTCA (black bars) and 2-BTCA (open bars) from alkaline 
oxidative degradation of eluates at increasing pH of mixed pheomelanin A (panel a) 
and reported as BTCA/2-BTCA ratio (panel b). Grey dashed line is in correspondence 
of BTCA/2-BTCA ratio of the entire pigment.  
 
This trend can be interpreted as an evidence of a coating process: at the beginning the 
solubilization of 5SCD-units occurs and, only after these components had been washed 
away, the 2SCD-units are exposed to the action of the washing solutions and pass into 
the eluates. A complete recovery of the pigment from the filter was obtained following 
this procedure. Moreover the average BTCA/2-BTCA ratio from all eluates was 5:1. 
Subsequently the mixed pheomelanin B was analyzed. Analysis of the degradation 
mixture of the entire pigment afforded a BTCA/2-BTCA ratio of 3.3:1 (grey dashed 
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line, Fig. 34, panel b). When this mixed pheomelanin was subjected to the solubilization 
treatment and subsequent oxidative degradation of the eluates it was observed that, 
differently from the case of mixed pheomelanin A, the 5SCD and 2SCD components 
showed a comparable solubility (Fig. 34, panel a). Analysis of the BTCA/2-BTCA ratio 
showed in the first eluates values slightly in favor of 2-BTCA, but at higher pHs they 
remained constant to a ratio of 3.3 (Fig. 34, panel b). This trend would indicate that in 
this case the coating process did not occur. Also in this case the recovery of the pigment 
from the filter was complete. 
 
 
 
Figure 34. Yields of BTCA (black bars) and 2-BTCA (open bars) from alkaline 
oxidative degradation of eluates at increasing pH of mixed pheomelanin B (panel a) 
and reported as BTCA/2-BTCA ratio (panel b). Grey dashed line is in correspondence 
of BTCA/2-BTCA ratio of the entire pigment.  
 
Control experiments with pheomelanin from 2SCD and 5SCD allowed to rule out that 
the observed behavior for the mixed pheomelanins was due to different solubility 
properties of the two pigments.  
The mixed pheomelanin A represents a valid model of the pheomelanin casing, 
according to which the 2SCD-pheomelanin core is protected by a 5SCD-pheomelanin 
surface, that results much exposed to (photo)degradation. In Figure 35 the degradation 
of 5SCD-units, observed during hair growth, is represented. 
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Figure 35. Schematic illustration of pheomelanin with a 5SCD-units surface on a 
2SCD-units core and degradation of exposed 5SCD-units during red hair growth. 
 
The pheomelanin casing is just one of the possible interpretation of the 5SCD-units 
degradation during red hair growth but other processes may well contribute. 
 
 
2SCD-units  
5SCD-units 
Hair growth 
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2.4. Biosynthesis-inspired one-pot access routes to 4-
hydroxybenzothiazole aminoacids, red hair-specific markers of UV 
susceptibility and skin cancer risk 
 
 
4-Hydroxybenzothiazole aminoacids BTCA and 2-BTCA are specific structural markers 
of pheomelanins.
163,165
 They can be obtained in small amounts by oxidative degradation 
of red hair or synthetic pigments.
141
 On the other hand, available syntheses of the 4-
hydroxybenzothiazole system are lengthy and require several steps (from six to eight to 
obtain BTCA and 2BTCA).
166-168
 This is a most critical gap since BTCA and 2-BTCA 
appear to be selective markers for red-haired individuals
40
 at higher risk for skin cancer, 
and the current lack of straightforward synthetic routes has hampered their use for 
routine population screenings, and for genetic and epidemiologic correlations studies. 
For biomedical research purposes, synthetic procedures for analytical marker 
preparation should in fact be facile, cheap and easy to do even by non-experts. 
Prompted by the urgent and increasing demand for these markers, the feasibility of the 
biosynthetic pathway leading to 4-hydroxybenzothiazole aminoacids was explored as a 
practical access route to BTCA and 2-BTCA as well as their decarboxylated derivatives 
6-(2-amino-2-carboxyethyl)-4-hydroxybenzothiazole (BT) and 7-(2-amino-2-
carboxyethyl)-4-hydroxybenzothiazole (2-BT).  
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2.4.1. Access protocol to 4-hydroxybenzothiazole aminoacids 
 
The protocol to BTCA involves a rationally devised sequence of enzymatic and 
chemical steps that have been elaborated into a remarkable one-pot procedure. The 
developed methodology involves i) oxidation of L-DOPA and L-cysteine in 0.05 M 
phosphate buffer (pH 7.4) with mushroom tyrosinase; ii) treatment of the mixture with 
potassium ferricyanide/zinc sulfate; and then iii) acidification and oxidation with 
sodium persulfate. HPLC-RP purification eventually gives the desired compound in 
pure form (57% yield) (Fig. 36, route a). By a simple additional operation, i.e. iv) 
heating of the final mixture at 90 °C for 1.5 h, the decarboxylated derivative BT can be 
obtained instead in similar (55%) yield, after HPLC-RP purification.
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Figure 36. Reagents and conditions: i) tyrosinase, O2; ii) K3Fe(CN)6/ZnSO4; iii) 
Na2S2O8/HCl; iv) 90 °C ,1.5 h. 
 
Three critical steps underpin the synthetic methodology: a) the enzymatic conversion of 
L-DOPA to dopaquinone (DQ) followed by the addition of L-cysteine to give 5SCD (the 
prevalent isomer); b) the ferricyanide-promoted oxidative cyclization of 5SCD to a 
benzothiazine intermediate stabilized by Zn
2+
 ions; c) the persulfate-induced oxidative 
ring contraction of the benzothiazine-Zn
2+
 complex I to give BTCA (Fig. 37). 
Consistent with the proposed mechanism is an alternate procedure to BTCA/BT which 
has been developed in the course of this study based on the oxidation of 5SCD, 
prepared following a reported procedure,
169 
according to the above steps ii) and iii) (and 
iv, if appropriate) to give the products in quite similar yields (Fig. 36, route b).
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The successful conversion of L-DOPA and L-cysteine to BTCA/BT reflects a careful 
choice of oxidation methods and sequential operation times that have been optimized 
within the one-pot protocol after a thorough and careful screening of oxidizing systems 
and experimental conditions. Thus, for example, commercially available mushroom 
tyrosinase proved to be the most efficient oxidizing system for in situ conjugation of L-
cysteine to L-DOPA,
29
 but was ineffective in promoting subsequent oxidation of 
cysteinyldopa. On the other hand, ferricyanide was effective on the latter step but not in 
the initial conjugate formation.  
The crucial experimental expedient favouring efficient benzothiazole formation is the 
addition of Zn
2+
 which is known to stabilize 3-carboxy-4-hydroxybenzothiazines by 
forming a chelate complex, such as I, as evidenced by the typical absorption maximum 
at around 390 nm.
37,163
 Thus, in the presence of Zn
2+
, the key benzothiazine 
intermediate can be accumulated in suitable amounts for the oxidative ring contraction 
(Fig. 37).
141
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Figure 37. Proposed routes of formation of BTCA from benzothiazine-Zn
2+
 complex I. 
 
The latter step was efficiently achieved by using persulfate combined with acid 
conditions while other oxidants or reaction media proved much less effective. 
Interestingly, the acid-promoted ring contraction of a remarkably stable 2-alkoxy-7-
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hydroxy-2H-[1,4]benzothiazine intermediate is the key step in a strategically similar 
synthesis of 6-hydroxybenzothiazole-2-carboxylic acid.
170
  
Extension of the L-DOPA + L-cysteine coupling route to the synthesis of 2-BTCA/2-BT 
was precluded by the low formation ratio of 2SCD/5SCD (1:5) in the tyrosinase 
promoted conjugation.
29
 After extensive unfruitful efforts to direct the coupling 
reaction, we eventually resorted to use 2SCD as the precursor. This was made possible 
by the facile synthesis recently described for this melanogen.
171
 As expected, oxidation 
of 2SCD as in Figure 36, route b, afforded the desired 2-BTCA/2-BT in similar yields 
(52-57%).  
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2.5. Pheomelanin-related benzothiazole isomers in the urine of patients 
with diffuse melanosis of melanoma 
 
 
Currently used as structural markers for pheomelanin identification and quantitation, 
benzothiazole compounds have been indicated by recent in vitro studies as new 
potential pheomelanogenesis intermediates.  
The conditions for chemical degradation and analysis of these compounds were recently 
improved by introduction of wettable octadecylsilane columns
39
 simpler eluents, 
hydrophilic interaction liquid chromatography (HILIC)
78
 and GC/MS analysis.
79
 Using 
the latter methodologies evidence was obtained for the presence of pheomelanin 
pigments in the urine of melanoma patients.
77
 1,4-Benzothiazole compounds were 
obtained in melanoma patients on HI degradation of urinary pigments followed by ethyl 
chloroformate derivatization and GC/MS analysis.
79
 The presence of an active 
pheomelanogenic pathway associated with melanoma was also indicated by the 
occurrence of trichochromes in the urine of melanoma patients
80
 particularly when 
diffuse melanosis occurs in metastasizing melanoma.
81
  
On this basis and relying on the newly developed analytical methodologies urine from 3 
patients with melanosis due to melanoma and from 16 patients with metastatic 
melanoma without melanosis were examined to assess the presence of pheomelanin-
related metabolites and particularly benzothiazole isomers.  
 
 
2.5.1. Method development and identification of BTCA and 2-BTCA in the urine of 
melanoma patients  
 
Standards of BTCA (BTCA-5), 2-BTCA (BTCA-2), BT (HBTA-5) and 2-BT (HBTA-
2) obtained as described (paragraph 2.4) were injected on a ZIC-HILIC column. 
Baseline separation was obtained (Fig. 38). The HPLC method developed for the 
analysis of AHP isomers
78
 was initially used for peak purity determination and 
quantification of BTCA-5 and BTCA-2 in human urine from a patient with diffuse 
melanosis. To achieve the sensitivity and selectivity required for the analysis of the 
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isomers in biological samples, a photo-diode array detector (PDA) was employed. This 
allowed monitoring at several wavelengths and provided UV spectra which could be 
used to assess peak purity and safely identify the compounds by comparison of the 
peculiar spectral features against those of standard samples. The absorption spectra of 
BTCA isomers showed maxima at approximately 210, 250, 285 and 325 nm (Fig. 38).  
 
 
 
Figure 38. LC-PDA profile of a calibrator of benzothiazole isomers separated with the 
HILIC. Spectra at 50% of the peak height before and after peak apex are compared 
with spectrum at the apex. The match degree of all three spectra is a criterion for the 
peak purity.  
 
By direct injection of urine (diluted with mobile phase before injection) the peaks with 
the same spectra as standards of BTCA-5 and BTCA-2 were observed but peaks 
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fronting and interferences from other compounds from urine were considerable. BT and 
2-BT could not be identified in the urine with this method. Small changes in mobile 
phase composition (pH or aqueous phase content and even sample matrix) influenced 
separation vigorously. Retention times for BTCA isomers increased when mobile 
phases with lower contents of aqueous phase were used. This is probably due to the 
hydrophilic character of BTCAs and also due to the ionic interactions with the 
stationary phase. Lower pH resulted in shorter retention time but poorer separation from 
interfering peaks. With a mobile phase composition of acetonitrile:ammonium acetate 
buffer pH 5 (82:18, v/v), BTCA isomers were eluted as single peaks with the retention 
times of approximately 31 and 37 min when flow rate was set at 300 l/min. 
In order to obtain higher sensitivity and purer peaks a solid phase extraction (SPE) step 
was employed using 200 mg of C18 sorbent. Optimization of the elution conditions led 
us to choose a ratio of 1 ml urine/ 100 mg sorbent. The BTCA isomers were eluted in a 
1 ml fraction. To obtain detectable levels of BTCA isomers in samples with expected 
low BTCA concentrations the eluates were evaporated and analyzed after dilution with 
mobile phase.  
In peak purity studies we found that a wavelength of 285 nm gave the best selectivity 
and purest chromatographic peak despite that sensitivity was higher at lower 
wavelengths (Fig. 39, panel a). After SPE treatment of the samples, chromatograms 
extracted at 250 nm were improved, and due to good sensitivity and pure peaks 250 nm 
was used for quantification of BTCA (Fig. 39, panel b).  
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Figure 39. Chromatograms and 3D spectra of a urine sample from a patient with 
melanoma a) before sample preparation, b) after sample purification. 3D spectra were 
obtained for 190–400 nm. The black lines show recordings at 210 nm and the red lines 
are obtained after flexible screening of 3D spectra and plotted at 250 nm. 
 
 
The HILIC-PDA method was validated with respect to linearity, limit of detection 
(LOD), extraction, recovery, precision, and interferences. Calibration curves were built 
using the areas of the chromatographic peaks (y) from standards of 4 increasing 
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concentrations in the range 0.05–2.5 mM (x). The responses were linear with following 
equation y=30.8x−0.136 (R2=0.9996) and y=73.9x+0.073 (R2=0.9995) for BTCA-5 and 
BTCA-2 respectively at all four wavelengths tested, but for quantification the 
wavelength 250 nm was optimal. This wavelength gave the best sensitivity, and the 
selectivity was significantly improved after interfering peaks were removed with SPE. 
The LODs were calculated using the 3  S/N criterion. Results were based on the 
responses and the slopes of specific calibration curves containing the analytes. The 
estimated LOD values were 5.98 g and 2.13 g for BTCA-5 and BTCA-2 at 250 nm. 
For comparison LODs at 285 nm were also calculated and were 11.22 g and 5.48 g 
respectively. For recovery studies aqueous samples with known amounts of the standard 
solution of BTCA-5 were extracted according to the described SPE protocol. Extraction 
recovery was estimated by analysis of the peak area of the samples before and after 
extraction. Urine from a healthy subject was spiked with known amount of the standard 
solution of BTCA-5 before extraction and analytical recovery was estimated as 85% by 
comparison with a pure standard. For comparison 0.05 M acetic acid was also used the 
medium following the same spiking protocol and a recovery of 93% was obtained. 
Intra-day relative standard deviation (RSD) was calculated from repeated analysis of 
one patient's sample and was 4.55% for BTCA-5 and 1.89% for BTCA-2. Inter-day 
assay was calculated from mean variance of three patients' samples analyzed repeatedly 
at four occasions during one month. The total RSD was less than 10% for BTCA 
isomers. These data suggests that the method was reproducible for the determination of 
BTCAs in the urine of melanoma patients. Since 5SCD is a known marker of melanoma 
progression and a precursor of BTCA its possible conversion to BTCA in urine samples 
of melanoma patients was assessed at different temperatures (between −20 and+20 °C) 
and storage time (up to 1 month). Stability of 5SCD has been studied before.
172
 An 
aqueous solution of 5SCD 650 M was prepared in 0.01 M acetic acid and in the urine 
of a healthy subject. The urine was analyzed for BTCA isomers before spiking. No 
detectable amounts of BTCA-5 were formed from 5SCD with the exception of very low 
amounts obtained in a single sample after one month storage at 4 °C. 
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2.5.2. Free BTCAs and 5SCD concentrations in the urine from patients with 
melanoma and diffuse melanosis 
 
Urines from three patients with diffuse melanosis and 16 patients with melanoma but 
not diffuse melanosis were analyzed using the above developed methodologies. In all 
three urines from patients with diffuse melanosis and from one patient with melanoma 
(no information of melanosis was available) significant amounts of BTCA-5 and 
BTCA-2 were found (Table 6). 
 
Table 6. Urinary free BTCAs, 5SCD and S100 protein concentrations in melanoma 
patients with or without melanosis and healthy subjects. 
 
Sample BTCA-5 
mol/l 
BTCA-2 
mol/l 
5SCD 
mol/l 
5SCD/creatinine
a
 
mol/mol 
S100 
protein
b
 
mol/l 
Stage
c
 
Melanosis Pt 1 342.7 81.4 831.0 75400 3.2 IV, M1c 
After 4 m 95.4 80.5
d
 754.0 87474 10.0 Progress 
Melanosis Pt 2 118.7 37.4 713.0 169762 9.4 IV, M1c 
Melanosis Pt 3 28.9 6.8 52.0 8966 - IV, MX 
Melanoma Pt 1 / / 8.6 587 0.09 III, N1b 
After 5 m / / 26.7 1701 0.25 Stable 
After 6 m / / 7.2 1600 0.33 Stable 
After 10 m 4.8 / 23.3 2678 0.23 IV, M1c 
After 17 m 6.8 1.6 54.9 6949 - Progress 
Melanoma Pt 2 / / 15.9 3118 - IV, M1c 
After 14 days / / 49.3 4695 - Progress 
After 1 m / / 66.0 6055 0.25 Progress 
Melanoma Pt 3 / / 7.1 826 0.69 IV, M1c 
After 1 m / / 9.4 1133 0.93 Progress 
After 1.5 m / / 12.8 1164 0.62 Progress 
Melanoma Pt 4 / / 9.7 4217 - III, N1b 
Melanoma Pt 5 / / 1.1 396 0.17 III, N1b 
After 2 m / / 2.8 2000 - IV, M1b 
Melanoma Pt 6 / / 4.3 286 - IV, M1a 
Melanoma Pt 7 / / 11.4 726 0.88 IV, M1c 
Melanoma Pt 8 / / 20.2 2220 - IV, M1bc 
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Melanoma Pt 9 / / 4.7 564 - IV, M1c 
Melanoma Pt 10 / / 8.3 1587 0.83 IV, M1c 
Melanoma Pt 11 / / 22.2 1531 5.10 III, N2b 
Melanoma Pt 12 / / 5.9 426 0.13 IV, N1b 
Melanoma Pt 13 / / 18.9 867 0.44 IV, M1a 
Melanoma Pt 14 / / 8.1 976 5.29 IV, M1abc 
After 11 m / / 33.1 1715 7.00 Stable 
Melanoma Pt 15 / / 60.0 3704 - IV1a 
Melanoma Pt 16 / / 0.8 130 1.06 IV, M1bc 
Red haired 
normal 
/ / 0.3 <70   
Black haired 
normal 
/ / 0.2 <70   
Brown haired 
normal 
/ / 0.3 <70   
a
 Normal reference range<70 mol/mol. 
b
 Normal reference range<0.12 g/l. 
c
 Highest stage regarding N and M is reported. 
d
 This peak was not purely separated from interfering peaks. 
 
Data in Table 6 do not show a straightforward correlation between the levels of 
excreted BTCAs and 5SCD, although patients with significant amounts of BTCA 
isomers in the urine had generally high levels of 5SCD. Similar results were obtained 
when excretion of trichochromes and 5SCD in patients with diffuse melanosis were 
compared.
80,81,173
 It should be noted also that abnormally high levels of 5SCD were 
observed in melanoma patients with melanosis as reported in previous studies.
80,174
 No 
detectable amounts of BTCAs were found in the urine of healthy subjects either 
belonging to the pheomelanic or the eumelanic phenotype. The BTCA-5/BTCA-2 ratios 
found for patients with melanosis ranged from 3 to 4. The urine from one of the patients 
was analyzed after four months and a lowering of the concentrations of BTCA-5 in the 
last urine was observed. However, this urine was more diluted than the former one and a 
correction to BTCA-5/creatinine (mol/mol), revealed that the total excretion of BTCA-
5 was similar between the two samples, 77.8 mol/mmol creatinine and 73.4 
mol/mmol creatinine. Interestingly enough the quotient between free BTCA and 
BTCA in the sediment varied greatly. This may be due to how much free BTCA and 
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trichochromes relative to pigment with higher molecular weight is formed and excreted. 
The absence of BTCAs in the urines of melanoma patients without melanosis, even 
those with high 5SCD, indicates that BTCA formation may not primarily be the result 
of a process related to melanoma cell proliferation. It may be that, different from most 
melanoma patients, those with diffuse melanosis have melanoma cells overactive in 
pheomelanin formation. Diffuse melanosis may therefore be the result of spread of such 
melanoma cells through the body. These cells may continue to produce melanosomes 
which eventually are deposed in dermal macrophages.
68,69
 Another possible 
interpretation would invoke an increased tyrosinase activity associated with metastatic 
malignant melanoma, which might lead to an accelerated conversion of tyrosine to 
melanin precursor and the formation of metabolic intermediates that accumulate in the 
blood and are excreted into the urine.
66,175
 The fact that in most cases the higher BTCA 
levels are associated with the higher cysteinyldopa levels may point to a non-enzymatic 
oxidative conversion of this metabolite to benzothiazines and hence benzothiazoles as 
evidenced by in vitro studies.
34
 This conversion could be induced by reactive oxygen 
species whose levels have been shown to rise in malignant transformations such as in 
dysplastic nevi compared to dermal nevi producing a chronic oxidative stress 
condition.
68,176
  
 
 
2.5.3. Analysis of urinary soluble pigments and sediment by chemical degradation 
 
The urines of melanoma patients were subjected to chemical degradation according to 
the alkaline hydrogen peroxide procedure currently used for identification of 
pheomelanin in pigmented tissues.
39
 As with analysis of BTCAs in untreated urine, 
separation was greatly improved by SPE pretreatment (Fig. 40). Oxidation mixtures 
were also analyzed using conventional chromatographic conditions previously 
employed for BTCAs analysis.
163
 However, peak separation was not satisfactory and we 
decided to continue with the HILIC-PDA methodology for BTCA-5 and BTCA-2 
quantification.  
The yields of BTCA-5 and BTCA-2 are reported in Table 7. When compared with the 
concentrations of free BTCAs, BTCAs obtained after chemical degradation of mixed 
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urine are around 2.5 fold higher. It should be observed that BTCAs were analyzed 
quantitatively in the three compartments: mixed urine (total BTCA), urinary sediment, 
and supernatant obtained after centrifugation. Thus separate chemical degradation of the 
sediment and the supernatant showed that most of the pigment remained in solution.  
 
 
 
Figure 40. Chromatogram of urine from a patient with melanoma after chemical 
degradation a) before SPE, b) after SPE. 
 
The relation between different fractions is more clearly shown for melanosis patients in 
Table 8. When considering BTCA amount from supernatant and sediment together they 
constitute close to 100% of BTCA from mixed urines. Assuming that free BTCA was 
un-affected by oxidation (as observed in separate control experiment) we subtracted this 
concentration from that obtained after oxidation of the supernatant from centrifuged 
urine. This fraction was called LowMW pigment and we think that this corresponds to 
soluble low-molecular weight components, possibly including trichochromes and 
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dimers formed from both 5SCD and 2SCD. The quotients between BTCA-5 and BTCA-
2 were calculated for all the fractions (except for the second free urine fraction of 
patient 1). The ratio between the two markers varied between 2.0 and 4.9, which 
corresponds fairly well with the ratio of BTCA-5 and BTCA-2 obtained after oxidative 
degradation of synthetic pheomelanin obtained from L-dopa and cysteine. By 
comparing the yields of BTCAs of the sediment with those obtained from a synthetic 
pheomelanin it was estimated that pheomelanin represented about 15% of the sediment.  
 
Table 7. BTCAs by oxidative degradation of urinary soluble pigment and sediment in 
melanoma patients with or without melanosis and healthy subjects. 
 
Sample Mixed urine 
mol/l 
Urine sediment 
mol/l 
Centrifugated urine 
mol/l 
 BTCA-5 BTCA-2 BTCA-5 BTCA-2 BTCA-5 BTCA-2 
Melanosis Pt 1 856.9 240.1 105.7 44.4 681.6 245.9 
After 4 m 632.8 290.0 257.2 75.3 457.1 227.0 
Melanosis Pt 2 436.7 92.4 60.9 13.3 362.1 74.4 
Melanosis Pt 3 101.8 38.2 34.7 10.4 75.3 29.8 
Melanoma Pt 1 - / / / / / 
After 5 m - / / / / / 
After 6 m - / / / / / 
After 10 m - / / / 46.1 15.6 
After 17 m - / / / 88.3 29.0 
Melanoma Pt 2 - / / / / / 
After 14 days - / / / / / 
After 1 m - / / / / / 
Melanoma Pt 3 - / / / / / 
After 1 m - / / / / / 
After 1.5 m - / / / / / 
Melanoma Pt 4 - / / / / / 
Melanoma Pt 5 - / / / / / 
After 2 m - / / / / / 
Melanoma Pt 6 - / / / / / 
Melanoma Pt 7 - / / / / / 
Melanoma Pt 8 - / / / / / 
Melanoma Pt 9 - / / / / / 
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Melanoma Pt 10 - / / / / / 
Melanoma Pt 11 - - / / / / 
Melanoma Pt 12 - - / / / / 
Melanoma Pt 13 - - / / / / 
Melanoma Pt 14 - - / / / / 
After 11 m - - / / / / 
Melanoma Pt 15 - - / / / / 
Melanoma Pt 16 - - / / / / 
Red haired 
normal 
- - / / / / 
Black haired 
normal 
- - / / / / 
Brown haired 
normal 
- - / / / / 
Pheomelanin - - 14.9
a
 2.7
a
   
a 
These values are calculated in mg BTCA/mg pheomelanin (%). 
 
The possibility that some eumelanin was as well present was indicated by the yields of 
the typical marker pyrrole-2,4,5-tricarboxylic acid (PTCA) which exceeded those 
expected for a pheomelanin. In any case eumelanin was only a minor constituent of the 
whole pigment in the sediment. Analyses of urine of melanoma patients without 
melanosis shown in Table 6 did not provide detectable amounts of BTCA. Only in 
melanoma patient number 4, who could be monitored for a long period, appreciable 
amounts of BTCA-5 were obtained after 10 months (BTCA-5 110 mol/l) with an 
increase at 17 months (151 mol/l), a trend already observed for free BTCA (see Table 
6). Hence it can be concluded first that the BTCA obtained after degradation does not 
reflect free BTCA already present in the urine, and second that the urinary pigment can 
be regarded as a pheomelanin giving rise to the BTCAs markers after degradation. This 
trend was also confirmed in the other melanosis patients. Control healthy patients with 
pheomelanic or eumelanic pigmentation did not provide detectable amounts of BTCA. 
Our results suggest that several intermediate metabolites involved in pheomelanin 
formation are excreted into the urine of patients with melanosis from melanoma. As 
regards cysteinyldopas and the eumelanic precursor dihydroxyindole and 
dihydroxyindole carboxylic acid, their excretions have mainly been considered as 
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overflow from melanoma cells and their concentration in the urine as proportional to the 
melanoma load.
75
 
 
Table 8. Relation between analyzed free and by oxidative degradation derived BTCA 
isomers from different urinary fractions of patients with melanosis. Concentration of 
low-molecular weight pigment structures (LowMW pigment) were calculated as 
BTCACentrifuged urine−BTCAFree urine. 
 
Sample Mixed urine Urine sediment Centrifugated 
urine 
Free BTCA LowMW pigment 
 mol/l % mol/l %
a
 mol/l % mol/l %
b
 mol/l %
 b
 
BTCA-5           
Melanosis 
Pt 1 
856.9 100.0 105.7 12.3 681.6 79.5 342.7 50.3 338.9 49.7 
After 4 m 632.8 100.0 257.2 40.6 457.1 72.2 95.4 20.9 361.7 79.1 
Melanosis 
Pt 2 
436.7 100.0 60.9 13.9 362.1 82.9 118.7 32.8 243.4 67.2 
Melanosis 
Pt 3 
101.8 100.0 34.7 34.1 75.3 74.0 28.9 38.4 46.4 61.6 
BTCA-2           
Melanosis 
Pt 1 
262.0 100.0 44.6 17.0 245.9 93.9 81.4 33.1 164.5 66.9 
After 4 m 290.0 100.0 75.7 26.1 227.0 78.3 80.5
c
 35.5 146.5 64.5 
Melanosis 
Pt 2 
92.4 100.0 13.3 14.4 74.4 80.5 37.4 50.3 37.0 49.7 
Melanosis 
Pt 3 
38.2 100.0 10.4 27.2 29.8 78.0 6.8 22.8 23.0 77.2 
a
 Calculated as % of mixed urine. 
b
 Calculated as % of centrifuged urine. 
c
 This peak was not purely separated from interfering peaks. 
 
The occurrence of free BTCAs in the urine is an entirely new finding. The mechanism 
by which this excretion occurs is not clear at present although melanuria and 
melanogenuria are wellknown phenomena.
66,177
 Several earlier studies have shown that 
other benzothiazine related compounds such as trichochromes are also excreted into the 
urine of such patients.
81,173,178
 A number of histological studies have revealed dermal 
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melanin pigment in extracellular connective tissue and within histiocytes and 
fibroblastsin otherwise normal skin, and it should be noted that diffuse melanosis is 
observed in almost all organs, including the liver, spleen, gut, lungs, bone marrow, and 
heart.
66
 Others have also observed melanosomes and pigment even in endothelial cells 
or as cell-free material in tissues.
67
 An interesting theory is that tumor-derived melanin 
granules are liberated to the lymph and blood and are circulated to various organs where 
they are phagocytosed by endothelial cells and the pigment deposited in macrophages 
and other cells.
66
 In the studies by Gambichler et al.
66
 the histopathologic appearance of 
the kidney tissue was consistent with acute kidney injury caused by melanin 
accumulation within the tubules, tubular cells, and endothelial cell of the vessels and 
glomeruli. Acute lysis syndrome is a rare event that occurs mainly in 
lymphoproliferative disease. It has been described in less than ten cases of malignant 
melanoma,
179
 and it has been described initially in the development of melanosis.
71
 The 
findings of Busam et al.
71
 however, documented that diffuse melanosis may result from 
tumor lysis, with release of melanosomes into the bloodstream. Although acute lysis 
syndrome occurs much more seldom in advanced melanoma than melanosis it is 
possible that lysis of melanoma cells is the cause of melanosis, however rarely resulting 
in progression to acute renal failure. Even if melanosomes are found circulating as cell-
free material to tissues
67,71
 these particles measure up to 1.5 m in diameter and such 
subcellular granulae as well as melanin granules of comparable size are unlikely to 
cross an intact glomerular membrane. We found free BTCAs to constitute 15–40% of 
total detected BTCAs (mixed urine after chemical degradation) and the soluble fraction 
(supernatant after centrifugation of urine) constituted around 75% of total (mixed urine). 
This indicates that at least most of the pheomelanic pigment and pigment precursors are 
excreted into the urine as low-molecular compounds and not as high molecular weight 
pigments. It could be speculated that part of the low-molecular compounds are dimers 
of or trichochromes formed from 5SCD and 2SCD. 
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2.6. Mapping structural diversity in red hair pheomelanin: key elusive 
benzothiazolyldihydroisoquinoline building blocks and their formation 
pathway uncovered 
 
 
A definitive assessment of the actual role of pheomelanin in UV susceptibility and 
actinic damage awaits complete elucidation of the fundamental molecular components 
of these heterogeneous and elusive biopolymers.
63,163
 Defining the basic structural 
motifs of human red hair pheomelanin is of the utmost importance in the prospects of 
determining what chromophores activate molecular oxygen and mediate phototoxic 
reactions in cellular systems.
57 
Oxidation of 5SCD and its isomers to pheomelanin proceeds via an array of 
benzothiazine intermediates (Fig. 2). Further oxidation leads to dimers and the 
trichochromes
37
 which overall would take part in pheomelanin build-up (Fig. 4; Fig. 
5).
63,163
 Beyond this level, knowledge of the mechanisms of pheomelanogenesis is 
virtually lacking.  
Direct investigation of the natural pigments, on the other hand, was largely based on 
spectroscopic analysis coupled with chemical degradation studies
44,165 
(Fig. 6), 
supporting the notion that pheomelanins consist of benzothiazine and benzothiazole 
units at various oxidative levels and linked through different bondings.
5
  
A series of studies carried out in the late 1960‟s suggested the presence of isoquinoline 
units in natural pheomelanins, but this hypothesis has remained so far unverified 
(paragraph 1.1.5). 
The lack of information on the occurrence and levels of isoquinoline moieties in human 
pheomelanin is a serious drawback toward an understanding of the role and implication 
of this peculiar pigment in photocarcinogenic processes in redheads.
5
  
Described herein are the results of an integrated approach which allowed for the first 
time the demonstration, characterization and quantitation of isoquinoline-containing 
structural motifs in the human pigment. Evidence is also provided for a possible role of 
these units as determinants of human pheomelanin chromophore.  
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2.6.1. Chemical degradation of natural and synthetic pheomelanins 
 
An initial series of experiments was directed to gauge the presence of isoquinoline-
containing constituents in human red hair pheomelanin by chemical degradation. To this 
aim, it seemed of interest to revisit the alkaline KMnO4 oxidation method successfully 
applied in the early studies to the characterization of gallopheomelanins.
42
 HPLC 
analysis of the red hair degradation mixture (Fig. 41) revealed the presence of two 
distinct peaks attributed to known fragmentation products, thiazoletricarboxylic acid 
(TTCA) and thiazole-4,5-dicarboxylic acid (TDCA), along with other components 
eluted at higher retention times whose properties did not match with those of other 
known degradation products of pheomelanins. Among these a major species eluting at 
around 36 min (I) was well discernible. The same product was generated, together with 
TTCA and TDCA, by degradation of a set of synthetic pheomelanins prepared under 
different conditions (Fig. 41). 
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Figure 41. HPLC traces of the alkaline permanganate degradation mixtures of red 
human hair (A), dopa/cysteine pheomelanin (B), and 5SCD/Zn
2+
/peroxidase/H2O2 
pheomelanin (C). Elutographic profiles are shown with different intensities.  
 
No detectable amount of the product I, however, was present in the degradation 
mixtures from black hair eumelanin, indicating that it derived from an important and 
specific pheomelanin component (Fig. 42).  
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Figure 42. HPLC traces of the alkaline permanganate degradation mixtures of red 
human hair (A), and black human hair (B). Elutographic profiles are shown with 
different intensities. 
 
Accordingly, a procedure was set up which allowed the isolation of the main 
degradation product in sufficient amounts for spectral characterization. For this purpose, 
120 mg of pheomelanin obtained by oxidation of 5SCD with peroxidase/H2O2 in the 
presence of Zn
2+
 ions were treated with alkaline KMnO4 yielded a complex degradation 
mixture from which the desired product could eventually be isolated in small amounts 
by preparative HPLC. The mass spectrum (ESI(-)/MS) displayed a pseudomolecular ion 
peak at m/z 381 (HR/MS 380.9672 calcd for C13H5N2O10S 380.9670) and an absorption 
maximum at 292 and 318 nm.
41
 The 
1
H NMR spectrum was remarkably simple, 
exhibiting a single resonance (singlet) at  8.56. On this basis, the product I was 
unambiguously formulated as the previously described TPCA.
41
 This result allowed to 
conclude that human red hair pheomelanin contains units akin to those found in 
gallopheomelanin and giving on degradation the structurally significant TPCA.  
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The pheomelanin obtained by oxidation of 5SCD with peroxidase/H2O2 in the presence 
of Zn
2+
 ions was selected because of the higher formation yields of the product relative 
to other synthetic pigments prepared under different oxidation conditions (Table 9). 
 
Table 9. Yields of TPCA from alkaline permanganate degradation of red human hair 
and synthetic pigments. 
 
 
2.6.2. Biomimetic oxidation of 5SCD and product isolation 
 
Information about the nature of the TPCA precursor units was then sought through 
careful investigation of the oxidation of 5SCD with peroxidase/H2O2 in the presence of 
Zn
2+
. As shown above, this reaction led to a synthetic pigment which provided the 
richest source of TPCA on degradation. The role of Zn
2+
 ions was to slow down the 
kinetics of pheomelanin synthesis favoring the accumulation of benzothiazine 
intermediates.
37,163
 Such an effect has also been confirmed in studies on catechol 
compounds model of 5SCD.
180
 Besides being chemically convenient for intermediate 
isolation and characterization, the addition of Zn
2+
 is also of biological relevance since 
relatively high levels of zinc are found in normal human skin and are known to 
accumulate in red hair.
139
 HPLC analysis coupled with ESI(+)-MS (Fig. 43) showed in 
the early stages of the reaction the generation of two main products, identified as the 
reduced 3,4-dihydrobenzotiazine-2-carboxylic acid derivative (BTZCA),
163
 and ODHB. 
Sample TPCA (ng/mg)
a
 
Red human hair 690 
Dopa/cysteine pheomelanin 25950 
5SCD/tyrosinase/O2 pheomelanin 15370 
5SCD/Zn
2+
/tyrosinase/O2 pheomelanin 40750 
5SCD/peroxidase (16.7 U/mL)/H2O2 pheomelanin 23940 
5SCD/Zn
2+
/peroxidase (16.7 U/mL)/H2O2 pheomelanin 95700 
5SCD/Zn
2+
/peroxidase (50 U/mL)/H2O2 pheomelanin 110520 
a
 Shown are the mean values for three separate experiments with SD ≤ 10%  
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While compound ODHB accumulated with time, and remained largely unchanged in the 
mixture, intermediate BTZCA attained its maximum concentration after about 1 h and 
then gradually decayed, being replaced by a complex pattern of products including 
BTZCA-dimers and two additional species, A and B, separated by quite different 
elution times but sharing a pseudomolecular ion peak [M+H]
+ 
 in common at m/z 515.0, 
suggesting isomeric dimers of 5SCD.  
 
 
 
Figure 43. HPLC traces of the oxidation mixture of 5SCD with peroxidase/H2O2 in the 
presence of Zn
2+
 at 1 h reaction time (after reduction with NaBH4, 280 nm, blue trace), 
and at 5 h reaction time (340 nm, red trace).  
*7-(2-amino-2-carboxyethyl)-3-carboxy-5-hydroxy-3,4-dihydro-2H-1,4-
benzothiazine.
163
 
 
To gain insight into the structure of these products, the oxidation of 5SCD was repeated 
under similar conditions but on a larger scale, and products A and B were isolated 
accordingly the following procedure. Briefly, when the formation yield of A and B was 
maximum (ca. 5 h), the mixture was cautiously acidified to pH 2 (care being taken to 
avoid artifactual side reactions), and the products that precipitated were collected by 
centrifugation and eventually purified by preparative HPLC. Product A, the most 
abundant (m/z 515.0 [M+H]
+
, max 248, 282, 346, 392 nm), was obtained as an oil 
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poorly soluble in water and markedly unstable to acids. It displayed three singlets in the 
aromatic region of the 
1
H NMR spectrum at  7.05, 7.09 and 7.65, the latter two 
exhibiting a distinct cross-peak in the 
1
H,
1
H COSY spectrum, and two sets of 
resonances ( 3.39, 3.50 and 4.73 and δ 3.60, 3.64 and 5.09) belonging to two alanyl 
side chains, in one of which the CH proton was unusually down field shifted. Product B 
(m/z 515.0 [M+H]
+
, max 245, 330, 394 nm) proved highly unstable and could not be 
further characterized. Based on these data compounds A and B were tentatively 
formulated as the isomeric dihydroisoquinolines 4 and 5.  
The unfavorable properties of products A and B prevented a more in-depth spectral 
analysis.  
In a mildly acidic medium, both A and B were rapidly converted into more retained 
species on reverse phase, featuring a pseudomolecolar ion peak [M+H]
+
 at m/z 513.0, 
suggesting that they were oxidized species (Fig. 44).  
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Figure 44. HPLC (detection at 280 nm) traces and UV-vis spectra (HCl 0.1 M) of A 
(Plot A) and B (Plot B) and their conversion to the oxidized forms, following treatment 
with acids as described. 
 
Whereas A and B could be reduced to tetrahydroisoquinoline derivatives by treatment 
with NaBH4 (Fig. 45), their oxidized forms were fairly stable. Accordingly, a 
convenient protocol for structural characterization of the oxidized forms was developed, 
which involved isolation of A and B in pure form followed by quantitative conversion 
to the oxidized forms. 
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Fig. 45. HPLC (detection at 280 nm) traces and UV-vis spectra (HCl 0.1 M) of 
compound A as such and after reduction with NaBH4.  
 
The 
1
H NMR spectra of the latter compounds featured four aromatic singlets and the 
lack of one of the alanyl chains suggesting formation of an isoquinoline ring system as 
shown in structures 6a and 7a. However, also these compounds proved not definitely 
stable and a derivatization procedure was then considered to allow for a complete 
structural analysis. After several trials it was found that reaction of the products with 
ethyl chloroformate in ethanol/pyridine
181
 by an optimized procedure was the most 
useful strategy for the purposes of this study, converting 6a and 7a into stable 
derivatives fairly soluble in organic solvents. These latter were purified and subjected to 
extensive spectral analysis. 
The product obtained by oxidation and derivatization of A exhibited a pseudomolecular 
ion peak [M+Na]
+ 
at m/z 807 (HR ESI (+)/MS found 807.1629 calcd. for 
C35H36N4O13S2Na 807.1613), indicating a pentasubstituted derivative. Noticeable 
features of the 
1
H NMR spectrum were: a) a 1H singlet resonating at  8.54 and 
showing a one-bond correlation with a carbon signal at  125.1 and a ROESY contact 
with a singlet at  7.98, correlating in turn with a carbon at  117.1; b) two 1H singlets 
at  7.19 and 7.71, showing cross peaks in the HSQC spectrum with carbon resonances 
at  120.7 and 120.2, respectively. Close scrutiny of the 2D spectra of the compound 
and comparison of the data with those of compound ODHB following analogous 
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derivatization with ethyl chloroformate led eventually to formulate the compound as the 
N,O-ethoxycarbonyl-ethyl ester of 10-[6-(2-amino-2-carboxyethyl)-4-
hydroxybenzothiazol-2-yl]-8-carboxy-5-hydroxy-3-oxo-3,4-dihydro-2H-
[1,4]thiazino[5,6-h]isoquinoline (6b). 
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The product obtained from oxidation and derivatization of B displayed relatively similar 
NMR spectra which, in combination with ESI-MS and UV data, allowed 
straightforward identification as the isomeric N,O-ethoxycarbonyl-ethyl ester of 6-[6-(2-
amino-2-carboxyethyl)-4-hydroxybenzothiazol-2-yl]-8-carboxy-5-hydroxy-3-oxo-3,4-
dihydro-2H-[1,4]thiazino[6,5-g]isoquinoline (7b).  
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2.6.3. Chemical degradation behavior of isoquinoline derivatives 
To assess whether and to what extent isoquinoline derivatives 4 and 5 are representative 
of structural components in human red hair pheomelanin, and whether they are 
precursors to TPCA, further experiments were aimed at determining the fragmentation 
products formed by chemical degradation of these compounds in comparison with 
BTZCA-dimers, the 3-oxobenzothiazine ODHB, human pheomelanin and synthetic 
pigment from dopa and cysteine currently used as a standard pheomelanin.
136
 
Degradation methodologies included oxidation with KMnO4
42
 or alkaline H2O2
39
 and 
HI treatment,
76
 and the results are summarized in Table 10. 
 
Table 10. Yields of degradation products from pheomelanins and related compounds.  
 
Sample  Yield (ng/mg)
a
 
 TPCA BTCA 4-AHP 
Red hair 690 1210 1371 
Synthetic 
dopa/cysteine 
pheomelanin 
25950 285500 205000 
Compound 4 21260 203000 75400 
a Shown are the mean values for three separate experiments with SD ≤ 10% 
 
In view of the lower stability and unfavorable solubility properties of 5 most of the 
degradation reactions were carried out on 4 which was available in sufficient amounts to 
allow for reliable quantitative analysis. The most relevant finding was that KMnO4 
degradation of 4 leads to a significant yield of TPCA, supporting the conclusion that 4 
or related units are the missing precursors of this “orphan” pheomelanin degradation 
product. TPCA was also obtained by degradation of 5. A possible artifactual formation 
of TPCA was ruled out by control experiments in which no trace of the marker was 
detected from other precursors, including 5SCD, ODHB, or BTZCA-dimers (data not 
shown). Interestingly, compound 4 gave on degradation all of the pheomelanin markers 
analyzed in this study, i.e. it could account for the entire pigment degradation profile 
(Fig. 46). Further analysis of data in Table 10 indicated moreover a higher ratio of 
formation yield (on a weight basis) of TPCA relative to 4-AHP (an index of 
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benzothiazine units and a quantitative pigment marker)
34,76
 in the case of human 
pheomelanin with respect to compound 4 or synthetic pheomelanin. The main 
conclusion would therefore be that the red hair pigment contains a remarkably high 
level of isoquinoline units, exceeding that expected if it was made up mainly or 
exclusively of dimeric constituents related to 4. It should be noted, in this connection, 
that formation of 4-AHP from 4 is intriguing since AHP markers are known to arise 
from benzothiazine but not benzothiazole units.
34
 It is possible that 4-AHP derives in 
part from the pyridobenzothiazinone system via a reductive carbon-carbon bond fission 
as shown in the case of 3-oxobenzothiazine ODHB,
34
 but this requires verification.  
 
 
 
Figure 46. Origin of the main pheomelanin degradation products from fission of the 
skeleton of compound 4: shadowed area indicates the structural moiety responsible for 
TPCA formation. 
 
 
2.6.4. Absorption properties 
 
Studies of the photochemical and photobiological properties of pheomelanins 
demonstrated that different molecular components may be involved in the transient 
absorption, emission and oxygen photoconsumption responses.
63,64,182
 To determine 
whether dihydroisoquinoline-containing structures may play a role in the photoactivity 
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of pheomelanin pigments, the absorption properties of purified 4 were briefly 
investigated in comparison with those of human hair pheomelanin.  
The absorption spectrum of 4 (Fig. 47) showed a broad band with a shoulder around 
310 and 360 nm in neutral buffer, and displayed reversible shifts in acids to 290, 340 
and 400 nm, reflecting the superimposition of different chromophores. 
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Figure 47. UV-visible absorption spectra of  compound 4 in 0.1 M phosphate buffer, pH 
7.4 (blue trace) and 0.1 M HCl (red trace).  
 
However, the acid-induced band at 400 nm could not be accounted for by either of the 
benzothiazole moiety (ca. 300 nm with shoulders at 320 nm) (Fig. 38)
 
or the 3-oxo-2H-
1,4-benzothiazine system (300 nm) alone. Since the spectrum of 4 completely lost the 
feature at 400 nm upon reduction to the corresponding tetrahydroisoquinoline ([M+H
+
], 
m/z 517.0) with NaBH4 (Fig. 45), it was argued that this band was due to the 
dihydroisoquinolinethiazinone chromophore.  
Interestingly, a similar spectrophotometric behavior was exhibited by red hair 
pheomelanin, which showed in acids a distinct band around 400 nm (Fig. 48, black 
trace). Considering that this feature does not match with those of any of the known 
pheomelanin intermediates, including BTZCA, ODHB, BTZCA-dimers and the 
trichochromes,
62
 it could be speculated that the absorption band at 400 nm in the human 
pheomelanin spectrum is due at least in part to the contribution of structural units 
related to 4.  
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Figure 48. UV-visible absorption spectra of human red hair pheomelanin (black line) 
and compound 4 (red line) in 0.1 M HCl.  
 
 
2.6.5. Mechanistic issues 
 
The isolation of 4 and 5 raised a number of issues concerning the mechanism of 
formation of the isoquinoline moiety. In principle, diverse reaction pathways can be 
envisaged that could lead to the benzothiazole-linked pyridine substructure. For 
example Minale et al.
41
 suggested that TPCA arises from breakdown of partial structure 
8 (Fig. 49) which features a tetrahydroisoquinoline moiety, and went on to propose that 
partial structure 8 is generated via benzothiazine ring contraction causing the C2 carbon 
to become exocyclic thus providing the necessary requisite for isoquinoline ring 
closure.  
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Figure 49. Suggested mechanisms of generation of TPCA from tetrahydroisoquinoline 
precursor units according to Minale et al.
41
  
 
The details of the benzothiazole-forming step are unknown and remain one of the open 
issues in pheomelanin biosynthesis. According to a classical view, benzothiazine ring 
contraction results in the generation of an aldehyde group that is then engaged in Pictet-
Spengler chemistry with another benzothiazine intermediate (Fig. 49, path a). 
Alternatively, two benzothiazine precursor units could couple at the 2- and 8-positions 
and then may undergo a transformation by which the benzothiazole and 
tetrahydroisoquinoline components are formed simultaneously (Fig. 49, path b).
38,41
 
Although both options are reasonable, they have never been supported by direct 
experimental evidence. Moreover, the biomimetic experiments reported in the present 
study indicated the formation of dihydroisoquinoline compounds, whereas previously 
suggested mechanisms led to tetrahydroisoquinoline derivatives. Since it is known that 
oxidation of tetrahydroisoquinoline compounds would not stop at the 
dihydroisoquinoline stage without further conversion to the fully aromatic 
derivatives,
183
 the origin of this discrepancy was addressed by studying the reaction of 
3-oxobenzothiazine ODHB with commercially available 2-formylbenzothiazole as a 
model aldehyde compound for Pictet-Spengler chemistry. Under neutral conditions, two 
main products were formed, that could be isolated and identified as the regioisomeric 
tetrahydroisoquinoline derivatives 9 and 10 (Fig. 50).  
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Figure 50. Pictet-Spengler reaction of 3-oxobenzothiazine ODHB with 2-
formylbenzothiazole. 
 
Notably, no dihydroisoquinoline or higher oxidation product could be detected. 
Moreover, attempts to oxidize 9 and 10 by peroxidase/H2O2 were defeated, the 
compounds being remarkably stable. On this basis, it was concluded that 4/5 are 
unlikely to arise by oxidation of tetrahydroisoquinoline precursors, as suggested by the 
previous authors.
41 
An alternate scheme accounting for the generation of 
dihydroisoquinoline derivatives was therefore worked out, which is shown in Figure 
51. In this figure, which illustrates formation of 4, initial attack of the enamine tautomer 
of benzothiazine BTZCA to the corresponding quinoneimine would generate a dimer 
intermediate. Oxidation of the latter would lead to a spirocyclic intermediate which 
would evolve via a ring-contracting rearrangement to give the dihydroisoquinoline 
derivative. Formation of the 3-oxobenzothiazine moiety would follow from a water 
addition-oxidation-decarboxylation sequence occurring during or after the coupling 
process. 
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Figure 51. Suggested mechanism of formation of 4. 
 
The reaction sequence in Figure 51, though basically similar to the mechanism 
proposed by the early authors
38,41
 envisages an additional oxidation step preceding the 
intramolecular attack of the amino group to give the spirocyclic intermediate. This 
oxidation step is pivotal for production of 4/5 since it would not only facilitate 
nucleophilic attack by the amino group in the intramolecular cyclization process but 
would also convincingly explain generation of the isoquinoline system at the dihydro 
level. Besides providing an explanation to dihydroisoquinoline formation, the proposed 
scheme is of considerable importance as it offers a most viable mechanism for the origin 
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of benzothiazole rings during pheomelanin synthesis, and may well account for the 
consistent proportion of benzothiazole units evidenced in natural pheomelanins, 
particularly red hair and chicken feathers by degradative analysis.
34
 This specific issue 
was recently addressed in detail,
5,34
 but while the formation of benzothiazole moieties 
was demonstrated as a late event in the process, the possibility that this process is at 
least in part the outcome of a benzothiazine-coupling step has been so far overlooked 
and opens entirely new vistas into the process of pheomelanin synthesis in vivo. To 
stretch this speculation further, it may be guessed that similar coupling mechanisms 
may be extended beyond the dimer level, as previously suggested,
41
 thus pointing to 
dihydroisoquinoline ring closure as a chief benzothiazole-forming mechanism of 
pigment chain elongation. Moreover the mechanism of coupling of BTZCA as the 
enamine tautomer to the corresponding quinonimine may actually offer a unifying 
pathway accounting also for the formation of 2,2‟- bibenzothiazine BTZCA-dimers and 
on further oxidation of trichochromes,
37
 significant components of pheomelanic tissues. 
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2.7. Reaction of dihydrolipoic acid with juglone and related 
naphthoquinones: unmasking of a spirocyclic 1,3-dithiane intermediate 
en route to naphtho[1,4]dithiepines 
 
 
 
As part of this PhD studies on thiol-quinone coupling as a viable biomimetic access to 
novel bioactive compounds for practical applications in medicinal and food chemistry, 
the attention was focused on the reaction of dihydrolipoic acid ((R)-6,8-dithiooctanoic 
acid, DHLA) with juglone (5-hydroxy-1,4-naphthoquinone), a characteristic constituent 
of walnut husks which has received considerable attention as a useful scaffold for the 
synthesis of bioactive compounds, e.g. antioxidants,
184
 cysteine protease inhibitors,
185
 
and antitubercular
186
 and antimelanoma agents.
187
 Studies of this chemistry were further 
prompted by the growing interest in sulfur-substituted naphthoquinones as bioactive 
compounds.
188-191
 During this study unexpected mechanistic features of this reaction led 
to the discovery of a novel class of spirocyclic DHLA derivatives of potential chemical 
and practical interest. Main outcomes of this investigation were 1) the characterization 
of the novel reaction products of DHLA with juglone and other naphthoquinones, 2) the 
expedient isolation of the spirocyclic juglone-DHLA adduct, and 3) the extension of the 
study to the spirocyclic adduct formed by reaction with a representative 2-substituted 
naphthoquinone. 
 
 
2.7.1. Reaction of dihydrolipoic acid with juglone 
 
-Lipoic acid (LA) possesses a stereocenter at C-6 and the R-isomer, which is 
synthesized naturally, was used in this study. DHLA was prepared fresh before, 
accordingly a reported procedure.
192
 Briefly, to an aqueous solution of LA (0.25 M) in 
0.25 M NaHCO3, NaBH4 (1.0 M) at -25°C was added. After 2h the mixture was 
acidified to pH 1 and extracted with toluene. The organic layer was analyzed by NMR. 
The 
1
H NMR spectrum of the extract showed signals only in the region between  1.4-
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2.9 and no one around  2.9-3.6, suggesting that a quantitative conversion of LA in 
DHLA has happened to give DHLA in 90 % yield (Fig. 52). 
 
S S
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dihydrolipoic acid
         (DHLA)
NaBH
4
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Figure 52. Reduction of LA to DHLA. 
 
Addition of DHLA to an ethanol solution of juglone in the presence of triethylamine 
(TEA) as basic catalyst resulted in the fast development of a purple red coloration due 
to the formation of a main product ([M+H]
+
 m/z 379) which was isolated and subjected 
to complete NMR spectroscopic characterization. The lack in the proton spectrum of the 
expected resonances for the H-2 and H-3 protons of juglone suggested a cyclic adduct in 
which both the SH functionalities of lipoic acid were linked  to the 1,4-naphthoquinone 
unit forming a [1,4]dithiepine ring. Analysis of the 
13
C NMR spectrum showed, 
unexpectedly, that some of the signals were present as a close pair, in particular those at 
 145.7/145.9 and  143.0/143.2, attributed to the C-2 and C-3 carbons of the 
naphthoquinone moiety, and those at  34.7/34.8 and 45.3/45.5, assigned to the C-5 and 
C-6 carbons of the lipoic acid unit. Based on this observation, it was concluded that the 
isolated product was in fact an intimate 1:1 mixture of two closely related species. 
Accordingly, the products were formulated as the two positional isomers  5-(2H-3,4-
dihydro-7-hydroxy-6,11-dioxonaphtho[3,2-b][1,4]dithiepin-2-yl)pentanoic acid (11a) 
and 5-(2H-3,4-dihydro-7-hydroxy-6,11-dioxonaphtho[2,3-b][1,4]dithiepin-4-
yl)pentanoic acid (11b) (overall isolated yield 70%, formation yield >95% as 
determined by HPLC). Unfortunately, all attempts at separating the compounds, e.g. by 
TLC and reverse phase HPLC under a variety of elutographic conditions, were defeated.  
Compounds 11a,b displayed a chromophore with max at 416 and 533 nm (EtOH), 
which shifted to 497 and 547 (sh) in alkali (Fig. 53) and was stable both in the solid 
state and in solution. It was insensitive to hydrogen peroxide or thiols.  
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Figure 53. UV-vis spectra of 11a,b (160 M) in 0.1 M phosphate buffer at different 
pHs. 
 
Upon reduction with NaBH4 it was changed into a finely structured chromophore (Fig. 
54), which rapidly recovered the original features by reoxidation in air. 
 
 
 
Figure 54. A solution of 11a,b (6 mg, 15 mol) in chloroform (1 mL) was treated with a 
saturated solution of NaBH4 in water. After color discharge, the mixture was acidified 
to pH 1 with HCl 6 M. UV-vis spectra of the organic layer, before and after reduction, 
were recorded after a 100-fold dilution in EtOH. The chromophore of the reduced 
species was stable over 15 min. 
+ NaBH4 
pH 8 
pH 9 
pH 10 
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Formation of regioisomeric 11a,b by the reaction of DHLA with juglone was of 
mechanistic interest. Previous studies of the reactions of juglone with thiols (e.g. 
thioglycolic acid, arylthiols) indicated the 3-position as the most reactive site.
193-194
 This 
was attributed to electron delocalization from the OH group to the carbonyl group at 
position 4, decreasing the electrophilic character of the corresponding position at C-2 
and, hence, favoring attack at C-3. On this basis, and assuming a preferential reactivity 
of DHLA via the less hindered SH group at C-8,
134,195
 isomer 11a was predicted to be 
the main product via an initial chemo- and regioselective coupling. Though somewhat 
disappointing from a synthetic perspective, the unexpected lack of selectivity raised 
mechanistic issues that prompted further insights into this reaction. An explanation for 
this inconsistent result came eventually from careful HPLC analysis of the reaction 
course under higher dilution conditions. Kinetic monitoring showed the initial formation 
of a species (max 356 nm) that gradually decayed concomitant to formation of the 
purple adducts. Initial attempts to isolate this unstable intermediate were unsuccessful. 
However after several trials it was found that conversion of this intermediate to products 
was blocked by acidification of the reaction mixture. Thus, acid quenching of a 
preparative scale mixture allowed the isolation of the labile intermediate. NMR 
spectroscopic analysis of this latter indicated a significant structural difference in the 
naphthoquinone moiety relative to 11a,b. In particular, the resonances due to the C-2 
and C-3 carbons ( 145 and 143 in 11a,b) were apparently replaced by a quaternary 
carbon signal at  53.1, suggestive of a dithioketal function, and a methylene resonance 
at  50.0 (HSQC cross peak with protons at 3.33). A down-field shift of the carbonyl 
resonances by ca. 10 ppm was also apparent, indicating loss of the conjugated double 
bond. Moreover, the proton signals at 3.33 showed long-range correlations with the 
quaternary carbon resonances at 133.6 and 53.1, as well as with the carbonyl signals 
(191 and 196). Likewise, correlations were apparent between one of the C-8 protons 
of the lipoic acid unit ( 2.8) and the carbon signal at 53.1. 
Based on these extensive 2D-NMR data, the compound was identified as the spirocyclic 
1,3-dithiane derivative 11c. Inspection of the proton and carbon spectrum revealed that 
most signals were present as a close pair, indicating that the compound was in fact a 
mixture of two diastereoisomers that differed in the configuration of the spirocenter, and 
could not be separated under a variety of chromatographic conditions. Exposure of 11c 
 - 108 - 
 
 
to TEA in ethanol or to phosphate buffer, pH 7.4, resulted in quantitative conversion to 
an equimolar mixture of 11a,b, confirming its intermediacy in the route to 
naphthodithiepines.  
On this basis, a plausible reaction mechanism for the reaction of DHLA with juglone 
can be proposed (Fig. 55).  
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Figure 55. Proposed mechanism of reaction of juglone with DHLA.  
 
In this figure, selective addition of DHLA via the SH group at C-8 to the 3-position of 
juglone leads to adduct I which then evolves via a fast intramolecular cyclization to give 
the spirocyclic 1,3-dithiane 11c. This latter would be engaged in fast equilibria with the 
starting adduct I and the isomer II. Generation of products 11a,b would then be the 
final outcome of slow, irreversible cyclization/oxidation processes from the ring-opened 
adducts I and II. The equimolar formation of 11a,b is therefore the signature of the 
spirocyclic compound 11c which partitions equally between the ring opening routes a 
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and b. Kinetic analysis of the reaction course (Fig. 56) demonstrates indeed the fast 
accumulation of 1c and its slow decay concomitant to product formation. 
 
 
Figure 56. Kinetic profile of juglone decay (starting concn 0.5 mM) and product 
formation with DHLA; ♦: juglone, □: 11c, ▲: 11a,b.  
 
The reversible formation of the spirocyclic adduct raised the issue of what factors orient 
the initial ring closing attack of SH toward the S-substituted 3-position instead of the 
adjacent unsubstituted 2-position of I. 
 
 
2.7.2. Reaction of dihydrolipoic acid with 1,4-naphthoquinones 
 
To address the last issue, the reactions of DHLA with the parent 1,4-naphthoquinone, 
acetylated juglone and naphthazarin (5,8-dihydroxy-1,4-naphthoquinone) were 
investigated. In all cases the corresponding naphtho[1,4]dithiepines 12-14 were 
obtained in 25-44% isolated yields. 
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For these reactions, the mass balance was accounted for by side products, possibly ring-
opened diadducts and polymeric species that were not investigated further. Notably, all 
attempts to identify or isolate the first formed adducts of the type I met with failure, on 
account of their marked tendency to cyclize or react further via the free SH group.  
The generation of an equimolar mixture of regioisomers from acetylated juglone 
supported operation of the spirocyclic mechanism which, however, could not be 
demonstrated despite several efforts. Nonetheless, the failure to isolate spirocyclic 
dithiane precursors to 12-14 under various concentration, pH and temperature 
conditions does not rule out their transient generation in the mixtures. On this basis, it 
can be argued that the observed accumulation of the spirocyclic intermediate in the case 
of juglone reflects specifically remote electronic control exerted by the OH substituent 
disfavoring fast attack at C-2.  
To address in more detail the generation and fate of spirocyclic dithianes, subsequent 
experiments were directed to investigate the reaction of DHLA with menadione (2-
methyl-1,4-naphthoquinone). Product analysis showed the formation of the S,S’-
bisnaphthoquinone adduct 15a (16%) and of a spirocyclic 1,3-dithiane intermediate 
which was isolated and identified as 15b. For this latter product the presence of the 
spirodithiane ring at the 3-position of the menadione unit was deduced from distinct 
correlations of both the methyl protons at  1.5 and one of the C-8 protons of the lipoic 
acid unit ( 2.77) with the dithioketal carbon resonating at  60 in the HMBC spectrum. 
Also in this case, most of the proton and carbon signals appeared as a couple, 
suggesting that this product, too, was a mixture of diastereoisomers. Thus, the presence 
of the methyl group on the 2-position inhibits formation of stable seven-membered 
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intramolecular cyclization products, by preventing the irreversible oxidation step 
leading to the thermodynamic stable 1,4-naphthoquinone system. The ring-opened 
isomeric adducts deriving from the spiro compound can then evolve only by coupling of 
the SH group with a second molecule of quinone to give 15a (Fig. 57).  
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Figure 57. Proposed mechanism of reaction of menadione with DHLA. 
 
The reaction behavior of the spirocyclic intermediates described herein is worthy of 
further attention. 1,3-Dithianes are valuable synthetic tools and have been employed in 
rearrangement reactions leading to ring expanded derivatives, but these reactions 
proceed usually in poor yields under conditions of acid or metal catalysis.
196-199
 No 
report is available of fast, efficient and mild, base-induced conversion of 1,3-dithianes 
to 1,4-dithiepines.  
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2.8. Synthesis and antioxidant activity of new conjugates of dietary 
polyphenols of plant origin with dihydrolipoic acid 
 
 
In the field of antioxidants research, recent efforts are direct to the preparation and 
properties evaluation of thioconjugates of polyphenols from natural sources.  
Herein, it is described the set up of an efficient one pot strategy to prepare conjugates of 
hydroxytyrosol (HTYR), caffeic acid (CA) and piceatannol (PIC) with dihydrolipoic 
acid (DHLA) from the commercially  available parent  phenols.  
The antioxidant properties of the conjugates were also examined and compared with 
those of the parent o-diphenols. For this purpose it was assessed the ability of the 
conjugated compounds to act as hydrogen donors by the 2,2-diphenyl-1-picrilidrazile 
(DPPH)
110
 assay and their tendency to oxidation, also in comparison with the related o-
diphenols. 
 
 
2.8.1. Synthesis of 5-S-lipoylhydroxytyrosol 
 
To synthesize the conjugate of HTYR with DHLA, prepared as described (paragraph 
2.7.1), a strategy was adopted, that involved the generation of the ortho-quinone of 
HTYR from the related phenol, tyrosol, followed by in situ addition of DHLA. 
Regioselective hydroxylation of tyrosol was achieved by use of 2-iodoxybenzoic acid 
(IBX)
200
 affording the ortho-quinone of HTYR. The reaction mechanism, shown in 
Figure 58, envisages the initial reaction of the phenol with IBX with elimination of a 
molecule of water to form the intermediate A, which subsequently rearranges leading to 
the specie B, with oxygenation of the ortho-position of the phenolic group. During this 
process the iodine (V) is reduced to iodine (III). Tautomerization of B leads to the 
intermediate C, from which the o-quinone and 2-iodobenzoic acid derive, with 
reduction of iodine (III) to iodine (I).
201
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Figure 58. Reaction mechanism of tyrosol oxidation to o-quinone by IBX. 
 
In detail, solid IBX (1.5 eq.) was added to a solution of tyrosol (75 mM) in methanol at 
–25°C, due the high instability of quinones at room temperature. After 1h DHLA (4 eq.) 
was added, and after 15 min the reaction mixture was treated with an aqueous solution 
of Na2S2O5 and acidified until pH 1. 
HPLC/UV analysis of reaction mixture (Fig. 59) showed the presence of 2-iodobenzoic 
acid formed as a by-product of the reaction from IBX (Fig. 58) and of a partially 
resolved component eluting at  tR 20.5 min. The peak at tR 8.2 min was identified as the 
HTYR, product of a redox exchange between the o-quinone and DHLA, a reaction 
which competes with the nucleophilic addition of the thiol to the o-quinone. 
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Figure 59. HPLC-UV trace of the reaction mixture of tyrosol with IBX and DHLA. 
 
For product isolation the mixture was extracted with solvents of increasing polarity, 
toluene, chloroform and ethyl acetate. In particular with toluene 2-iodobenzoic acid and 
possible traces of unreacted DHLA and lipoic acid were removed, as confirmed by 
HPLC analysis of the aqueous layer. The product at 20.5 min was extracted with 
chloroform, while the more polar HTYR remained in solution and could be recovered 
by ethyl acetate extaction. 
The ESI+/MS spectrum of the product exhibited a pseudomolecular ion peak [M+H]
+
 at 
m/z 361.1, indicative of the addition of one DHLA unit to one moiety of HTYR. 
Consistent with this conclusion was the 
1
H NMR spectrum in CH3OD, showing in the 
aliphatic region resonances typical of DHLA and two triplets at  2.65 e 3.67 
characteristic of the hydroxyethyl chain of HTYR. On the contrary the protons of the 
catechol displayed as two doublets at  6.63 and 6.72 with a J of 2.0 Hz typical of a 
meta relation. On this basis, the product was formulated as 5-S-lipoylhydroxytyrosol 
(lipoyl-HTYR) (Fig. 60). 
The regiochemistry of the addition was similar to that of 4-alkyl o-quinones, as for 
example dopa and dopamine, with cysteine.
29,136,169,202,203
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Figure 60. 
1
H and 
13
C NMR resonances of 5-S-lipoylhydroxytyrosol. 
 
The product was isolated in 30% yield. The reaction scheme of lipoyl-HTYR 
preparation is shown in Figure 61. 
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Figure 61. Reaction of tyrosol with IBX and DHLA. 
 
 
2.8.2. Synthesis of 2-S-lipoylcaffeic acid 
 
The conjugation reaction of CA with DHLA was carried out using the same strategy 
described in the synthesis of lipoyl-HTYR, but with coumaric acid as starting product. 
In the early experiments the reaction with IBX was performed at -25°C, but HPLC/UV 
analysis of the reaction mixture showed a small consumption of the coumaric acid. The 
reaction was therefore carried out at room temperature. DHLA was added after 7 min, 
when all the coumaric acid had been converted to o-quinone of CA, as evidenced by 
periodical HPLC analysis. 
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The HPLC/UV profile of the final reaction mixture (Fig. 62) showed  the presence of 2-
iodobenzoic acid, of CA, resulting from a redox exchange between the o-quinone and 
DHLA, and of a component eluted at tR 20.8 min. 
 
 
 
Figure 62. HPLC-UV trace of the reaction mixture of coumaric acid with IBX and 
DHLA. 
 
To isolate this compound the mixture was extracted with solvent at increasing polarity, 
a mixture of hexane/ toluene (8:2, vol/vol), chloroform and ethyl acetate. Initially the 
pure toluene was used to remove 2-iodobenzoic acid and possible traces of unreacted 
DHLA and lipoic acid, but also the product at tR 20.8 min was partially extracted, as 
confirmed by HPLC analysis of the aqueous layer. Consequently, a less polar solvent, 
as the mixture of hexane/toluene, was chosen. The product at 20.8 min was extracted 
with chloroform, while the more polar CA remained in solution and could be recovered 
with ethyl acetate extraction. 
The ESI+/MS spectrum of product exhibited pseudomolecular ion peaks [M+H]
+
 at m/z 
387.1, indicative also in this case of the addition of one DHLA unit to one moiety of 
CA. By 
1
H NMR and 
13
C NMR analysis the product was identified as 2-S-lipoylcaffeic 
acid (lipoyl-CA) (Fig. 63). 
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Figure 63. 
1
H and 
13
C NMR resonances of 2-S-lipoylcaffeic acid. 
 
The regiochemistry of the addition was elucidated by 
1
H NMR analysis of the 
catecholic nucleus, displaying two doublets at  6.86 and 7.22 with a J of 8.4 Hz typical 
of a ortho relation. 
Indeed the cinnamic acids undergo nucleophilic addition at 2 position because of the 
conjugation of the propenoate chain with the acyl group.
171,204-206
 
The product was isolated in 44% yield. The reaction scheme of lipoyl-CA preparation is 
shown in Figure 64. 
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Figure 64. Reaction of coumaric acid with IBX and DHLA. 
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2.8.3. Synthesis of 5-S-lipoylpiceatannol 
 
The conjugation reaction of piceatannol with DHLA was carried out using the same 
strategy described in the synthesis of lipoyl-HTYR, but with resveratrol as starting 
product. 
The HPLC/UV profile of the final reaction mixture (Fig. 65) shown the presence of 2-
iodobenzoic acid, of the piceatannol, product of a redox exchange between the o-
quinone and DHLA, and of a peak at tR 23.1 min. 
 
 
 
Figure 65. HPLC-UV trace of the reaction mixture of coumaric acid with IBX and 
DHLA. 
 
The mixture was extracted with solvent at increasing polarity. In particular, 2-
iodobenzoic acid and possible traces of unreacted DHLA and lipoic acid were extracted 
with a mixture of hexane/ toluene (7:3, vol/vol), the product at tR 23.1 min was extracted 
with chloroform and, subsequently, the piceatannol with ethyl acetate, as confirmed by 
HPLC analysis of the aqueous layer, after each extraction. 
The ESI+/MS spectrum of product at tR 23.1 min exhibited a pseudomolecular ion peak 
[M+H]
+
 at m/z 451.1, indicative also in this case of the addition of one DHLA unit to 
one moiety of piceatannol. By 
1
H NMR and 
13
C NMR analysis the product was 
identified as the 5-S-lipoylpiceatannol(lipoyl-PIC) (Fig. 66). 
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Figure 66. 
1
H and 
13
C NMR resonances of 5-S-lipoylpiceatannol. 
 
Also in this case, the regiochemistry of the addition was elucidated by 
1
H NMR analysis 
of the catechol unit, displaying two doublets at  7.00 and 7.07 with a J of 1.7 Hz 
typical of a meta relation.
 29,136,169,202,203
 
The product was isolated in 33% yield. The reaction scheme of lipoyl-PIC preparation 
is shown in Figure 67. 
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Figure 67. Reaction of resveratrol with IBX and DHLA. 
 
 
 
 - 120 - 
 
 
2.8.4. Antioxidant properties of lipoylconjugates 
 
In a further series of experiments the antioxidant properties of lipoyl-HTYR, lipoyl-CA 
and lipoyl-PIC were tested by the 2,2-diphenyl-1-picrilidrazile (DPPH) assay,
110
 also in 
comparison with the related catechols, HTYR, CA and PIC.  
DPPH is a stable nitrogen-centered free radical. A quantitative analysis of the H-atom 
transfer reaction from a given phenol to DPPH provides a very simple and 
straightforward way to characterize the phenol by a set of parameters (i.e., rate constants 
and stoichiometry) tightly related to its intrinsic antioxidant activity. The H-transfer 
reactions are monitored by UV/VIS spectroscopy by recording the decay of the DPPH 
visible absorption band (λmax=515 nm in MeOH) that reflects the conversion of the 
DPPH radical into the corresponding colorless hydrazine by the antioxidant (Fig. 
68).
110,207
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Figure 68. Reaction of DPPH with a generical H-transfer compound. 
 
The experiments were run at a DPPH/antioxidant molar ratio of 4:1, in order to exhaust 
the H-donating ability of the antioxidant. With potent antioxidants, the visible 
absorbance quickly decays over 1–3 min as a result of the transfer of the most labile H-
atoms of the antioxidant (fast step). This step may be followed by a much slower 
decrease of the visible absorbance featuring the residual H-donating ability of the 
antioxidant (slow step). All the experiment were extended over 20 min, monitoring  the 
absorbance decay of DPPH every 5 sec. 
The absorbance decays monitored for the three lipoyl-conjugates and related catechols 
are shown in Figure 69. 
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Figure 69. Decay of the visible absorbance (515 nm) of a DPPH solution in MeOH (0.2 
mM) following addition of the antioxidant catechol (final concentration 50 M). 
 
In all the cases the lipoylconjugates produced a higher decay of DPPH absorbance (after 
20 min) than the parent catechols.  
Furthermore, each reaction was kinetically analyzed, accordingly a reported method.
207
 
Experiments extending over 20 min were used for the determination of the total 
stoichiometry (ntot) of the antioxidant using the equation 1 (Af, final visible absorbance; 
A0, initial absorbance; c, initial antioxidant concentration; , DPPH molar absorption 
coefficient, 11240 M
-1
cm
-1
). 
 
(1)     ntot= Ao- Af / c 
 
The equation 2 gives the percentage of DPPH inhibition. 
 
(2)    DPPH inhibition (%)=Af /Ao% 
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The kinetic model used for analyzing the H-atom-transfer reaction during the fast step 
does not afford hypothesis about the mechanism of antioxidant degradation.
207
 An 
antioxidant of stoichiometry n is simply regarded as n independent antioxidant subunits, 
AH, which all transfer a single H atom to DPPH with the same second-order rate 
constant k. The initial rate (R0) of DPPH consumption may be written as (c0, initial 
DPPH concentration): 
 
(3)      R0= kncc0 = k1cc0 
 
assuming that  
 
(4)      k=k1/n 
 
where k1 is the rate constant for the first H atom abstraction from the antioxidant. 
The curve-fittings using this model were carried out with n and k1 as the floating 
parameters, since k1 allows a more straightforward comparison between antioxidants 
than k. The estimation of n and k1 can be carried out simply: n can be estimated by 
using eq 1, with Af now standing for the visible absorbance at the end of the fast step. 
On the other hand, eq 2 has to be integrated to yield eq 5.  
 
(5)   ln{(1 - Af/A)/(1 - Af/A0)}= -{k1c/(A0/Af-1)} 
 
Plotting eq 5 as function of time, a straight line with zero intercept is obtained over most 
of the duration of the fast step. The slope of the line with higher value of R
2
 readily 
gives access to k1. 
The results of the test obtained for the compounds under investigation are reported in 
Table 11. 
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Table 11. H-atom transfer reactions from catechols, lipoylconjugates and DHLA to 
DPPH. 
 
 
t (s) k1 n k nTOT 
DPPH inhibition % 
(50 s) 
HTYR 40 266.10 0.67 400.12 1.20 17.3 
Lipoyl-HTYR 30 746.24 1.43 520.77 1.88 37.0 
CA 35 673.54 1.43 470.04 2.18 42.5 
Lipoyl-CA 30 1024.30 1.82 562.93 2.90 55.6 
PIC 50 492.30 0.93 526.34 1.29 24.7 
Lipoyl-PIC 50 954.8 1.61 591.87 2.13 42.5 
DHLA* 35 168.48 0.50 337.09 1.03 15.4 
Shown are the mean values for three separate experiments with SD ≤ 5% 
* DHLA concentration is 0.25 M. 
 
It must be noted that the duration of the fast step, and consequently the n value, displays 
a somewhat arbitrary character since the visible absorbance typically keeps decaying 
over much longer periods, although much more slowly. Indeed, the duration of the fast 
step is determined by visual appreciation. Typically most of the H-donating activity of 
the tested compounds is dissipated within 50 s.  
The reported t(s) is the time when the H-atom transfer reaction relative to the fast step 
is completed, as evaluated by deviation from linearity of eq 5, and it is always less than 
50 s. Consequently, DPPH inhibition % was calculated at 50 s. These data are 
independent on the number of H, that each compound can transfer and so allow a direct 
comparison among the tested compounds. 
In each case the conjugation with DHLA enhanced the DPPH inhibition, in particular 
for HTYR. The lipoylconjugates showed also an higher value of k1, similarly for the 
three couple of compounds. Moreover, the lipoylconjugates displayed values of k, ntot 
and n much higher than the parent catechols.   
Overall, these data suggested that the conjugation with DHLA lead to an increase of the 
H-atom transfer tendency.  
To assess the contribution to this increase provided by  the SH group of the lipoyl-
chain, the kinetic parameters of DHLA were also calculated. The experiments were 
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carried out with a concentration of DHLA (0.25 M) half of that used for the other 
tested compound, to account for the two SH-groups. 
Data in Table 11 indicate that n and ntot values are those expected on the basis of the 
stoichiometry of the DHLA. On the other hand, no indication can be derived from the 
simple sum of the rate of catechol and DHLA, since the relevant kinetic data and in 
particular k1 do not refer to the total stoichiometry of H. 
However, the conjugation with DHLA enhanced the H-donating activity of the 
catechols, not just for the presence of an additional H. 
In a second series of experiments the antioxidant properties of the lipoylconjugates were 
tested by aerial oxidation of an equimolar mixture 500 M of the couples lipoyl-
HTYR/HTYR, lipoyl-CA/CA and lipoyl-PIC/PIC in phosphate buffer 0.1 M at pH 7.4 
under vigorous stirring. The decay of the compounds was monitored by periodical 
HPLC/UV analysis. 
In Figure 70 the decay of each couple of compounds is reported at a reaction time of 30 
min. 
 
 
 
Figure 70. Lipoylconjugates (grey bars) and parent catechols (black bars) decay 
(starting concn 0.5 mM) in the aerial oxidation reaction after 30 min (A: HTYR/lipoyl-
HTYR; B: CA/lipoyl-CA; C: PIC/lipoyl-PIC ). 
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In all the three cases the lipoylconjugates decayed much faster than the parent catechols. 
Significant differences in the oxidation reaction were observed for lipoyl-HTYR and 
lipoyl-PIC, while lipoyl-CA decay was similar to CA. The conjugation with DHLA 
seemed to enhance the oxidability of PIC, more than in the case of CA. However, even 
in the latter case a decay of 50% for lipoyl-CA was observed after 3 h, when the decay 
of CA was not remarkable. 
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3. Conclusions 
 
 
 
The unsolved questions in the studies of pheomelanins, the pigment of red hair, were 
recently summarized in a paper by Simon, et al. “Current challenges in understanding 
melanogenesis: bridging chemistry, biological control, morphology, and function”.5 
Herein, a short excerpt is reported: 
“…several important and challenging issues remain to be resolved. First consider the nature of 
postpolymerization modifications of eumelanin and pheomelanin. Two recent studies (Greco et al., 2009; 
Wakamatsu et al., 2009) have addressed the issue of post-polymerization modification of pheomelanin 
and have made much progress... 
There are also important issues around the structure of pheomelanin itself and its post-polymerization 
modifications. It should be mentioned that we have not unambiguously established how the isoquinoline 
moiety is produced in the late stages of pheomelanogenesis. Pyridine-2,3,4,6-tetracarboxylic acid serves 
to indicate the participation of isoquinoline units in pheomelanin structure (Fattorusso et al., 1969). 
Unfortunately, this useful degradation product has not been studied since this original work. When we 
consider the possibility that the isoquinoline moiety may be of equal importance to the benzothiazine and 
benzothiazole species in defining the molecular structure of pheomelanin, the lack of information on the 
content (or even the presence) of isoquinoline moiety is a serious drawback.  
Another issue that remains unsolved in the post-polymerization modifications is how the benzothiazine 
moiety is converted to the benzothiazole moiety… It is clear that the biological functions of melanin 
pigments are closely related to their structural features. In this review, we have shown how the process of 
mixed melanogenesis can be interpreted in terms of chemistry. However, several important issues remain 
to be solved through multi-disciplinary approaches. One of those important unsolved problems is the 
precise biochemical mechanism of switching between eumelanogenesis and pheomelanogenesis in vivo, 
which appears to depend not only on tyrosinase activity but also on the availability of cysteine (or cystine) 
in melanosomes... Finally, the assembly of the pigment within the intact melanosome remains unknown. 
Our insight into this important issue is likely to remain at a very qualitative level until there is a better 
understanding of the molecular structures of melanins.” 
 
Most of these  issues , underlined in the above text, have been addressed in this research 
work. Investigation on human red hair has shown that post-polymerization modification 
of pheomelanin do occur during hair growth probably as a consequence of oxidative 
processes related in part to sun exposure. Indeed the pigment derived from oxidative 
polymerization of cysteinyldopa isomers, namely 5SCD and 2SCD, suffers extensive 
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degradation during hair growth affecting mainly the 5SCD-derived components, 
whereas the 2SCD-derived units remain largely unaltered.  
Moreover, a proof-of-concept investigation of a chemical mimic of the natural casing 
model of mixed melanogenesis has been disclosed. The new system relies on the 
hitherto unrecognized redox cycling properties of pheomelanin-like polymers, which 
can accelerate the aerial polymerization of catecholamines to give eumelanin-like 
deposits that encapsulate the pheomelanic core and gradually quench the redox centers. 
This model suggested that assembly of the pigments within the intact melanosomes is a 
process not dependent on external factor, as enzymes, but rather related to the intrinsic 
redox properties of the eumelanins and pheomelanins. 
Related model studies carried out with synthetic pigments led to development of a 
pheomelanic casing model, according to which the pigment of red hair consists of a 
2SCD-derived units core associated to a 5SCD-derived units surface, that turns out to be 
more exposed to air and sunlight and so more easily degradable, as observed during hair 
growth. 
An improved analytical methodology of the oxidative degradation mixture of natural 
and synthetic pheomelanins led to identification of  benzothiazole isomers BTCA and 2-
BTCA which resulted predictive markers of skin cancer and melanoma. An efficient 
access to BTCA and 2-BTCA, as well as the decarboxy-derivates was developed. The 
proposed route is efficient, applicable up to hundreds milligram scale, environmentally 
benign (use of organic solvents or toxic reagents is avoided), and attractive for routine 
preparation of standard samples. The procedure which involves sequential oxidation 
and, where appropriate, decarboxylation steps in a single pot and including only a final 
purification step, avoids time-consuming isolation of intermediates, including labile 
benzothiazines, with significantly decreased operation costs 
An extension of this study concerns the identification by ZIC-HILIC coupled with PDA 
detection of BTCA markers into urine in melanoma patients with diffuse melanosis but 
not in other melanoma patients or healthy subjects. This finding provides for the first 
time straightforward evidence that benzothiazoles are indeed intermediate pheomelanin 
metabolites. Formation of BTCA isomers seems to be associated with advanced stage of 
melanoma and might be the result of a chronic oxidative stress condition or due to an 
increased enzymatic process associated with melanocyte activity. Identification of free 
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BTCA isomers in urine provides a significant contribution in the field of urinary 
melanogens, with implications for biosynthetic activity of normal and pathologic 
melanocytes. 
As part of studies aimed at defining the molecular bases of the photosensitizing and 
photocarcinogenesis properties of pheomelanins, the occurrence of isoquinoline 
moieties in human pheomelanin and their origin was demonstrated providing 
unambiguous experimental evidence to the long postulated isoquinoline cyclization 
pathway in cysteinyldopa oxidation. More specifically, the isolation of unprecedented 
dihydroisoquinoline-containing products from the biomimetic oxidation of 5SCD was 
achieved and a new mechanism for benzothiazole formation via benzothiazine ring 
contraction in the pigment pathway was proposed, also based on the results obtained 
with model compounds. Isoquinoline-derived pyridine fragments were identified by 
oxidative degradation of human red hair pheomelanin and synthetic pigments. In 
addition a remarkable matching of the chemical degradation products of the novel 
dihydroisoquinoline-containing intermediates with the entire pattern of diagnostic 
pheomelanin markers was observed.  
The novel dihydroisoquinoline substructures showed absorption features closely  similar 
to those of natural pheomelanin. Considering that this feature does not match with those 
of any of the known pheomelanin intermediates, it could be speculated that the 
characteristical absorption band at 400 nm in the human pheomelanin spectrum is due at 
least in part to the contribution of dihydroisoquinoline structural units. 
Although caution should be exercised in applying the results from model reactions for 
interpreting the behavior of natural systems, the results presented would point to the 
diversity of structural motifs as emerging from the model synthetic studies as a basis to 
interpret the chemical and photobiological properties of natural pigments, supporting 
the value of the integrated approach described as a unique investigative tool.  
Well framed in the general context of the PhD research work on conjugates of phenolic 
system with thiol compounds, the reaction of DHLA with representative 2,3-
unsubstituted 1,4-naphthoquinones was explored uncovering an attractive, chemically 
robust novel heterocyclic system of potential practical interest. Besides the novel 
naphtho[1,4]dithiepine derivatives, a significant outcome of this study is the 
identification and chemical investigation of labile spirocyclic 1,3-dithiane derivatives of 
 - 129 - 
 
 
DHLA. This is the first example of base-induced ring expansion of 1,3-dithianes to 1,4-
dithiepines under mild conditions.  
Furthemore, a straightforward synthetic access to new lipophilic antioxidants derived 
from conjugation of DHLA with naturally occurring polyphenols, such as 
hydroxytyrosol, caffeic acid and piceatannol, was developed. The synthetic route 
presented is based on one-pot hydroxylation and oxidation of the parent commercially 
available phenols to the o-quinones, followed by in situ coupling with DHLA. The 
lipoylconjugates were purified with simple extraction procedure in good yields (30-
45%). They showed higher antioxidant power than the parent catechol, as evidenced by 
the higher H-donating ability and the tendency to oxidation at physiological pHs. 
These conjugates are of potential interest as additives for preparation of functional 
foods.  
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4. Experimental Section 
 
 
 
4.1. General methods 
 
Materials. L-Dopa, L-cysteine, dopamine hydrochloride, L-epinephrine, hydrogen 
peroxide (30% v/v), zinc sulphate heptahydrate, potassium ferricynide, potassium 
permanganate, sodium persulfate, sodium metabisulfite, 57% wt hydriodic acid, 30% wt 
hypophosphorous acid, sodium borohydride, ethyl chloroformate, benzothiazole-2-
carboxaldehyde, 3-nitrotyrosine, 1,4-naphthoquinone, 5-hydroxy-1,4-naphthoquinone 
(juglone), 5,8-dihydroxy-1,4-naphthoquinone, 2-methyl-1,4-naphthoquinone 
(menadione), (R)-(+)-1,2-dithiolane-3-pentanoic acid (lipoic acid), sodium acetate, 
acetic anhydride, and triethylamine (TEA), 2-iodobenzoic acid, oxone®, resveratrol, 
tyrosol, coumaric acid, DPPH, horseradish peroxidase (EC 1.11.1.7), mushroom 
tyrosinase (EC 1.14.18.1), bovine erythrocytes superoxide dismutase (EC 1.15.1.1), 
bovine liver catalase (EC 1.11.1.6)  were commercially available and were used as 
obtained. 
5-S-cysteinyldopa (5SCD),
169
 2-S-cysteinyldopa (2SCD),
171
 7-(2-amino-2-
carboxyethyl)-5-hydroxy-3,4-dihydro-2H-1,4-benzothiazine-3-one (ODHB),
208
 7-(2-
amino-2-carboxyethyl)-3-carboxy-5-hydroxy-3,4-dihydro-2H-1,4-benzothiazine,
209
 
2,2‟-bi[7-(2-amino-2-carboxyethyl)-3-carboxy-5-hydroxy-2H-1,4-benzothiazine] 
(BTZCA-dimers),
37
 6-(2-amino-2-carboxyethyl)-2-carboxy-4-hydroxybenzothiazole 
(BTCA),
141
 thiazole-2,4,5-tricarboxylic acid (TTCA),
40
 thiazole-4,5-dicarboxylic acid 
(TDCA),
210
 4-amino-3-hydroxyphenylalanine (4-AHP)
76
, 5,6-dihyroxyindole-2-
carboxylic acid (DHICA),
211
 5-S-cysteinyldopamine,
212
 pyrrole-2,3,5-tricarboxylic acid 
(PTCA)
213
 were obtained as reported.  
Synthetic pheomelanins from L-dopa and L-cysteine, 5SCD or 2SCD were prepared by 
tyrosinase oxidation as reported,
139
 when not differently specified. 
Biological samples. Lethal yellow (A
y
/a) and recessive yellow (Mc1r
e
/Mc1r
e
) mice hair 
samples were those used previously.
214
 Red feathers were obtained from New 
Hampshire chickens. Red and black hair locks were donated from healthy volunteers. 
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Informed consent was obtained from all subjects. Only hair samples that had not 
received dyeing or other chemical treatments were included in the present study. 
Natural pheomelanin from red hair and natural eumalanin from black hair were isolated 
by enymatic treatment as reported.
215
 
Urines from three patients who earlier had been operated for melanoma and had 
developed melanoma metastases and diffuse melanosis were analyzed. These patients 
had evidence of gray–blue discoloration of the skin at the time of investigation and their 
urines were dark colored.  
Case 1 was a man who at the age of 25–30 years had several blue nevi surgically 
removed. At the age of 49 a local recurrence of malignant blue nevus was removed and 
a control computer tomography showed multiple metastases in the liver, adrenal gland, 
skeleton and several lymph node metastases in the abdomen. Laboratory investigation 
showed serum protein S100 to be 16 g/l (reference interval<0.12 g/l) and lactate 
dehydrogenase 23 katal/l (reference interval<0.8 cat/l). A carboplatin-DTIC course 
was givenas well as X-ray treatment to the thoracic metastases. One month later a bluish 
melanotic coloration of his skin was noted, characteristic of melanosis. After the third 
carboplatin-DTIC course, the first urinary sample was taken. Three months later his 
clinical condition worsened. A new urinary sample was obtained, and he died a few 
days after the last urinary collection.  
Case 2 was a man who at the age of 52 had a superficial spreading melanoma (Breslow 
thickness 0.82 mm, Clark III) removed from his back. Twelve years later the patient had 
a dark-bluish discoloration of the skin. Computer tomography showed multiple 
metastases of the liver, spleen and lungs. A liver biopsy confirmed malignant 
melanoma. Chemotherapy courseswith carboplatin-DTICwere Fig. 1. protein was 9.4 
g/l and lactate dehydrogenase was 10.4 μkatal/l. The urine for pigment analysis was 
obtained after the third chemotherapy course. He died twomonths later because of brain 
metastases.  
Case 3 was a patient with melanosis according to initial information obtained. 
Unfortunately the identity of this patient was obscure so the data from the medical 
record of the patient could not be reported. The urines obtained from the melanosis 
patients were very dark colored, melanuric, and had very high concentrations of 5SCD. 
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Urines from patients with melanoma sent routinely to the laboratory for analysis of 
5SCD in urine were used as control samples. The control samples were selected to 
include 5SCD excretions over a wide range. Their color ranged from normal yellow to 
moderately colored. As a routine 5SCD concentrationwas determined for clinical 
purposes by a method previously described. These urine samples were thus also used 
for analysis of BTCAs. The clinics of the control samples were evaluated by review of 
their medical records. At the time urinary samples were sent to us they had metastatic 
disease from melanoma, which alsowas obvious fromtheir S100 protein in serum and 
5SCD in the urine. None of them had any notes of melanosis. 
Urines from healthy persons of different skin phenotypes were collected on voluntary 
basis. Urine collection: 24-h specimens were collected in plastic bottles containing 35 
ml concentrated acetic acid and were aliquoted and stored at −20 °C. 
Methods. UV-vis spectra were obtained on a diode array spectrophotometer equipped 
with a thermostated sample cell holder. 
1
H NMR spectra were recorded at 200, 400, 500 
or 600 MHz, 
13
C NMR spectra at 50 or 100 MHz.
 1
H, 
1
H COSY,  
1
H, 
13
C (DEPT) 
HSQC, and 
1
H, 
13
C HMBC experiments were run at 400 or 600 MHz, on instruments 
equipped with a 5 mm 
1
H/broadband gradient probe with inverse geometry using 
standard pulse programs. The HMBC experiments used a 100 ms long-range coupling 
delay. Chemical shifts are reported in  values (ppm) downfield from TMS. Signals due 
to isomeric compounds are reported as /. IR spectra were obtained on a FT 
spectrophotometer. HR ESI+MS spectra were obtained in 0.5% TFA-methanol 1:1 v/v; 
HR ESI-MS spectra were obtained in methanol. 
Analytical and preparative TLC were carried out on silica gel plates (0.25 and 0.50 mm, 
respectively) using chloroform/methanol/acetic acid (90:10:1) (eluant I) or 
cyclohexane/ethyl acetate/acetic acid (70:30:1) (eluant II) as eluants. 
HPLC analysis of degradation mixtures. BTCA and 2-BTCA analyses were performed 
on an HPLC instrument equipped with UV-visible detector, set at 254 and 280 nm. A 
Synergi Hydro-RP80A column (250  4.60 mm, 4 m) was used, with 1% formic acid 
taken to pH 2.8 with sodium hydroxide/methanol 97:3 (v/v) as the eluant, at a flow rate 
of 0.7 ml/min.
39
 AHP and AT analyses were performed on an HPLC instrument 
equipped with an EC detector set at + 500 mV vs an Hg/Hg2Cl2 reference electrode. A 
JASCO Catecholpak column (150  4.60 mm, 7 m) was used, with 0.1 M sodium 
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citrate buffer (pH 3.0) containing 1 mM sodium octanesulphonate and 0.1 mM 
Na2EDTA/methanol 98:2 (v/v) as the eluant, at 50°C at a flow rate of 0.7 ml/min. 
TTCA analyses were performed on an HPLC instrument equipped with an UV detector 
set at 269 nm. A Shiseido Capcell Pak C18 (Type MG) column (250  4.60 mm, 5 m) 
was used, with 0.1 M potassium phosphate buffer (pH 1.9)/methanol 99:1 (v/v) as the 
eluant, at 35 °C at a flow rate of 0.7 ml/min.  
HILIC analysis with PDA detection. HILIC analysis was performed using an Ultimate 
300 HPLC system (Dionex, Germering, Germany). Extracted urine samples were 
diluted threefold with the mobile phase and 5 l was injected on a ZIC-HILIC column 
(length 150 mm, I.D. 2.1 mm particle size 3.5 m) with a preceding matched guard 
columnfromSeQuant (Umeå, Sweden). Themobile phase was acetonitrile: 0.1 M 
ammonium acetate buffer, pH 5 (82:18, v/v).Chromatography was completed at a flow 
rate of 0.3 mL/min. Waters photo-diode array detector 996 (Waters, Milford, MA, 
USA) was set at 210, 250, 285 and 325 nm for acquiring chromatograms; UV spectra 
and 3D plots were recorded between 190 and 400 nm. Chromatographic evaluation and 
quantitation at 250 nm was performed with Chromeleon software (Dionex, Germering, 
Germany). 
When it is not specified, the HPLC analysis was carried out on an apparatus equipped 
with a UV detector set at 254, 280 or 340 nm using a Sphereclone ODS (5 micron, 4.6 
250 mm) column, using  the eluant in brackets. 
Semipreparative HPLC was carried out on an instrument coupled with a UV detector set 
at 254 or 280 nm using an Econosil C18 (10 micron, 10  250 mm) column. Preparative 
HPLC was carried out on an instrument coupled with a UV detector set at 254 or 280 
nm using an Econosil C18 (10 micron, 22  250 mm). 
LC-MS analysis of pheomelanins. LC-MS analyses of the degradation mixtures of 
synthetic pheomelanins from 2SCD or 5SCD and pheomelanin isolated from red human 
hair were performed on an HPLC instrument with an electrospray ionization source in 
positive ion mode (ESI+) with single ion monitoring (SIM) detection at m/z 283. A 
Synergi Hydro-RP80A column (250  4.60 mm, 4 m) was used, with 1% formic acid 
taken to pH 2.8 with ammonium hydroxide/methanol 97:3 (v/v) as the eluant, at a flow 
rate of 0.7 ml/min. (High resolution) mass spectra were registered in ESI+ mode with 
the cone and the fragmentator voltage set at 4 kV and 80 V, respectively. 
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SEM analysis of melanin plymers. Morphological analyses of DOPA-melanin, CD-
melanin, polymer obtained by CD-melanin oxidation of DOPA (DOPA/CD-melanin 1:1 
or 10:1, w/w) were performed using a FEI Quanta 200 FEG environmental scanning 
electron microscope (ESEM) (Eindhoven, The Netherlands) in low vacuum mode, using 
a large-field detector (LFD) and an accelerating voltage ranging between 15 and 20 kV. 
Before the analysis, samples were air-dried at 25°C and 50% relative humidity and 
mounted on aluminium stubs by means of carbon adhesive disks. 
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4.2. Isomeric cysteinyldopas provide a (photo)degradable bulk component and a 
robust structural element in red human hair pheomelanin 
 
 
Isolation of 2-BTCA 
 
Synthetic pheomelanin from 2SCD (250 mg) was subjected to degradation in 1 M 
NaOH (50 ml) containing 1.5% H2O2.
40
 After 24 h the mixture was treated with 5% 
Na2S2O5 (10 ml), acidified to pH 3, and purified by preparative HPLC (eluant: 0.2% 
trifluoroacetic acid/methanol 8:2 (v/v); flow rate: 40 mL/min; UV: 280 nm) to give pure 
2-BTCA (30 mg, > 98% purity estimated by 
1
H NMR analysis). High resolution 
ESI+/MS found 283.0392, calcd for C11H11N2O5S 283.0389 [M+H]
+
, UV (0.5 M HCl) 
max 252, 287, 346 nm (log  3.89, 3.63, 3.12). NMR spectral data are listed in Table 1. 
 
 
Degradation procedure 
 
Synthetic pheomelanins, finely minced human hair samples taken at various distances 
from the scalp, mice hairs and chicken feathers were degraded with 1 M NaOH 
containing 1.5% H2O2
40
or 57% HI/30% H3PO2
76
 and were analyzed by HPLC after 
work up as above or as described, respectively.
40,76
 Hydrolytic treatments were carried 
out in a rubber cap sealed vial containing the minced hair samples to which a solution of 
1 M NaOH that had been prior purged with a flux of argon for at least 20 min was 
added via a syringe. After 24 h the mixture was worked up as usual.
40
 
 
 
Oxidation of pheomelanin precursors 
 
A solution of 5SCD or 2SCD or an equimolar mixture of the two isomers at 200 M in 
0.1 M phosphate buffer pH 9.0 was allowed to stand at room temperature under 
vigorous stirring. The mixtures were periodically analyzed by HPLC/UV (column:  
Synergi Hydro-RP80A (250  4.60 mm, 4 m); eluant: 1% formic acid pH 
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2.8/methanol 97:3 (v/v); flow rate: 0.7 ml/min; UV: 254 and 280 nm) and UV 
spectrophotometry. The pigment was collected after 4, 24 and 72 h by centrifugation at 
1300 g for 20 min at 4°C, lyophilized and subjected to degradation as above. Oxidation 
of L-dopa and L-cysteine by tyrosinase was performed as described
139
 and the mixture 
was allowed to stand in air under vigorous stirring. Aliquots (750 L) of the reaction 
mixture were periodically withdrawn, subjected to degradation with 4 M NaOH (250 
L) containing 1.5% H2O2 and then analyzed by HPLC.
39
 
 
 
Solar exposure experiments 
 
Red hair locks were split in two parts, one of which was exposed to sunlight in June 
from 10:00 to 19:00, in the southwest of Italy (40°52‟ N; 14°5‟ E). The accumulated 
exposure time for each sample was 135 h. The other part of each lock was stored over 
the same timespan in the dark. 
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4.3. A melanin-inspired pro-oxidant system for aerial catechol(amine)- 
polymerization: implementing a non-enzymatic mimic of the natural casing model 
 
 
Methods. Analytical HPLC was carried out on an apparatus equipped with a UV 
detector set at 254 or 280 using a Sphereclone ODS (5 micron, 4.6 250 mm) column, 
and as eluant a solution of 0.5% TFA/methanol (90:10, v/v) at flow rate of 0.8 mL/min. 
Analytical HPLC of the degradation mixtures was carried out as reported in general 
methods. 
 
Synthetic pigment preparation. Eumelanin from L-DOPA was prepared by tyrosinase/O2 
oxidation as reported.
216
 Pheomelanins from 5SCD were prepared by peroxidase/H2O2 
oxidation as previously described.
163
 The polymer from 5SCD-melanin induced 
oxidation of DOPA (DOPA/5SCD-melanin 10:1, w/w) was prepared according the 
following procedure. A solution of DOPA (35.0 mg, 0.17 mmol) in 0.1 M phosphate 
buffer (pH 7.4; 175 mL) in presence of 5SCD-melanin (3.5 mg) was allowed to stand at 
room temperature under vigorous stirring. After 24 h  HPLC analysis of the mixture 
revealed that residual DOPA was up to 30%. The mixture was then acidified to pH 3, 
the melanin precipitated was collected by centrifugation (6793 g × min, 4°C, 30 min) 
and washed with 1% acetic acid (3 × 10 mL). The polymer from 5SCD-melanin induced 
oxidation of DOPA (DOPA/5SCD-melanin 1:1, w/w) was prepared according the same 
procedure described above. A solution of DOPA (20.0 mg, 0.10 mmol) in 0.1 M 
phosphate buffer (pH 7.4; 100 mL) in presence of 5SCD-melanin (20.0 mg) was 
allowed to stand at room temperature under vigorous stirring. After 24 h HPLC analysis 
of the mixture revealed no traces of residual DOPA. The mixture was then acidified to 
pH 3, the melanin precipitated collected as above. 
The polymer from 5SCD-melanin induced oxidation of DOPA (DOPA/5SCD-melanin 
5:1, w/w) was prepared according the same procedure described above. A solution of 
DOPA (5.0 mg, 0.025 mmol) in 0.1 M phosphate buffer (pH 7.4; 25 mL) in presence of 
5SCD-melanin (1.0 mg) was allowed to stand at room temperature under vigorous 
stirring. After 24 h HPLC analysis of the mixture revealed no traces of residual DOPA. 
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The mixture was then acidified to pH 3, the melanin precipitated collected as above and 
lyophilized (3.0 mg).   
5-S-cysteinyldopamine-melanin was obtained by oxidation of a solution of 5-S-
cysteinyldopamine (27.0 mg, 0.1 mmol) in phosphate buffer (pH 6.8, 10 mL) with 
horseradish peroxidase (16.7 units/mL final concentration) and 30% v/v hydrogen 
peroxide (15 L). The mixture was allowed to stand at room temperature under 
vigorous stirring for 2 h and then acidified to pH 5. The melanin precipitated was 
collected by centrifugation (6793 g × min, 4°C, 30 min), washed with water (3 × 10 
mL) and then lyophilized.  
 
 
Catechol(amine) oxidation  
 
A solution of DOPA (10.0 mg, 0.05 mmol) in phosphate buffer (pH 7.4, 50 mL) was 
allowed to stand at room temperature under vigorous stirring. When required this 
reaction was carried out in the presence of 5SCD-melanin (2.0 mg) or  DOPA-
eumelanin (2.0 mg). In other experiments the reaction was repeated in the presence of 
CD-melanin as above and i) superoxide dismutase (4 U/mL final concentration), or ii) 
catalase (25 U/mL final concentration), or iii) superoxide dismutase (4 U/mL final 
concentration) and catalase (25 U/mL final concentration) or iv) under an Ar 
atmosphere. 
In other experiments a solution of DOPA (15.0 mg, 0.08 mmol) in phosphate buffer (pH 
7.4, 75 mL) was allowed to stand at room temperature under vigorous stirring in the 
presence of variable amounts of 5SCD-melanin (1.0 mg, 3.0 mg or 15.0 mg). 
A solution of DHICA, DA or EN (10.0 mg, 0.05 mmol) in phosphate buffer (pH 7.4, 50 
mL) was allowed to stand at room temperature under vigorous stirring in the presence 
or in the absence of 5SCD-melanin (2.0 mg). 
In other experiments a solution of DA (10.0 mg, 0.05 mmol) in phosphate buffer (pH 
7.4, 50 mL) was allowed to stand at room temperature under vigorous stirring in the 
presence of 5-S-cysteinyldopamine-melanin (2.0 mg)  
In all cases, aliquots of the reaction mixtures were periodically withdrawn and analyzed 
by HPLC/UV.  
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Oxidative degradation procedure 
 
5SCD-melanin or the polymer from 5SCD-melanin induced oxidation of DOPA 
(DOPA/5SCD-melanin 5:1, w/w) (1.0 mg) was degraded with 1 M NaOH containing 
1.5% H2O2 and was analyzed by HPLC after workup as reported.
39
 
In separate experiments each polymer (2.0 mg) was loaded on a nylon filter (Millex-
GV, 0:22 mm) and treated with solutions at increasing pHs (4  200 L phosphate 
buffer 0.1 M pH 8; 4  200 L phosphate buffer 0.1 M pH 9; 4  200 L 1 M NaOH). 
Each eluate was then treated with NaOH (100 L) and 30% v/v H2O2 (15 L) and 
allowed to stand at room temperature under vigorous stirring. After 24 h the reaction 
mixtures were treated with 5% Na2S2O5 (40 L), taken to pH 3 with 85% H3PO4 and 
analyzed by HPLC as reported.
39 
The insoluble material was treated with NaOH (300 L) and 30% v/v H2O2 (15 L) and 
analyzed by HPLC after workup as reported.
39
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4.4. Oxidative chemistry of cysteinyldopas and properties of related synthetic 
pheomelanins 
 
 
Synthetic pigment preparation. Synthetic pheomelanin from 5SCD or 2SCD was 
obtained by peroxidase/H2O2 oxidation as reported.
163
 
 
 
Oxidative chemistry of 2SCD 
 
A solution of 2SCD (50 mg, 0.16 mmol) in phosphate buffer (pH 6.8, 50 mL) was 
allowed to stand at room temperature under vigorous stirring in the presence of L-
DOPA (1.5 mg, 61mol) and tyrosinase (50 u/mL) under O2 bubbling. Aliquots of the 
reaction mixtures were periodically withdrawn, treated with NaBH4 and analyzed by 
HPLC/UV(eluant: 0.5% TFA (eluant A), methanol (eluant B); 0-15 min, from 10% to 
15% eluant B; 15-55 min, from 15% to 60% eluant B; flow rate: 0.8 mL/min, UV: 254 
nm).  For preparative purpose, after 30 min of the reaction time the mixture was treated 
with NaBH4 and purified by semipreparative HPLC/UV (eluant: 0.5% TFA (eluant A), 
methanol (eluant B); 0-5 min, 20% eluant B; 5-40 min, from 20% to 80% eluant B; flow 
rate: 3 mL/min, UV: 280 nm) to afford 1 (tR 11.2 min, 10.2 mg, 27% yield), 2 (tR 32.3 
min, 4.9 mg, 11% yield), and 3 (tR 36.6 min, 6.8 mg, 15% yield). 
8-(2-amino-2-carboxyethyl)-5-hydroxy-3,4-dihydro-1,4-benzothiazine (1) 
ESI(+)/MS: m/z 225 ([M+H]
+
) 
1
H NMR (D2O/DCl):  3.14 (1H, dd, J=8.6, 14.8 Hz, CH2CH), 3.38 (1H, m, CH2CH), 
3.40 (2H, t, J=4.8 Hz, H-2), 3.81 (2H, t, J=4.8 Hz, H-3), 4.39 (1H, t, J=8.6 Hz, 
CH2CH), 6.82 (1H, d, J=8.0 Hz, H-6), 7.19 (1H, d, J=8.0 Hz, H-7). 
13
C NMR (D2O/DCl):  24.2 (C-2), 34.2 (CH2CH), 43.1 (C-3), 53.5 (CH2CH), 113.4 
(C-6), 117.2 (C-4‟), 124.1 (C-8), 130.4 (C-8‟) 133.4(C-7), 151,7 (C-5), 172.5 (COOH). 
8-(2-amino-2-carboxyethyl)-3-carboxy-5-hydroxy-3,4-dihydro-1,4-benzothiazine 
(2) 
ESI(+)/MS: m/z 269 ([M+H]
+
) 
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1
H NMR (D2O/DCl): δ 3.00 (1H, dd, J=9.6, 14.8 Hz, H-2), 3.24 (1H, ddJ=3.6, 13.2 
Hz, CH2CH), 3.35 (1H, dd, J=5.2, 14.8 Hz, H-2), 3.41 (1H, ddJ=4.4, 13.2 Hz, 
CH2CH), 4.22 (1H, dd, J=5.2, 9.6 Hz, H-3), 4.65 (1H, m, CH2CH), 6.63 (1H, d, J=8.0 
Hz, H-7), 6.68 (1H, d, J=8.0 Hz, H-6). 
 
8-(2-amino-2-carboxyethyl)-3-carboxy-5-hydroxy-3,4-dihydro-1,4-benzothiazine 
(3) 
ESI(+)/MS: m/z 269 ([M+H]
+
) 
1
H NMR (D2O/DCl): δ 2.86 (1H, ddJ=10.0, 14.8 Hz, H-2), 3.22 (1H, ddJ=4.0, 13.2 
Hz, CH2CH), 3.29 (1H, ddJ=4.8, 14.8 Hz, H-2), 3.41 (1H, ddJ=4.0, 13.2 Hz, 
CH2CH), 3.89 (1H, ddJ=4.8, 10.0, Hz, H-3), 4.68(1H, t, J=4.0, CH2CH), 6.56 (1H, d, 
J=8.0, H-6 or H-7), 6.65 (d, J=8.0, H-7 or H-6). 
 
 
Aerial oxidation of 5SCD and 2SCD 
 
An equimolar solution of 2SCD (3 mg, 9.5 mol) and 5SCD (3 mg, 9.5 mol) in 0.1 M 
phosphate buffer (pH 7.4, 19 mL) was allowed to stand at room temperature under 
vigorous stirring. Aliquots of the reaction mixtures were periodically withdrawn and 
analyzed by HPLC/UV (0.5% TFA/methanol 90:10 (v/v); flow rate: 0.8 mL/min, UV: 
254 nm).   
 
 
Oxidation of 5SCD and 2SCD in the presence of synthetic and natural 
pheomelanins 
 
A solution of 5SCD or 2SCD (5 mg, 15.8 mol) in 0.1 M phosphate buffer (pH 7.4, 16 
mL) was allowed to stand at room temperature under vigorous stirring. When required 
this reaction was carried out in the presence of 2SCD-pheomelanin (1.0 mg), 5SCD-
pheomelanin (1.0 mg or 10 mg), natural pheomelanin from red hair (10 mg), natural 
eumelanin from black hair (10 mg). Aliquots of the reaction mixtures were periodically 
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withdrawn and analyzed by HPLC/UV (0.5% TFA/methanol 90:10 (v/v); flow rate: 0.8 
mL/min, UV: 254 nm).   
 
 
Preparation of mixed pheomelanins 
 
Mixed pheomelanin A. A solution of 5SCD (10 mg, 31.6 mol) in 0.01 M phosphate 
buffer (pH 6.8, 2.5 mL) in the presence of 2SCD-pheomelanin (2.0 mg) was treated 
with horseradish peroxidase (16.7 units/mL final concentration) and 30% v/v hydrogen 
peroxide (4 L). The mixture was allowed to stand at room temperature under vigorous 
stirring for 2h and then acidified at pH 3 with 2 M HCl.  The pigment precipitated was 
collected by centrifugation (6793 g × min, 4°C, 30 min) and washed with 1% acetic acid 
(3 × 10 mL) and water (10 mL) and lyophilized (7.5 mg). 
Mixed pheomelanin B. A solution of 2SCD (2 mg, 6.33 µmol) in 0.01 M phosphate 
buffer (pH 6.8, 2.5 mL) in the presence of 5SCD-pheomelanin (10.0 mg) was treated 
with horseradish peroxidase (16.7 units/mL final concentration) and 30% v/v hydrogen 
peroxide (4 L). The mixture was allowed to stand at room temperature under vigorous 
stirring for 2h and then acidified at pH 3 with 2 M HCl.  The pigment precipitated was 
collected as above and lyophilized (7.3 mg). 
 
 
Oxidative degradation procedure 
 
2SCD-melanin (2.0 mg), 5SCD-melanin (2.0 mg), a mixture of  2SCD-melanin (1.0 
mg) and 5SCD-melanin (1.0 mg), mixed pheomelanin A (2.0 mg) or mixed 
pheomelanin B (2.0 mg) was degraded with 1 M NaOH containing 1.5% H2O2 and was 
analyzed by HPLC after workup as reported.
39
 
In separate experiments each polymer (2.0 mg) was loaded on a nylon filter (Millex-
GV, 0:22 mm) and treated with solutions at increasing pHs (4  200 L H2O; 4  200 
L phosphate buffer 0.1 M pH 8; 4  200 L phosphate buffer 0.1 M pH 9; 4  200 L 
1 M NaOH). Each eluate was then treated with NaOH (100 L) and 30% v/v H2O2 (15 
L) and allowed to stand at room temperature under vigorous stirring. After 24 h the 
 - 143 - 
 
 
reaction mixtures were treated with 5% Na2S2O5 (40 L), taken to pH 3 with 85% 
H3PO4 and analyzed by HPLC as reported.
39 
The insoluble material was treated with NaOH (300 L) and 30% v/v H2O2 (15 L) and 
analyzed by HPLC after workup as reported.
39
 
 - 144 - 
 
 
4.5. Biologically inspired one-pot access routes to 4-hydroxybenzothiazole 
aminoacids, red hair-specific markers of UV susceptibility and skin cancer risk 
 
 
Preparation of BTCA from L-dopa 
 
A solution of L-dopa (158 mg, 0.80 mmol) in 0.05 M phosphate buffer (pH 7.4) (34 mL) 
was sequentially treated with L-cysteine (194 mg, 1.60 mmol) and mushroom tyrosinase 
(77,800 units) and the mixture was taken under vigorous stirring at rt. After 2 h the 
mixture was treated with a solution of zinc sulfate heptahydrate (275 mg, 0.96 mmol) in 
water (4 mL) and a solution of potassium ferricyanide (260 mg, 0.80 mmol) in 0.05 M 
phosphate buffer (pH 7.4) (4 mL); after 20 min, sodium persulfate (570 mg, 2.40 mmol) 
and 12 M HCl (40 mL) was added to the oxidation mixture and, after additional 20 min, 
the reaction mixture was treated with sodium disulfite (305 mg, 1.60 mmol). The 
resulting mixture was fractionated by preparative HPLC/UV (eluant: 0.2% 
TFA/methanol 65:35 (v/v); flow rate: 20 mL/min; UV: 254 nm). After evaporation of 
the solvent the residue was dissolved in 0.1 M HCl and taken to dryness to afford 
BTCA
4
 as hydrochloride salt (145 mg, 57% yield, purity >98% as determined by 
1
H 
NMR analysis). 
 
 
Preparation of BT from L-dopa 
 
The oxidation mixture obtained as above
 
for BTCA preparation was heated at 90 °C for 
1.5 h. The fraction obtained by preparative HPLC (eluant: 0.2% TFA/methanol 75:25 
(v/v); flow rate: 20 mL/min; UV: 254 nm) was taken to dryness and treated with 0.1 M 
HCl to afford BT
217
 as hydrochloride salt (120 mg, 55% yield, purity >98% as 
determined by 
1
H NMR analysis).  
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Preparation of BTCA or 2-BTCA from 5SCD or 2SCD 
 
The reaction of 5SCD or 2SCD (250 mg, 0.80 mmol) was carried out in 0.05 M 
phosphate buffer (pH 7.4) (34 mL) using zinc sulfate, potassium ferricyanide and 
sodium persulfate at the same reagent/substrate ratios indicated above followed by 
preparative HPLC as above. The residue was dissolved in 0.1 M HCl and taken to 
dryness to afford BTCA (152 mg, 60% yield, purity >98% as determined by 
1
H NMR 
analysis) or 2-BTCA, (145 mg, 57% yield, purity >98% as determined by 
1
H NMR 
analysis) respectively, as hydrochloride salt.  
 
 
Preparation of BT or 2-BT from 5SCD or 2SCD 
 
The mixture obtained by oxidation of 5SCD or 2SCD described above was heated at 90 
°C for 1.5 h, and purified by preparative HPLC under the conditions described above 
for BT. Treatment of the residue with 0.1 M HCl afforded BT (125 mg, 57% yield, 
purity >98% as determined by 
1
H NMR analysis) or 2-BT
167
 (114 mg, 52% yield, purity 
>98% as determined by 
1
H NMR analysis) respectively, as hydrochloride salt. 
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4.6. Pheomelanin-related benzothiazole isomers in the urine of patients with 
diffuse melanosis of melanoma 
 
 
Urine sample preparation 
 
The samples were used both for evaluation of methodology and for quantification of 
free BTCA isomers without oxidation procedure. The soluble and insoluble pigmented 
fractions of urine were subjected to oxidative degradation for determination of BTCAs. 
After thawing, urine samples were treated according to the following procedure. 
Free BTCA. 10 mL urine was centrifuged at 3000 rpm for 10 min at 15 °C and 2 mL of 
the supernatant was taken to SPE.  
Soluble and sedimented urinary pigment. 10 mL urine was centrifuged at 3000 rpm for 
10 min at 15 °C. From the supernatant 5 mL was taken for oxidation and further 
processed. The urinary sediment was collected and 1 mL of 1 M NaOH was added. The 
sediment was then oxidized as described below. 
Total urinary pigment. 5 mL of well-mixed urine was subjected to oxidation. 
 
 
Oxidation procedure 
 
The method was reported previously.
39
 In short, 200 mg NaOH was added to 5 mL 
urine to give a concentration of 1 M. 1 mg pheomelanin and sediment from 10 mL urine 
was suspended in 1 M NaOH (1 mL). The samples were treated with 1.5% H2O2 (final 
concentration) at room temperature and under vigorous stirring. After 24 h the mixture 
was treated with 5% Na2S2O5, and taken to pH 4 with 85% H3PO4. 
 
 
Extraction of degradation products 
 
The samples, 2 mL urine or oxidation mixtures, were adjusted to pH 1 and transferred to 
C18 cartridges (200 mg, 3 mL, Isolute SPE column, Sorbent, Sweden), previously 
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conditioned with 2 mL methanol, followed by 2 mL 0.1 M hydrochloric acid. After 
loading of the sample, the cartridge was dried out and washed with 1 mL 0.1 M 
hydrochloric acid. The components were eluted with 1 mL of acidified acetonitrile (600 
L 0.1 M hydrochloric acid to 25 mL acetonitrile) and diluted 1:3 with mobile phase 
before injection into HPLC. Alternatively the eluates were evaporated under nitrogen to 
a volume of 200 L and the residue was diluted 1:3 with mobile phase before injection 
into HPLC. 
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4.7. Mapping structural diversity in red hair pheomelanin: key elusive 
benzothiazolyldihydroisoquinoline building blocks and their formation pathway 
uncovered 
 
 
Synthetic pigment preparation 
 
Pheomelanin from L-dopa and L-cysteine was prepared by tyrosinase/O2 oxidation as 
reported.
139
 Pheomelanins from 5SCD were prepared by tyrosinase/O2 oxidation in the 
presence and in the absence of ZnSO4 × 7H2O (1.2 molar equivalents), as previously 
described.
139
 Pheomelanins from 5SCD by peroxidase/H2O2 oxidation were prepared as 
reported, with slight modifications.
163
 Briefly, to a solution of 5SCD (100 mg, 0.32 
mmol) in 0.1 M phosphate buffer (pH 6.8; 25 mL) horseradish peroxidase (16.7 
units/mL final concentration) and 30% v/v hydrogen peroxide (38 L) were added. The 
mixture was allowed to stand at room temperature under vigorous stirring for 2 h and 
then acidified to pH 3. The melanin precipitated was collected by centrifugation (6793 g 
× min, 4°C, 30 min), washed with 1% acetic acid (3 × 10 mL), water (10 mL) and then 
lyophilized. When required, the reaction was run in the presence of  ZnSO4 × 7H2O 
(111 mg, 1.2 molar equivalents). In other experiments, the reaction of 5SCD in the 
presence of ZnSO4 × 7H2O was run with 50 units/mL of peroxidase and 114 L of 30% 
v/v hydrogen peroxide. The mixture was taken under stirring for 24 h, acidified to pH 3, 
and the melanin precipitate collected as above. 
 
 
General degradation procedures 
 
Alkaline permanganate degradation. 5 mg of the appropriate sample (viz synthetic 
pheomelanins, compound 4, 5SCD, ODHB, BTZCA-dimers, 7-(2-amino-2-
carboxyethyl)-3-carboxy-5-hydroxy-3,4-dihydro-2H-1,4-benzothiazine, pheomelanin 
isolated from red human hair) were dissolved in 2 M Na2CO3 (200 L). Red or black 
human hair (5 mg) was pottered in 2 M Na2CO3 (200 L). The mixture thus obtained 
was treated with a 3% solution of KMnO4 (1 mL), added in ten portions at 10 min 
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intervals. Na2S2O5 (72 mg) was then added to destroy residual oxidant, and the mixture 
was filtered through nylon membranes (13 mm, 0.45m; Alltech Associates, Deerfield, 
IL, USA) and washed with water (2 × 2 mL). The filtrate was acidified to pH 1, 
concentrated to a final volume of 200 L and analyzed by HPLC/UV (Gradient A (0.5% 
TFA (eluant a)/methanol (eluant b): from 10 to 15% b, 0-15 min; from 15 to 60% b, 15-
55 min; 60% b, 55-65 min; from 60 to 80% b, 65-80 min; 80% b, 80-90 min); flow rate 
0.8 mL/min, UV: 254 nm). 
Alkaline hydrogen peroxide degradation. Synthetic pheomelanins (5 mg), compound 4 
(5 mg) or finely minced red human hair (10 mg) were degraded with 1 M NaOH 
containing 1.5% H2O2 and were analyzed by HPLC after workup as reported.
39
 
Hydriodic acid degradation. Synthetic pheomelanins (0.5 mg), compound 4 (0.5 mg) or 
finely minced red human hair (5 mg) homogenized in water were degraded with 57% 
HI/30% H3PO2 and were analyzed by HPLC after workup as reported.
76 
 
 
Isolation of 2-[2’-(4’,5’-dicarboxythiazolyl)]-3,4,6-pyridinetricarboxylic acid 
(TPCA).  
 
Pheomelanin (120 mg), obtained by oxidation of 5SCD (250 mg, 0.79 mmol) with 50 
units/mL of peroxidase and 285 L of 30% v/v hydrogen peroxide in the presence of 
ZnSO4 × 7H2O (273 mg, 1.2 molar equivalents) as described above, was dissolved in 2 
M Na2CO3 (4.8 mL) and oxidized with 3% aqueous solution of KMnO4 (16 mL), added 
in ten portions at 10 min intervals. The mixture was treated with Na2S2O5 (1.15 g) to 
destroy residual oxidant, filtered through nylon membranes (47 mm, 0.45m; Alltech 
Associates, Deerfield, IL, USA) and washed with water (2 × 50 mL). The supernatant 
was acidified to pH 1, concentrated to a final volume of 20 mL and extracted with ethyl 
acetate (6 × 30 mL). The organic layer was taken to dryness, dissolved in 0.1 M HCl (1 
mL) and purified by semipreparative HPLC (gradient A, flow rate 0.8 mL/min, UV: 254 
nm)) to give TPCA (yellowish oil, tR 35.8 min, 2 mg, purity > 95%); UV (MeOH): max 
292, 318 nm; HR ESI(-)/MS: found m/z 380.9672 ([M-H]
-
), calcd for C13H5N2O10S m/z 
380.9670; 
1
H NMR (D2O/DCl, 500 MHz): 8.56 (s). 
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Oxidation of 5SCD and isolation of 4 and 5.  
 
To a solution of 5SCD (12 mM) in 0.1 M phosphate buffer (pH 6.8; 150 mL) ZnSO4 × 
7H2O (1.2 molar equivalents), horseradish peroxidase (50 units/mL final concentration), 
and 30% v/v hydrogen peroxide up to a 38 mM final concentration were added. The 
mixture was allowed to stand at room temperature under vigorous stirring for 24 h. 
Aliquots of the reaction mixture were periodically withdrawn, reduced with NaBH4 
when required, and analyzed by HPLC (gradient A, flow rate: 0.8 mL/min; UV: 280 or 
340 nm). For preparative purpose the reaction was carried out on 500 mg of 5SCD and 
after 5 h the mixture was cautiously acidified to pH 2 and the solid that separated was 
collected by centrifugation (6793 g × min, 4°C, 30 min) and purified by preparative 
HPLC (gradient A; flow rate 20 mL/min; UV: 280 nm) to afford 4 (orange-brown oil, tR 
39.8 min, 20 mg, 3% yield, purity >95%) and 5 (brown oil, tR 63.7 min, 17 mg, 2% 
yield, purity >95% HPLC analysis ). 
10-[6-(2-Amino-2-carboxyethyl)-4-hydroxybenzothiazol-2-yl]-8-carboxy-5-
hydroxy-3-oxo-3,4,7,8-tetrahydro-2H-[1,4]thiazino[5,6-h]isoquinoline (4).  
UV (0.1 M HCl): max 248, 282, 346, 392 nm; ESI(+)/MS: m/z 515.0 ([M+H]
+
).  
 
 
 
 
 
 
 
 
 
a
 NMR spectra recorded in D2O/DCl. 
b
 Interchangeable. 
 
 
6-[6-(2-Amino-2-carboxyethyl)-4-hydroxybenzothiazol-2-yl]-8-carboxy-5-hydroxy-
3-oxo-3,4,8,9-tetrahydro-2H-[1,4]thiazino[6,5-g]isoquinoline (5). 
UV (0.1 M HCl): max 245, 330, 394 nm; ESI(+)/MS: m/z 515.0 ([M+H]
+
).
 
 
 H (multiplicity, J, Hz)
a
 
2 3.18 (s) 
6 7.05 (s) 
7 3.60 (dd, 6.0, 14.4) 
3.64 (dd, 6.0, 14.4) 
8 5.09 (t, 6.0) 
5’ 
b
 7.09 (s) 
7’ 
b
 7.65 (s) 
2’’ 4.73 (t, 6.8) 
3’’ 3.39 (dd, 6.8, 14.8) 
3.50 (dd, 6.8, 14.8) 
S
N
H
OH
N
S
N OH
NH
2
O
COOH
HOOC
4
1
2
4
6
7
1'
3'
5'
7'
1''
2''
3''
8
 - 151 - 
 
 
Preparation of 6a and 7a.  
 
A solution of 4 or 5 (15 mg, 0.03 mmol) in 15 mL methanol/acetic acid (99:1 v/v) was 
allowed to stand at room temperature under vigorous stirring. Aliquots of the reaction 
mixture were periodically withdrawn and analyzed by HPLC (gradient A; flow rate 0.8 
mL/min; UV: 340 nm). After 24 h the mixture was taken to dryness to afford, 
respectively, 6a (brown oil, tR 50.1 min, 15 mg, 99% yield, purity >95%) or 7a (brown 
oil, tR 80.6 min, 15 mg, 99% yield, purity >95%).  
 
10-[6-(2-Amino-2-carboxyethyl)-4-hydroxybenzothiazol-2-yl]-8-carboxy-5-
hydroxy-3-oxo-3,4-dihydro-2H-[1,4]thiazino[5,6-h]isoquinoline (6a). 
UV (EtOH): max 294, 355, 393 nm; HR ESI(-)/MS: found m/z 511.0400 ([M-H]
-
), 
calcd for C22H15N4O7S2 m/z 511.0388. 
 
 
a
 NMR spectra recorded in CD3OD. 
b
 Assignments based on 
1
H, 
13
C DEPT HSQC 
spectrum. 
c
 Interchangeable. 
 H (multiplicity, J, Hz)
a
 C
a,b
 
2 3.06 (s) 31.1 
6 7.36 (s) 108.3 
7 8.51 (s) 124.8 
5’ 
c
 6.93 (s) 113.6 
7’ 
c
 7.50 (s) 114.3 
2’’ 4.29 (m) 55.1 
3’’ 3.24 (m) 
3.44 (m) 
37.6 
S
N
H
OH
N
S
N OH
NH
2
O
COOH
HOOC
1
2
3
5 4
6
7
8
9
10
1'
3'
5'
6'7'
4'
1''
2''
3''
7a6a 
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6-[6-(2-Amino-2-carboxyethyl)-4-hydroxybenzothiazol-2-yl]-8-carboxy-5-hydroxy-
3-oxo-3,4-dihydro-2H-[1,4]thiazino[6,5-g]isoquinoline (7a). 
 
UV (EtOH): max 273, 318, 397 nm; HR ESI(-)/MS: found m/z 511.0410 ([M-H]
-
), 
calcd for C22H15N4O7S2 m/z 511.0388;
 13
C NMR (CD3OD, 400 MHz): 28.5 (CH2), 36.1 
(CH2), 53.8 (CH), 112.5 (CH), 112.8 (CH), 114.8 (C), 116.6 (CH), 125.2 (C), 125.8 
(CH), 127.4 (C), 133.8 (C), 135.1 (C), 137.0 (2 × C), 139.5 (C), 140.7 (C), 146.6 (C), 
151.3 (C), 165.7 (C), 168.9 (C), 169.7 (C), 171.6 (C). 
S
N
H
OH
O
N
SN
OH
NH
2
COOH
HOOC
1
2
45
8
7
9 10
1'3'
4'
5'
7'
1''
2''3''
7a  
 
a
 NMR spectra recorded in CD3OD.
 
b
 Assignments based on 
1
H, 
13
C DEPT HSQC spectrum. 
c
 Interchangeable. 
 
 H (multiplicity, J, Hz)
a
 C
a,b
 
2 3.57 (s) 28.5 
9 7.83 (s) 125.8 
10 
c
 7.09 (s) 116.6 
5’ 
c
 6.79 (s) 112.5 
7’ 
c
 7.24 (s) 112.8 
2’’ 4.35 (br s) 53.8 
3’’ 3.22 (m) 
3.37 (m) 
36.1 
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Ethyl chloroformate derivatization 
 
The ethyl chloroformate derivatization procedure was performed as reported, with 
modifications.
13
 
Ethyl chloroformate derivatization of ODHB. A solution of ODHB (17.5 mg, 0.065 
mmol) in 100 mL water/ethanol/pyridine (60:64:16 v/v) was treated with ethyl 
chloroformate (6 mL), added in ten portions at 3 min intervals. The mixture was 
extracted with chloroform (3 × 80 mL) and the combined organic layers were dried over 
sodium sulfate. The residue was dissolved in ethanol and taken to dryness (4 × 10 mL) 
to convert mixed anhydride formed at carboxyl groups into ethyl esters.
13
 The residue 
was then dissolved in chloroform and washed with 0.01 M HCl (3 × 80 mL) to remove 
residual pyridine. The final residue was taken up in chloroform/acetonitrile (1 mL, 1:1 
v/v) and purified by semipreparative HPLC (gradient B (H2O (eluant a)/acetonitrile 
(eluant b): 5% b, 0-5 min; from 5 to 90% b, 5-40 min), UV: 280 nm). The eluate was 
taken to dryness, the residue was dissolved in 
chloroform and dried over sodium sulfate to eventually 
afford N,O-ethoxycarbonyl-ethyl ester of ODHB 
(yellowish oil, tR 24.4 min, 6 mg, 20% yield, purity 
>95%). 
ESI(+)/MS: m/z 441.0 [M+H]
+
; 
1
H NMR (CDCl3, 400 
MHz):  1.24 (6H, m, OCH2CH3); 1.40 (3H, m, OCH2CH3); 4.12 (2H, q, J=7.2 Hz, 
OCH2CH3); 4.19 (2H, q, J=7.2 Hz, OCH2CH3); 4.33 (2H, q, J=7.2 Hz, OCH2CH3); 3.41 
(2H, s, H-2); 3.06 (2H, m, CH2CH); 5.20 (1H, m, CH2CH); 6.95 (1H, s, H-6 or H-8), 
6.98 (1H, s, H-8 or H-6); 7.87 (1H, s, NH). 
 
Ethyl chloroformate derivatization of 6a and 7a. A solution of 6a or 7a (10 mg, 0.020 
mmol) in 30 mL water/ethanol/pyridine (60:64:16 v/v) was treated with ethyl 
chloroformate (1.8 mL), added in ten portions at 3 min intervals. The final residue, 
obtained after workup as described above, was taken up in chloroform/acetonitrile (1 
mL, 1:1 v/v) and purified by semipreparative HPLC (gradient B, UV: 280 nm). The 
eluate was taken to dryness, the residue was dissolved in chloroform and dried over 
sodium sulfate to eventually afford N,O-ethoxycarbonyl-ethyl ester of 6a (6b, yellow 
S
O
N
H
N
H
O
O
O
O
O
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O
1
2
45
6
8
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oil, tR 31.2 min, 5 mg, 30% yield, purity >95%) or of 7a (7b, yellow oil, tR 31.6 min, 2 
mg, 10% yield, purity >95%).  
 
6b. UV (EtOH): max 294, 350, 385 nm; HR ESI(+)/MS: found m/z 807.1629 
([M+Na]
+
), calcd for C35H36N4O13S2Na m/z 807.1613. 
 
S
N
H
O
N
S
N O
O
O
O
O
O
O
O
O
O
N
H
O
O
1
2
45
6
7
8 10
10a
10b
1'
3'
5'
7'
1''
2''
3''
6b  
 
 
 
 
a
 NMR spectra recorded in CDCl3. 
b
 Resonances of ethoxy and ethoxycarbonyl groups: 
1
H NMR: 
 1.25 (3H × 2), 1.34 (3H), 1.46 (3H), 1.48 (3H), 4.14 (2H), 
4.20 (2H), 4.28 (2H), 4.43 (2H), 4.52 (2H); 
13
C NMR:  14.1 
(CH3 × 3), 14.4 (CH3), 14.5 (CH3), 61.4 (CH2), 61.8 (CH2), 
62.1 (CH2), 65.3 (CH2), 66.4 (CH2), 151.1 (CO), 153.3 (CO), 
155.9 (CO).    
c, d
 Interchangeable 
 
 H (multiplicity, J, Hz)
a,b
 C
a,b
 
2 3.06 (s) 30.8 
3  166.1 
4 8.21 (s)  
4a  131.3 
5  141.8 
6 7.98 (s) 117.1 
6a 
d
  138.9 
7 8.54 (s) 125.1 
8  135.0 
CO-C8  164.5 
10  150.0 
10a  125.1 
10b  121.7 
2’  170.0 
3’a  145.3 
4’ 
d
  144.9 
5’ 
c
 7.19 (s) 120.7 
6’  135.8 
7’ 
c
 7.71 (s) 120.2 
7’a 
d
  140.3 
1’’  171.2 
2’’ 5.26 (m) 54.7 
3’’ 3.30 (m) 38.5 
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7b. UV (EtOH): max 294, 341, 394 nm; HR ESI(+)/MS: found m/z 807.1630 
([M+Na]
+
), calcd for C35H36N4O13S2Na m/z 807.1613. 
 
 
       a
 NMR spectra recorded in CDCl3.
  
b
 
1
H and 
13
C NMR resonances of ethoxy and ethoxycarbonyl 
groups were in the range 1.20-1.50 (CH3), 3.80-4.60 (CH2) and 
14.0-15.0 (CH3 ), 61.4-66.3 (CH2 ) ppm, respectively. 
c
 Assignments based on 
1
H, 
13
C DEPT HSQC spectrum. 
d
 Interchangeable. 
 
The two series of signals in the 
1
H and 
13
C NMR spectrum were suggestive of two 
closely related species which could not be separated under a variety of conditions. It is 
possible that this reflects atropisomerism at the benzothiazole-isoquinoline bond due to 
the steric hindrance of the ethoxycarbonyl group at C-5, as would also be indicated by 
the lack of signal splitting in the underivatized compound. Yet, attempts to obtain 
experimental support to this hypothesis by analysis of the sample at higher temperature 
in different solvents failed because of the ease to decomposition exhibited by the 
compound.  
 
 H (multiplicity, J, Hz)
a,b
 C
a.b,c
 
2 3.49/3.59 (s) 33.7/28.8 
4 8.05 (s)  
9 8.42/8.50 (s) 126.5/123.7 
10 7.61/7.99 (s) 118.1/124.6 
5’ 
d
 7.22/7.23 (s) 120/121 
7’ 
d
 7.65/7.67 (s) 119.9/119.5 
2’’ 5.21 (m) 54.6 
3’’ 3.28/3.31 (m) 38.5 
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Isolation of 9 and 10a/b 
 
To a solution of ODHB (100 mg, 0.37 mmol) in 0.1 M phosphate buffer (pH 7.4; 25 
mL) a solution of benzothiazole-2-carboxaldehyde (60 mg, 0.37 mmol) in acetonitrile 
was added and the mixture was allowed to stand at room temperature under vigorous 
stirring. After 7 h the reaction mixture was analyzed by HPLC (gradient B, UV: 254 
nm, see profile below), acidified to pH 1 and extracted with ethyl acetate (10 × 30 mL).  
The combined organic layers were taken to dryness, the residue was dissolved in 
water/methanol (2 mL, 1:1 v/v) and purified by preparative HPLC (0.3 % 
TFA/methanol 35/65 (v/v), flow rate 9 mL/min, UV: 254 nm). The eluates were 
concentrated to a final volume of 20 mL, extracted with ethyl acetate (10 × 30 mL) and 
the combined organic layers were dried over sodium sulfate to eventually afford 9 
(yellow oil, tR 12.9, 7 mg, 4% yield, purity >98%), 10a (yellow oil, tR 26.8, 6 mg, 4% 
yield, purity >98%) and 10b (yellow oil, tR 39.3, 13 mg, 8% yield, purity >98%). Based 
on NMR analysis and the relative abundance (HPLC trace) compounds 10a and 10b 
were formulated as diastereomers.  
10 20 30 40 0 min 
400 
0 
1200 
800 
1600 
mAbs 
9 
10b 
10a 
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10-Benzothiazol-2-yl-8-carboxy-5-hydroxy-3-oxo-3,4,7,8,9,10-hexahydro-2H-
[1,4]thiazino[5,6-h]isoquinoline (9). 
UV (EtOH): max 236, 269, 299 nm; HR ESI(-)/MS: found m/z 412.0432 ([M-H]
-
), 
calcd for C19H14N3O4S2 m/z 412.0431. 
S
N
H
OH
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H
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9 10
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9  
 
 
 
 
 
 
 
 
a
 NMR spectra recorded in DMSO-d6. 
 H (multiplicity, J, Hz)
a
 C
a
 
2 3.19 (d, 14.8) 
3.33 (d, 14.8) 
29.4 
3  164.7 
4 9.61 (s)  
4a  125.6 
5  146.2 
6 6.75 (s) 113.2 
6a  127.0 
7 3.04 (m) 
3.28 (m) 
28.5 
8 4.36 (m) 51.0 
COOH  170.4 
10 6.11 (s) 53.8 
10a  118.3 
10b  120.4 
2’  166.6 
3’a  152.5 
4’ 7.98 (1H, d, 8.0) 123.6 
5’ 7.48 (m) 127.4 
6’ 7.45 (m) 126.4 
7’ 8.07 (d, 7.8) 122.8 
7’a  135.8 
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6(R/S),8(S)-6-Benzothiazol-2-yl-8-carboxy-5-hydroxy-3-oxo-3,4,6,7,8,9-hexahydro-
2H-[1,4]thiazino[6,5-g]isoquinoline (10a/b). 
10a: UV (EtOH): max 220, 244, 294 nm; HR ESI(-)/MS: found m/z 412.0436 ([M-H]
-
), 
calcd for C19H14N3O4S2 m/z 412.0431. 
10b: UV (EtOH): max 220, 243, 294 nm; HR ESI(-)/MS: found m/z 412.0436 ([M-H]
-
), 
calcd for C19H14N3O4S2 m/z 412.0431.  
 
S
N
H
O
NH
SN
OH
HOOC
1
2
3
44a
56
7
5a
8
9 10
10a9a
1'
2'3'
4'
5' 6'
7'
3a' 7a'
10a/b  
a
 NMR spectra recorded in DMSO-d6. 
b
 Interchangeable. 
10b H (multiplicity, J, Hz)
a
 C
a
 
2 3.40 (s) 29.4 
3  165.1 
4 9.48 (s)  
4a  125.4 
5  142.3 
5a  122.2 
6 5.76 (s) 53.0 
COOH  174.0 
8 3.82 51.6 
9 2.80 (m) 
2.93 (m) 
30.5 
9a  129.3 
10 6.78 (s) 119.2 
10a  120.3 
2’  177.5 
3’a  152.4 
4’ 7.90 (d, 8.0) 122.5 
5’ 7.47 (t, 8.0) 126.4 
6’ 7.40 (t, 8.0) 125.4 
7’ 8.03 (d, 8.0) 122.5 
7’a  134.8 
10a H (multiplicity, J, Hz)
a
 C
a
 
2 3.41 (s) 29.4 
3  165.1 
4 9.53 (s)  
4a  125.6 
5  142.5 
5a 
b
  120.7 
6 6.00 (s) 53.9 
COOH  167.3 
8 4.11 (m) 54.1 
9 2.85 (m) 
3.05 (m) 
30.0 
9a  129.8 
10 6.88 (s) 119.0 
10a 
b
  120.9 
2’  172.0 
3’a  152.2 
4’ 7.93 (d, 7.0) 122.6 
5’ 7.50 (m) 126.6 
6’ 7.44 (m) 125.9 
7’ 8.05 (d, 8.0) 122.6 
7’a  134.9 
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4.8. Reaction of dihydrolipoic acid with juglone and related naphthoquinones: 
unmasking of a spirocyclic 1,3-dithiane intermediate en route to 
naphtho[1,4]dithiepines 
 
 
Preparation of DHLA (6,8-dimercaptoottanoic acid) 
 
To 1.0 g of lipoic acid, previously dissolved in 20.0 mL of an aqueous solution of 
NaHCO3
 
(0.25 M), were added 740.0 mg of NaBH4
 
and the mixture was taken under 
stirring at –25 °C. After 2 h the reaction mixture was acidified until pH 1 with HCl 6 M 
and extracted with toluene (5 x 20 mL). The residue was analysed by 
1
H NMR to give 
DHLA in a pure form (920.0 mg, 91 % yield).  
 
 
5-acetoxy-1,4-naphthoquinone 
 
The title compound was prepared by acetylation of juglone according to a literature 
procedure with modifications.
171
 A solution of 5-hydroxy-1,4-naphthoquinone (100 mg, 
0.58 mmol) and sodium acetate (590 mg, 7.2 mmol) in acetic anhydride (2 mL) was 
stirred at 120°C. After 30 min the mixture was diluted in 0.1 M phosphate buffer (pH 
7.4) (5 mL) and extracted with chloroform (3 × 10 mL). The combined organic phases 
were dried over sodium sulfate, filtered and taken to dryness in vacuo. The compound 
was isolated as a brown powder (Rf 0.44 (eluant II), 110 mg, 88% yield, purity> 98%); 
UV (EtOH): max 340 nm (log  3.41); IR(CHCl3): max 1766, 1671, 1613, 1596 cm
-1
;  
HR ESI+/MS: found m/z 239.0332 ([M+Na]
+
), calcd for C12H8O4Na m/z 239.0320; H 
(200 MHz, CDCl3) 2.43 (3H, s), 6.83 (1H, d, J= 10.6 Hz), 6.93 (1H, d, J= 10.6 Hz), 
7.37 (1H, d, J= 7.8 Hz), 7.74 (1H, t, J= 7.8 Hz), 8.02 (1H, d, J= 7.8 Hz); 
 C (50 MHz, 
CDCl3) 21.0 (CH3), 123.2 (C), 124.9 (CH), 129.7 (CH), 133.5 (C), 134.8 (CH), 137.3 
(CH), 139.8 (CH), 149.4 (C), 169.3 (C), 183.6 (C), 184.1 (C). 
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5-(2H-3,4-dihydro-7-hydroxy-6,11-dioxonaphtho[3,2-b][1,4]dithiepin-2-
yl)pentanoic acid (11a) and 5-(2H-3,4-dihydro-7-hydroxy-6,11-dioxonaphtho[2,3-
b][1,4]dithiepin-4-yl)pentanoic acid (11b) 
 
To a solution of juglone (50 mg, 0.3 mmol) in absolute ethanol (6 mL) TEA (42 L, 0.3 
mmol) and DHLA (62 mg, 0.3 mmol), previously dissolved in ethanol (600 L), were 
added under vigorous stirring. Aliquots of the mixture were periodically analized by 
TLC (eluant I) and HPLC (gradient C: 0.5% TFA (solvent a), acetonitrile (solvent b), 0-
45 min from 5% to 90% solvent b, 45-50 min 90% solvent b, flow rate: 0.8 mL/min, 
UV: 254 nm). For preparative purpose after 10 min the reaction mixture was evaporated 
to dryness, and the residue obtained was dissolved in chloroform and fractionated by 
preparative TLC (eluant I) to afford 11a,b as a purple red oil (Rf 0.59, 79 mg, 70% 
yield, purity> 98%); UV (EtOH): max 291, 416, 533 nm (log  3.92, 3.38, 3.15); 
IR(CHCl3): max 3688, 3522, 1713, 1626, 1457 cm
-1
; HR ESI+/MS: found m/z 379.0658 
([M+H]
+
), calcd for C18H19O5S2 m/z 379.0674; DHLA moiety H (400 MHz, CDCl3) 
1.53 (1H, m, 4-H), 1.68 (5H, m, 3-H, 4-H and 5-H), 1.94 (1H, m, 7-H), 2.23 (1H, m, 7-
H), 2.38 (2H, m, 2-H), 2.97/2.99 (1H, m, 8-H), 4.19 (1H, m, 8-H), 4.37 (1H, m, 6-H); 
juglone moiety H 7.20 (1H, d, J= 8.0 Hz, 6-H), 7.55 (1H, t, J= 8.0 Hz, 7-H), 7.60 (1H, 
m, 8-H), 11.8 (1H, br s); DHLA moiety C (100 MHz, CDCl3) 24.3 (CH2, C-3), 26.3 
(CH2, C-4), 29.8 (CH2, C-8), 33.5 (2  CH2, C-2 and C-7), 34.7/34.8 (CH2, C-5), 
45.3/45.5 (CH, C-6), 178.5 (C, C-1); juglone moiety C 114.2 (C, C-4a), 119.7/119.8 
(CH, C-8), 124.3 (CH, C-6), 131.7 (C, C-8a) 136.1 (CH, C-6), 143.0/143.2 (C, C-3), 
145.7/145.9 (C, C-2), 161.4 (C, C-5), 179.5 (C, C-1), 185.1 (C, C-4). 
 
 
5-(2’,3’-dihydro-spiro[1,3-dithiane-2,3’-[5]hydroxy[1,4]naphthoquinone-4-
yl])pentanoic acid (11c) 
 
To a solution of juglone (50 mg, 0.3 mmol) in absolute ethanol (600 mL) TEA (42 L, 
0.3 mmol) and DHLA (62 mg, 0.3 mmol), previously dissolved in ethanol (600 L), 
were added under vigorous stirring. Aliquots of the mixture were periodically analized 
by TLC (eluant I) and HPLC (gradient C, flow rate: 0.8 mL/min, UV: 254 nm). For 
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preparative purpose after 10 min the mixture was treated with TFA (6 mL) and 
concentrated in vacuo. The residue was purified by preparative HPLC (gradient C, flow 
rate: 3 mL/min, UV: 254 nm)  to provide 11c as a yellow oil (tR 33.4 min, 50 mg, 44% 
yield, purity> 98%); UV (EtOH): max 232, 356 nm; IR(CHCl3): max 3689, 3510, 1704, 
1636, 1455 cm
-1
; HR ESI+/MS: found m/z 381.0845 ([M+H]
+
), calcd for C18H21O5S2 
m/z 381.0830; DHLA moiety H (400 MHz, CDCl3) 1.51 (4H, m, 3-H and 5-H), 1.54 
(1H, m, 7-H), 1.58 (2H, m, 4-H), 2.24/2.26 (1H, m, 7-H), 2.36 (2H, t, J= 7.2 Hz, 2-H), 
2.79/2.82 (1H, m, 8-H), 3.38 (1H, m, 8-H), 3.54 (m, 1H, 6-H); juglone moiety H 
(2H, s, 2-H), 7.28 (1H, d, J= 9.2 Hz, 6-H), 7.50 (1H, d, J= 7.2 Hz, 8-H), 7.60 (1H, m, 7-
H), 11.95 (1H, s, OH); DHLA moiety C (100 MHz, CDCl3) 24.4 (CH2, C-4), 25.4 
(CH2, C-3), 29.1 (CH2, C-8), 31.0 (CH2, C-7), 33.5 (CH2, C-2), 35.5 (CH2, C-5), 41.8 
(CH, C-6), 178.2 (C, C-1); juglone moiety C 50.0 (CH2, C-2), 53.1 (C, C-3), 114.1 (C, 
C-4a), 117.7/117.8 (CH, C-8), 124.6/124.7 (CH, C-6), 133.6 (C, C-8a) 136.6/136.7 
(CH, C-7), 162.8/163.1 (C, C-5), 191.4 (C, C-1), 196.3/196.4 (C, C-4). 
 
 
General procedure for conjugation of 1,4-naphthoquinones with DHLA 
 
The reaction was performed as described for 11a,b. The reaction mixture was 
evaporated to dryness, and the residue obtained was dissolved in chloroform and 
fractionated by preparative TLC (eluant I) to afford 12-4 (reaction time: 12 and 14, 10 
min; 13, 60 min).  
 
 
5-(2H-3,4-dihydro-6,11-dioxonaphtho[2,3-b][1,4]dithiepin-2-yl)pentanoic acid (12) 
 
Compound 12 was obtained as a purple red oil (Rf 0.62, 48 mg, 44% yield, purity> 98%); 
UV (EtOH): max 236, 293, 514 nm (log  4.07, 4.25, 3.32); IR(CHCl3): max  3522,  
1710, 1659, 1592 cm
-1
; HR ESI+/MS: found m/z 363.0710 ([M+H]
+
), calcd for 
C18H19O4S2 m/z 363.0725; H (400 MHz, CDCl3) 1.51 (1H, m), 1.68 (5H, m), 1.91 (1H, 
m), 2.21 (1H, m), 2.36 (2H, t, J= 6.8 Hz), 2.95 (1H, m), 4.18 (1H, m), 4.34 (1H, m), 7.66 
(2H, m), 8.03 (2H, m); C (100 MHz, CDCl3) 24.3 (CH2), 26.3 (CH2), 29.8 (CH2), 33.6 
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(CH2), 33.7 (CH2), 34.7 (CH2), 45.3 (CH), 126.8 (CH), 126.9 (CH), 131.7 (C), 131.8 (C), 
133.7 (2 × CH), 144.2 (C), 144.4 (C), 178.8 (C), 180.2 (2 × C). 
 
 
5-(7-acetoxy-2H-3,4-dihydro-6,11-dioxonaphtho[3,2-b][1,4]dithiepin-2-
yl)pentanoic acid (13a) and 5-(7-acetoxy-2H-3,4-dihydro-6,11-dioxonaphtho[2,3-
b][1,4]dithiepin-4-yl)pentanoic acid (13b) 
 
Compound 3 was obtained as a purple red oil (Rf 0.79, 48 mg, 38% yield, purity> 95%); 
UV (EtOH): max 296, 520 nm (log  3.92, 2.97); IR(CHCl3): max  3527,  1769, 1712, 
1655, 1509 cm
-1
; HR ESI+/MS: found m/z 421.0793 ([M+H]
+
), calcd for C20H21O6S2 
m/z 421.0779; H (400 MHz, CDCl3) 1.49 (1H, m), 1.66 (5H, m), 1.89 (1H, m), 2.19 
(1H, m), 2.35 (2H, m), 2.42/2.43 (3H, s), 2.93 (1H, m), 4.13 (1H, m), 4.31 (1H, m), 7.29 
(1H, d, J= 8.0 Hz), 7.67 (1H, t, J= 8.0 Hz), 7.99/8.01 (1H, d, J= 8.0 Hz); C (100 MHz, 
CDCl3) 21.1 (CH3), 24.3 (CH2), 26.3 (CH2), 29.7/29.8 (CH2), 33.5 (2  CH2), 34.7 
(CH2), 45.2/45.3 (CH), 122.9/123.0 (C), 125.3/125.4 (CH), 129.5 (CH); 133.4/133.5 
(C), 134.6 (CH), 143.1/143.3 (C), 145.4/145.6 (C), 149.6 (C), 169.4/169.5 (C), 178.5 
(C), 178.6 (C), 179.4 (C). 
 
 
5-(2H-3,4-dihydro-7,10-dihydroxy-6,11-dioxonaphtho[2,3-b][1,4]dithiepin-2-
yl)pentanoic acid (14) 
 
Compound 14 was obtained as a purple red oil (Rf 0.67, 48 mg, 25% yield, purity> 
95%); UV (EtOH): max 284, 507, 548 nm (log  4.14, 3.91, 3.74); IR(CHCl3): max  
3690, 3601, 3503,  1713, 1597, 1456 cm
-1
; HR ESI+/MS: found m/z 395.0606 ([M+H]
+
), 
calcd for C18H19O6S2 m/z 395.0623;
 H (400 MHz, CDCl3) 1.52 (1H, m), 1.68 (5H, m), 
1.94 (1H, m), 2.21 (1H, m), 2.35 (2H, m), 2.97 (1H, m), 4.18 (1H, m), 4.37 (1H, m), 7.18 
(2H, s), 12.17 (1H, br s); C (100 MHz, CDCl3) 24.2 (CH2), 26.2 (CH2), 29.7 (CH2), 33.4 
(CH2), 33.6 (CH2), 34.7 (CH2), 45.4 (CH), 110.8 (2  C), 129.1 (2  CH), 144.5 (C), 
144.8 (C), 157.5(C), 157.6 (C), 178.9 (C), 183.1 (2  C). 
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Procedure for conjugation of menadione with DHLA 
 
To a solution of menadione (52 mg, 0.3 mmol) in absolute ethanol (6 mL) TEA (42 L, 
0.3 mmol) and DHLA (62 mg, 0.3 mmol), previously dissolved in ethanol (600 L), 
were added under vigorous stirring. After 2 h the mixture was evaporated to dryness, 
and the residue obtained was dissolved in CHCl3 and fractionated by preparative TLC 
(eluant I) to afford 15a (yellow oil, Rf 0.79, 26 mg, 16% yield, purity >98%) and 15b 
(light yellow oil, Rf 0.70, 23 mg, 20% yield, purity >95%). 
 
 
S,S’-bis(2-methyl-1,4-naphthoquinon-3-yl)-6,8-dithiooctanoic acid (15a) 
 
UV (EtOH): max 261, 319, 425 nm; IR(CHCl3): max 3522, 1702, 1663, 1593, 1465  
cm
-1
; HR ESI+/MS: found m/z 549.1432 ([M+H]
+
), calcd for C30H29O6S2 m/z 549.1425; 
H (400 MHz, CDCl3) 1.60 (2H, m), 1.63 (2H, m), 1.68 (2H, m), 1.92 (2H, m), 2.25 
(3H, s), 2.33 (3H, s), 2.37 (2H, m), 3.38 (2H, m), 4.07 (1H, m), 7.64 (4H, m), 7.96 (4H, 
m); C (100 MHz, CDCl3) 15.1 (CH3), 15.4 (CH3), 24.3 (CH2), 26.1 (CH2), 31.4 (CH2), 
33.4 (CH2), 35.2 (CH2), 38.9 (CH2), 47.1 (CH), 126.4 (CH), 126.5 (CH), 126.6 (CH), 
126.7 (CH), 133.2 (CH), 133.3 (CH), 133.5 (CH), 133.7 (CH), 131.8 (C), 132.7 (C), 
134.4 (2 × C), 146.4 (2 × C), 147.7 (2 × C), 178.0 (C), 181.0 (C), 181.1 (C), 181.8 (C), 
182.0 (C). 
 
 
5-(2’,3’-dihydro-spiro[1,3-dithiane-2,3’-[2]methyl[1,4]naphthoquinon-4-
yl])pentanoic acid (15b) 
 
UV (EtOH): max 253, 301 nm; IR(CHCl3): max  3523,  1697, 1593, 1459 cm
-1
; HR 
ESI+/MS: found m/z 379.1022 ([M+H]
+
), calcd for C19H23O4S2 m/z 379.1038; DHLA 
moiety H (400 MHz, CDCl3) 1.44 (2H, m, 3-H), 1.50 (2H, m, 5-H), 1.56 (1H, m, 7-H), 
1.58 (2H, m, 4-H), 2.14/2.18 (1H, m, 7-H), 2.30/2.35 (2H, m, 2-H), 2.77 (1H, m, 8-H), 
3.16/3.26 (1H, m, 8-H), 3.43 (1H, m, 6-H); menadione moiety H 1.48/1.51(3H, d, J= 
7.0 Hz, CH3), 3.35 (1H, m, 2-H), 7.71 (1H, m, 6-H), 7.75 (1H, m, 7-H), 7.96 (1H, d, J= 
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7.2 Hz, 8-H), 8.12 (1H, d, J= 7.2 Hz, 5-H); DHLA moiety C (100 MHz, CDCl3) 24.3 
(CH2, C-4), 25.4 (CH2, C-3) 28.2/29.1 (CH2, C-8), 31.5 (CH2, C-7), 33.6 (CH2, C-2), 
35.5/35.7 (CH2, C-5), 41.1/41.8 (CH, C-6), 178.7 (C, C-1); menadione moiety C 
12.8/13.4 (CH3), 53.0/53.6 (CH, C-2), 60.4/60.7 (C, C-3), 126.3/126.4 (CH, C-8), 
128.0/128.1 (CH, C-5), 132.2 (C, C-4a or C-8a), 132.4 (C, C-8a or C-4a), 134.0 (CH, C-
7), 134.4 (CH, C-6), 189.1 (C, C-4), 195.6/195.9 (C, C-1). 
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4.9. Synthesis and antioxidant activity of new conjugates of dietary polyphenols of 
plant origin with dihydrolipoic acid 
 
 
Preparation of trans-5-S-lipoylhydroxytyrosol  
 
A solution of tyrosol (150.0 mg, 1.09 mmol) in methanol (15 mL) was treated with IBX 
(462 mg, 1.65 mmol) under vigorous stirring at -25°C. After 1h a solution of DHLA 
(920 mg, 4.42 mmol) in methanol (15 mL) was added. After additional 15 min the 
reaction mixture was treated with a solution of Na2S2O5 (270 mL) and acidified with 
HCl 6 M to pH 1. Then the mixture was extracted with toluene (3  100 mL), 
chloroform (3  100 mL) and ethyl acetate (3×100 mL). Aqueous layer was periodically 
analyzed by HPLC (eluant: 0.5% TFA (solvent A), methanol (solvent B); 0-45 min 
from 5% to 90% solvent B; flow rate: 0.7 mL/min; UV: 280 nm). The combined 
chloroform layers were dried over sodium sulfate and taken to dryness to afford pure 
lipoyl-HTYR (117 mg, 30% yield) as an oily solid. 
5-S-lipoylhydroxytyrosol (lipoyl-HTYR)  
ESI+/MS: m/z 361 ([M+H]
+
), 383 ([M+Na]
+
); 
UV: max (CH3OH) 256, 291 nm; 
1
H NMR (CD3OD)  (ppm): 1.54 (m, 7H), 1.84 (m, 1H), 2.26 (t, J= 7.2 Hz, 2H), 2.65 (t, 
J= 7.2 Hz, 2H), 2.91 (m, 2H), 3.07 (m, 1H), 3.67 (t, J= 7.2 Hz, 2H), 6.62 (d, J=2.0 Hz, 
1H), 6.71 (d, J= 2.0 Hz, 1H). 
13
C NMR (CD3OD)  (ppm): 25.9 (CH2), 27.8 (CH2), 32.6 (CH2), 35.1 (CH2), 39.6 
(CH2), 39.7 (CH2), 39.8 (CH2), 40.3 (CH), 64.5 (CH2), 116.8 (CH), 121.7 (C), 125.5 
(CH), 132.0 (C), 144.9 (C), 146.4 (C), 178.0 (C).  
 
 
Preparation of 2-S-lipoylcaffeic acid  
 
A solution of coumaric acid (177.0 mg, 1.08 mmol) in methanol (15 mL) was treated 
with IBX (462 mg, 1.65 mmol) under vigorous stirring at room temperature. After 7 
min a solution of DHLA (920 mg, 4.42 mmol) in methanol (15 mL) was added. After 
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additional 15 min the reaction mixture was treated with a solution of Na2S2O5 (270 mL) 
and acidified with HCl 6 M to pH 1. Then the mixture was extracted with 
hexane/toluene 8:2 (10  200 mL), chloroform (7  200 mL) and ethyl acetate (3×100 
mL). Aqueous layer was periodically analyzed by HPLC (eluant: 0.5% TFA (solvent 
A), methanol (solvent B); 0-45 min from 5% to 90% solvent B; flow rate: 0.7 mL/min; 
UV: 280 nm). The combined chloroform layers were dried over sodium sulfate and 
taken to dryness to afford pure lipoyl-CA (182 mg, 44% yield) as an oily solid. 
2-S-lipoylcaffeic acid (lipoyl-CA) 
ESI+/MS: m/z 387 ([M+H]
+
), 409 ([M+Na]
+
); 
UV: max (CH3OH) 252, 320 nm; 
1
H NMR (CD3OD)  (ppm): 1.38 (m, 1H), 1.54 (m, 1H), 1.54 (m, 2H), 1.42(m, 1H), 
1.62 (m, 1H), 1.78 (m, 1H),e 1.81(m, 1H), 2.26 (m, 2H), 2.88 (m,1H), 2.90 (m, 1H), 
2.96 (m, 1H), 6.29 (d, J=16 Hz, 1H), 6.86 (d, J=8.4 Hz, 1H), 7.22 (d, 1H), 8.40 (d, J= 16 
Hz, 1H). 
13
C NMR (CD3OD)  (ppm): 25.4 (CH2), 27.3 (CH2), 34.1 (CH2), 34.1 (CH2), 39.4 
(CH2), 39.4 (CH2),  40.2 (CH), 117.2 (CH), 118.1 (CH), 119.9 (CH), 121.7 (C), 130.7 
(C), 144.2 (CH), 147.7 (C), 147.8 (C), 168.2 (C),  174.8 (C). 
 
 
Preparation of 5-S-lipoylpiceatannol  
 
A solution of resveratrol (87.0 mg, 0.38 mmol) in methanol (5 mL) was treated with 
IBX (266 mg, 0.95 mmol) under vigorous stirring at -25°C. After 20 min a solution of 
DHLA (316 mg, 1.52 mmol) in methanol (5 mL) was added. After additional 15 min 
the reaction mixture was treated with a solution of Na2S2O5 (90 mL) and acidified with 
HCl 6 M to pH 1. Then the mixture was extracted with hexane/toluene 7:3 (10  200 
mL), chloroform (4  200 mL) and ethyl acetate (3×100 mL). Aqueous layer was 
periodically analyzed by HPLC (eluant: 0.5% TFA (solvent A), methanol (solvent B); 
0-45 min from 5% to 90% solvent B; flow rate: 0.7 mL/min; UV: 280 nm). The 
combined chloroform layers were dried over sodium sulfate and taken to dryness to 
afford pure lipoyl-PIC (58.8 mg, 33% yield) as an oily solid. 
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5-S-lipoylpiceatannol (lipoyl-PIC) 
ESI+/MS: m/z 451 ([M+H]
+
), 473 ([M+Na]
+
); 
UV: max (CH3OH) 222, 268, 312, 325 nm; 
1
H NMR (CD3OD)  (ppm): 1.42 (m, 1H), 1.73 (m, 1H), 1.54 (m, 2H ), 1.54 (m, 2H), 
1.91 (m, 1H), 2.01 (m, 1H), 2.26 (m, 2H), 2.95 (m, 1H), 2.97 (m, 1H), 3.08 (m, 1H), 
6.23 (d, J =1.6 Hz, 1H), 6.50 (d, J= 1.6 Hz, 2H), 6.83 (d, J=16.3 Hz, 1H), 6.91 (d, 
J=16.3 Hz , 1H), 7.00 (d, J=1.7 Hz, 1H), 7.07 (d, J=1.7 Hz, 1H). 
13
C NMR (CD3OD)  (ppm): 25.3 (CH2), 27.3 (CH2), 31.9 (CH2), 34.1 (CH2),  39.3 
(CH2), 39.4 (CH2),  40.3 (CH), 102.8 (CH), 105.8 (CH), 113.1 (CH), 122.1 (C), 123 
(CH), 127.7 (CH), 128.8 (CH), 130.6 (C), 140.6 (C), 145.8 (C), 145.9 (C), 159.5 (C), 
174.9 (C). 
 
 
DPPH assay 
 
To a freshly prepared 0.2 mM solution of  DPPH in methanol compounds under exam 
(50 M solution in methanol) were added separately. Spectra were recorded at 25°C 
every 0.5 s over 1-2 min for the determination of rate constants and stoichiometries. 
Kinetic runs over 20 min were used for the determination of total stoichiometries (see 
text for details). Tested compounds were HTYR, lipoyl-HTYR, CA, lipoyl-CA, PIC, 
lipoyl-PIC and DHLA (DHLA used at 25M concentration). The reported values 
represent the media ± SD obtained by three separate experiments. 
 
 
Aerial oxidation of lipoylconjugates and parent catechols 
 
A solution of HTYR (5 mol) and lipoyl-HTYR (5 mol) in phosphate buffer 0.1 M 
(pH 7.4, 10 mL) was allowed to stand at room temperature under vigorous stirring. 
Aliquots of the reaction mixture was periodically withdrawn and analyzed by HPLC-
RP/UV (eluant: 0.5% TFA (solvent A), methanol (solvent B); 0-45 min from 5% to 
90% solvent B; flow rate: 0.7 mL/min; UV: 280 nm).. 
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The experiment was repeated in the same conditions on the couple CA/lipoyl-CA and 
PIC/lipoyl-PIC. 
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